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Chemical labelling of antibodies, to
enable the site of antigen-antibody reactions to
be visualised, was introduced by Mar rack (1934-)
who used a visible dye attached to the antibody
by an azo linkage. Two other types of label have
been introduced, namely, fluorochromes and radio¬
isotopes. Coons et al (199-1) used an anthracene
derivative conjugated to antipneumococcal serum,
|but found that the blue colour emitted after excit-
sation by ultra-violet light was distinguishable
only with difficulty from the natural blue
autofluorescence of most animal tissues (Hamperl,
193*+; Sjostrand, 199-5-6). They found subsequently
(Coons et al., 199-2) that fluorescein isocyanate
could be conjugated to antibody protein and that
I its brilliant apple-green fluorescence was readily
'
identifiable in the tissues. This method - the
fluorescent antibody technique - permits very
.
I accurate histological localisation by the naked eye
but cannot be used for quantitative studies.
Essentially it involves performing a precipitin
test on tissue sections with the fluorochrome-
j
labelled antibody and examining the sections in
the fluorescence microscope. The labelling of
antibodies/
antibodies with radio-isotopes, introduced by-
Pressman & Keighley (194-8), has the advantage of
greater sensitivity than either of the other types i
of label, thus enabling accurate quantitative
work. However, the tissues cannot be examined
with the naked eye and the definition of auto-
t
:radiographs is as yet inferior to that obtainable
with antibodies labelled with fluorescein. The
use of labelled antibodies to detect sites of
antigen-antibody reactions in the tissues is a
form of histochemistry - immunohistochemistry -
which is being applied to a rapidly expanding field
It provides a method by which proteins and other
antigens, distinguishable with difficulty, or not
at all, by other methods, can be specifically
differentiated from each other. The main applica¬
tions of the fluorescent antibody technique have
been the fate of foreign antigens injected into
experimental animals, the identification of
viruses and bacterial products in the tissues, the
identification of sites of antibody formation and
the localisation of normal tissue components.
The main purpose of this thesis is to des¬
cribe experiments in the last-named group, in parti¬
cular the localisation of connective tissue and kidney
components in man. There have been remarkably
few/
few immunological studies of normal human tissues,
so it was necessary to apply the method to such
tissues before using it for studies on pathological
material. The two largest sections of the thesis !
; are derived from a study of antigenic components
of rat kidney (Hill & Cruickshank, 1953)' Section
II describes studies on several normal connective I
! tissue components, namely basement membrane,
reticulin, collagen and chondroitin sulphate,
and Section III describes studies of the antigenic-
;ity of normal human and monkey kidney and the
| application of the fluorescent antibody technique
| and other immunological methods to an investigation
I
of acute glomerulonephritis and anaphylactoid
purpura for auto-antibodies to normal kidney and
blood vessel components. Section IV - an attempt
to produce specific antibodies to several human
anterior pituitary hormones - is not connected
with the rest of the work other than by the
methods used. It is included because it illus-
strates some of the difficulties involved in
immunological and immunohistochemical studies of
tissue antigens. The thesis ends with a general
discussion of the work and suggestions for further
work (Section V).




with the fluorescent antibody technique entails
a complicated series of procedures, namely:
a) preparation of a tissue, or extract therefrom,
for
b) immunisation of animals;
c) analysis of the immune serum to identify
antibodies and remove those not required;
d) preparation and attachment of the fluorescent!
label;
e) preparation of tissue sections for
f) treatment with the labelled antiserum, or
its globulin fraction;
g) establishment of the specificity of the
reaction in the tissues;
h) examination of sections in the fluorescence
microscope;
i) identification of the site of staining3* with
histological or histochemical methods.
The technical procedures and animal
protocols for the present work will be described
separately from the main text, in the Appendix.
The procedure for establishment of specificity of
staining will be found on pp.8 - 11.
"Staining" is not a strictly accurate term for
a procedure which results in the appearance in
sections of an antigen-antibody precipitate
identifiable in ultra-violet light by virtue
of a fluorochrome attached to the antibody. However,
it is a convenient and short way of describing both
the procedure and the presence of specific fluor¬
escence in treated tissues and is accepted in
the literature. It will be used throughout this
thesis in this as well as its more usual sense.
SECTION II.
IMMUNOLOGICAL AND IMi>lUN0HI3T0CHEMICAL
STUDIES ON CONNECTIVE TISSUES
5.
BASEMENT MEMBRA.HE MP RETICULUM
Since the experiments of Pearce
(1903-04-) evidence has been gradually accumula¬
ting that renal cortex contains an antigenic
component capable of provoking, in another
species, antibodies which will react with
vascular tissue in the original species. During
the last decade attempts have been made to
identify the tissue component which is responsible.!
Heymann & Lund (194-8) confirmed Pearce's observa¬
tion that the cortex contains more of this
component than the medulla, and Solomon et al.
(194.9) discovered that isolated glomeruli
could effectively absorb the antibody from anti-
ikidney serum. The antibody content of such a
serum can be demonstrated in vivo by its
nephrotoxicity, that is the production of a
form of nephritis which in many ways resembles
human glomerulonephritis. Greenspon & Krakower
(195'0) discovered that isolated glomeruli were
able to produce a potent nephrotoxic serum,
whereas other components of the renal cortex
were ineffective. These workers (Krakower &
Greenspon, 1951) subsequently immunised animals
with various components of glomeruli, separated
by ultrasonic vibration, and concluded that
the/
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the basement membrane of the tufts accounted
for most of the antigenic activity of whole
glomeruli. Further information on the source
of the antigen was obtained by Pressman et al.
(194-9)5 who injected anti-mouse-kidney globulin
131
labelled with i into living mice and found
a high concentration of radioactivity in the
glomeruli.
There is evidence that one, or more,
of the antigens in the glomerulus is present in
other tissues. Thus anti-lung (Chikarnitsu,
194-0), anti-placenta (Seegal & Loeb, 194-6) and
anti-aorta (Strehler, 1951) sera have proved to
be nephrotoxic, and Pressman and his colleagues
have shown that ^"^^I-labelled antisera to rat
lung (Pressman & Sisen, 1956a)5 rat liver blood
vessels (Pressman et al.,1951) and rat aorta
(Pressman et al., 1952) all localise in kidney,
lung and liver.
Hill & Cruickshank (1953) applied the
fluorescent antibody method, to this problem
and were able to demonstrate two separate
antigens in the rat kidney - one in glomerular
basement membrane, the other in the epithelium
of the convoluted tubules - and that anti-rat-
lung serum contained an antibody to the basement
membrane/
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membrane antigen. This section of the thesis
describes the extension of that work to studies
on basement membrane and reticulin in many
tissues of the rat and, later, man.
BASEMENT MEMBRANE AND RETICULIN IN THE RAT
METHODS
Antisera were prepared in rabbits by
immunisation with suspensions of perfused whole
rat kidney (Rabbits 4-2-4-4-), isolated rat glomeruli
(Rabbit 4-7)? perfused rat lung (Rabbit 4-6), and
alum-precipitated rat serum (Rabbit 4-9). The
details of preparation of the antigens, immunisa-
:tion of the rabbits and titration of the
antisera are described in the Appendix (pp. 186,191-2,
198).
Immunisation with the organ extracts was
continued until the antisera gave a strong
precipitin reaction with a saline extract of the
relevant organ. Cross-reactions between the
anti-organ sera and rat serum and erythrocytes
were eliminated by appropriate absorptions (see
Appendix, p. 199 )• Sera, or their globulin
fractions, were conjugated with fluorescein
isocyanate by the method of Coons & Kaplan (1950)
(see Appendix, p. 201 ). Fresh-frozen tissues
were/
! were used throughout the work and were obtained
from adult rats killed by ether. The method of
preparing, treating and examination of the tissues
was essentially similar to that used by Coons
and his collaborators (see Appendix, p. 202 ).
Specific staining due to fixation of
fluorescent antibody by its homologous tissue
antigen was seen as bright green fluorescence.
Tissues in which no reaction had occurred were
visible because of their autofluorescence, which
varied from dull blue in most tissues to bright
bluish-white in elastic tissue. Ceroid,
particularly in the liver and kidney, could
be identified by its yellow autofluorescence.
The specificity of the green fluorescence
was tested in several ways (Table I). It was
necessary to establish that the staining was
dependent upon a factor (antibody) present in
the immune sera, but not in normal rabbit serum,
and that this factor was active in the absence
of the fluorescein label. This was accomplished
by an inhibition test. Sections were exposed
to unlabelled antiserum and to normal rabbit
serum respectively for 3 hours, and thereafter
treatment of both sections for 1-lg- hours with
fluorescent globulin prepared from an antiserum.
Fluorescent/
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J Fluorescent staining failed to develop in the
first of these sections, indicating that the
reactive groups of the antigen had been specifi¬
cally bound by the unlabelled antibody, but
; appeared as usual in the second. As a further
check on the absence of the specific antibody
i from the serum of a non-immunised rabbit, a third
section was treated with a conjugate prepared
from such a serum and was found to show no staining.
Absorption tests were also used to prove
the specificity of the staining. Thus 3 parts
of labelled anti-rat-glomerulus serum and 1 part
of a wet, packed suspension of rat kidney were
mixed and allovTed to stand for 1 hour at room
temperature. The preparation was spun and the
process repeated. No staining occurred when
this absorbed, labelled serum was applied to
sections. Similar results were obtained when
the serum was absorbed with rat lung or rat
spleen. Absorption with heterologous (pig)
kidney had no effect upon staining.
The full battery of tests for specificity
was carried out only with sections of kidney,
skin, trachea, thyroid and lung. With other
tissues, staining was regarded as specific if it
appeared only in the first and last of four
sections treated with:-
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a) fluorescent immune rabbit globulin,
b) fluorescent normal (non-immune) rabbit
globulin,
c) unlabelled immune globulin, followed
by fluorescent immune globulin
(specific inhibition), and
d) unlabelled normal rabbit globulin
followed by fluorescent immune globulin.
The species specificity of the reaction
was investigated by applying fluorescent anti-
rat-kidney serum to sections of mouse, guinea-
pig, rabbit, monkey and human kidney. Staining
was produced, in the mouse similar to that in
the rat, whereas no reaction occurred in the
other species. An immunological cross-reaction
between rat and mouse kidney has been noted
previously (Pressman, 194-9).
The following rat tissues were treated
with anti-rat-kidney (AK), anti-rat-glomerulus
(AG) or anti-rat-lung (AL) globulins:- heart
(AIC), femoral artery (AK, AG), trachea (AK,AG,
AL), lung (AK,AG,AL), tongue (AK,AG), submand¬
ibular gland (AK), oesophagus (AK), stomach
(AK), small intestine (AK), colon (AK), liver
(AK), pancreas (AK), kidney (AK,AG,AL), bladder
(AK), testis (AK), ovary (AK), uterus (AK),
uterine tube (AK), placenta (AIC), breast (AK,AX),
spleen (AK,AL), lymph node (AK,AG,AL), thymus(AK),
pituitary (AIC), adrenal (AK,AG), thyroid (AIC, AG,AL),
parathyroid/
parathyroid (AG), brain (AE,AG), peripheral
nerve (AK,AG), skin (AK,AG,AL), skeletal muscle
(AK,AG), tendon (AK,AG), lacrimal gland (AK).
Many of these tissues were treated with two
separate antisera to rat kidney, with identical
results.
The pattern of staining obtained with
the fluorescent sera was compared with that of
adjacent sections stained with haematoixylin and
eosin or the periodic acid-Schiff technique
(McManus, 19^+6), counterstained with haematoxylin.
It was sometimes impossible to obtain satisfactory
restilts with the periodic acid-Schiff technique
on fresh-frozen sections and even haematoxylin
and eosin staining was difficult to interpret
accurately. For this reason, identification
of structures in serial sections was not always
possible and some of the conclusions,particularly
regarding sites of non-specific staining, are
tentative. Much more satisfactory results
with histological and histocheinical procedures
were obtained in later work (see p. 1M-9 ).
RESULTS
The pattern of specific fluorescent
staining obtained with the sera prepared against
rat kidney, rat glomeruli and rat lung was,
except/
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except for the kidney, the same in all the tissues
studied. In the kidney, the anti-glomerulus
and anti-lung globulin produced identical
staining of basement membranes and reticulin,
whereas the anti-kidney globulin also stained
the cytoplasm of the cortical tubular epithelium.
This peculiarity of the anti-kidney globulin is
not relevant to the present discussion and will
not be considered further. No specific staining
occurred in the cells of other tissues and
staining of nuclei was not observed. These
results have been described by Cruickshank &
Hill (1953a).
Basement Membrane
Fluorescent staining of basement
membrane occurred in the trachea (flg.l), intra-
pulmonary branches of the bronchial tree, tongue,
submandibular gland (Fig.2), oesophagus, stomach,
small intestine, colon (Fig.3), intrahepatic
bile ducts, kidney (Figs.H-6), bladder (Fig.7)?
testis, ovary, Fallopian tube, uterus (Fig.8),
breast (Fig.9), skin (Fig.10), thyroid (Figs.11-
13) and lacrimal gland.
The membrane varied in thickness in the
different organs, being thinnest beneath
squamous epithelium (Fig.10) and thickest in the
uterus (Fig.8). In most situations only a
single/
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Figs. 1-4-0 and ^-8 are photomicrographs
of tissues treated with fluorescein-labelled immune
globulins. The general structure of each tissue
is seen by virtue of its dull blue auto-fluorescence.
White lines and masses are due either to specific
I apple-green fluorescence at sites of antigen-
antibody union, or to the bright bluish-white
: auto-fluorescence of elastic tissue.
AK - anti-kidney: AG - anti-glomeruli: AL - anti-
lung.
Fig.l. Rat trachea. The basement
membrane is seen as an almost complete
line deep to the columnar epithelium.
The bright fragments beneath it are
elastic tissue. In the lamina propria
specific staining is seen in the basement
membrane of a gland (centre right) and in
the reticulin of capillaries. AK (x 300)-
Fig.2. Rat submandibular gland.
Basement membrane is seen around acini
and a duct. AK (x 300).
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Fig.3. Rat colon. Basement membrane
beneath epithelium and reticulin in
capillaries of the villi. AK (x 300).
Fig.if. Rat kidney. Basement membrane of
glomeruli and convoluted tubules is
stained. AG (x 50).
Fig.5. Rat glomerulus. The basement membrane
of the tuft, of Bowman's capsule and of
convoluted tubules is seen as a single line.
Epithelial cells in the glomerulus and
tubules are also stained specifically as the
section was treated with anti-kidney globulin,
(x 385).
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Fig.6. Rat kidney. Basement membrane
of convoluted tubules and reticulin of
capillaries are seen. AG (x 250).
Fig.7. Rat bladder. Subepithelial basement
membrane and capillary reticulin are stained.
AK (x 250).
Fig.8. Rat uterus. Thick subepithelial
basement membrane. AK (x 500).
17.
Fig.9- Rat breast, shortly before
parturition. Note the splitting of the
acinar basement membrane to enclose
unstained nuclei. AK (x 250).
Fig.10. Rat skin. A basement membrane
is seen beneath the epidermis and around
a sweat gland (bottom right). Capillary
reticulin stains brightly. AK (x 250).
18.
Fig. 11. Rat thyroid-. A complete basement
membrane surrounds the acini and splits
occasionally to enclose unstained nuclei.
AK. (x 250).
Fig.12. Rat thyroid. The splitting of the
acinar basement membrane is seen even better
here. AK (x 365)..
Fig.13. Rat thyroid. Appearance similar to
Figs. 11 & 12, but obtained with anti-lung
globulin. (x 520).
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single layer could be demonstrated, but this
layer occasionally split to enclose an unstained
space. This feature was noted in the thyroid
(Fig.12) and in the breast (Fig.9), where, in
haematoxylin and eosin-stained sections, the
space appeared to contain nuclei, smaller and
more hyperchromatic than those of the acini,
spindle-shaped or oval and arranged tangentially
to the acini. In the seminiferous tubules of
the testis and in the ducts of the breast, the
basement membrane had two layers. In the
trachea, alimentary canal, uterus and skin, a
membrane was present not only beneath the lining
epithelium but also around the glands and ducts
in the underlying tissue (Fig.l). In exocrine
glands, it was seen around both acini and ducts
(Fig.2). There was considerable variation in
the appearance of the glandular basement membrane
in the alimentary canal. Thus, the membrane
was distinct in the necks of the glands of the
gastric mucosa., but could be seen only with
difficulty in their deeper parts. In the small
intestine the membrane was more easily seen in
the crypts than in the villi; in the colon it
was easily seen throughout the mucous membrane.
In the bladder (Fig.7), the membrane was single
in some places and double elsewhere. The
basement/
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basement membrane of the ovarian follicles was
distinct, but none was seen in the zona pelluc-
;ida of the ova. However, the integrity of the
ova was poorly preserved, since, in adjacent
'
.
1 quick-frozen, unfixed sections stained with
haematoxylin and eosin, they were seen only
indistinctly. In the kidney, no more than a
single membrane was detected in the glomerular
tufts lying between the unstained endothelium
and the faintly stained epithelium (Fig.5). The
basement membrane of Bowman's capsule was also
stained, but was thinner than those of the tuft
or the tubules. All cortical tubules had a
well-defined basement membrane (Tig.6), but in
the medulla this was faint and irregular so that
it was impossible to identify the type of
medullary tubule around which staining occurred.
Completely satisfactory sections of
lung could not be obtained, partly on account of
the difficulty of cutting quick-frozen unfixed
sections of this tissue and also because
collapse of the organ made the interpretation of
the staining of fine structures difficult. So
far as could be seen, no alveolar basement membrane
was present and staining in the alveolar walls
occurred/
21-
occurred only in the retieulin of the capillaries
(Fig.l^f). The basement membrane of small intra-
:pulmonary branches of the bronchial tree was
finer than in the larger extrapulmonary branches
and lay close to a more or less complete lamina
of elastic tissue. It was thus not always easy
to; differentiate these two layers.
Reticulin
A reticular network was demonstrated
in the spleen (Figs.15 & 16), lymph nodes and
thymus, in the walls of capillaries (Figs.1,2,
7,10,12 & 16), brain, arterioles (Fig.15) and
sinusoids (Figs.17 & 18), and around plain muscle
fibres in all situations where that tissue was
observed (Fig.19). In the spleen (Figs.15 & 16),
lymph nodes and thymus a fine network outlined
the individual cells, both in the pulp and
in the lymphoid follicles. Sinuses in the lymph
nodes were outlined by a definite membrane, which
was sometimes double. No such membrane was
seen in the splenic sinuses, but the reticulum
cells of both lymph node and splenic sinuses
| were outlined in the same way as cells in the pulp.
]
Capillaries in all tissues were outlined
by a single fluorescent reticular membrane. The
j
internal elastic lamina of arterioles was
surrounded by one or more concentric laminae of
reticulin/
22.
Fig.14-. Rat lung. No basement membrane is
seen beneath the alveolar epithelium,
staining being confined to the capillary
reticulin. AK (x 300),
Fig.15. Rat spleen. Longitudinal section
of an arteriole showing reticulin around the
muscle fibres of the media, outside the
continuous elastic lamina. AK (x 250).
Fig.16. Rat spleen. Two arterioles in cross
section in a Malpighian corpuscle with several
concentric reticulin laminae around the elastic
lamina. The reticulin of the corpuscle is seen
as a fine pericellular network. (x 250).
23.
Fig.17- Rat pituitary. Bright staining of
reticulin of sinusoids in pars anterior,
pars intermedia and pars posterior (from
left to right). ML (x 50).
Fig.18. Rat adrenal. Rather faint reticulin
in sinusoids in cortex (above) and brighter
reticulin around clumps of cells and sinusoids
in medulla (below). AG (x 250).
Fig.19. Rat femoral artery. The internal elastic
lamina is distinctly seen as a serpiginous line,
the external elastic lamina less distinctly as the
outermost fluorescent layer. Between the two, the
muscle fibres of the media are outlined by a
brightly stained network of reticulin fibres.
AK (x 265).
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reticulin (Fig.l6), whilst the plain muscle
fibres of the media of larger vessels were out-
:lined by a network limited by the two elastic
laminae (Fig.19). Sinusoids in the pituitary
(Fig.17) and adrenal (Fig.18) were limited by a
distinct membrane, but, in the liver, this was
clearly seen only in the neighbourhood of
portal tracts or central veins. Capillaries and
other vessels in several organs were separated
from the parenchyma by strands of reticulum, as
in the parathyroid and thymus glands. In the
placenta, a very delicate reticular network
surrounded capillaries in the labyrinth, whereas
a much coarser membrane covered the outer surface
and outlined the septa which dip into the labyr-
sinth. No specific staining was seen in the
decidua.
Plain muscle was readily recognisable
by the reticular network which surrounded its
fibres. This was seen in larger vessels, as noted
above, and in the trachea, oesophagus, muscularis
mucosae and muscular layers of the stomach and
intestines, bladder and uterus and in the trabec-
sulae of the spleen. Reticulin was also
demonstrated between the cells of adipose tissue
(Fig.20), in the serous coat of the alimentary
canal/
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canal, in the leptomeninges and in the adrenal
capsule.
Other Connective-tissue Components
The sapoolemma of striated (Fig.21) and
cardiac muscle was readily demonstrated and could
be distinguished from reticulin in the walls of
the capillaries. The pattern of staining in
peripheral nerves is seen in Fig.22. The nerve
bundles are surrounded by several fine concentric
laminae and the individual fibres by a single
layer lying outside the myelin sheath. No
staining was seen in other connective-tissue
j elements, such as collagen fibres, elastic fibres,
i cartilage matrix, or ground substance, although
these were encountered in many situations.
Unstained collagen, which was readily differentiated
from the specific green staining of basement membrane
reticulin by its blue autofluorescence, was seen
in the trachea, tongue, oesophagus, stomach,
intestines, skin (Fig.10), ovary, uterus, capsule
of spleen, adventitia of vessels (Fig.19) and
tendon (Fig.21).
Miscellaneous investigations
Accurate chemical identification of the
antigen was not attempted. The absence of a
reaction/
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Fig. 2.0. Rat breast. Fat cells (centre) are
surrounded by reticulin fibres. (x 50).
Fig.21. Rat skeletal muscle and tendon. The sarco-
:plasm is unstained but the sarcolemma of each
fibre is clearly seen. The collagen of the tendon
is unstained, but is 'pervaded by irregular fine






Fig.22. Rat nerve. The nerve fibres are recognisable
by the faint dark blue autofluorescence of the
myelin sheath, outside which is the specific staining
of the neurilemma. The whole nerve is also surroun¬
ded by specifically stained fibres.
AK (x 350).
2-7.
| reaction in the matrix of' tracheal cartilage
.
I suggested that it was not chondroitin sulphuric
; acid-A (Meyer, 1951). In order to determine
whether hyaluronic acid was concerned, a section
: of rat kidney was treated with hyaluronidase
j (Benger's Eyalase), 1000 units per ml. of phos-
:phate buffer, at pH 7«b for 23 hours at room
temperature before staining with fluorescent
anti-rat-kidney rabbit globulin. The pattern
of staining was not altered by the enzyme treat-
:ment. The activity of the enzyme preparation
| was confirmed by the mucin-clot-prevention test
|
with human synovial fluid (Warren & Durso, 1951).
Hon-spec1fic 31aining
The green fluorescence described so far'
was all due to specific precipitation of labelled j
antibody. Precipitated fluorescein was also seen
in sites where it did not fulfil the criteria for
| specificity. It was seen in the cytoplasm of
large "plasma cells" which were most numerous in
the interstitial tissue of the tongue and were
present in small numbers in the interstitial
tissue of the bladder, uterus, breast, thyroid,




They were also seen in some lymph nodes. These
cells were considerably larger than human
plasma cells, measuring 120/*- x 90/^ , but had
the same cytoplasmic and nuclear appearances in
sections stained with haematoxylin and eosin
as human plasma cells. Similar staining was
seen in the cytoplasm of cells, which were probably
eosinophils, in the mucous membrane of the
stomach, small intestine and colon and in the
spleen and lymph nodes. Non-specific staining
of this pattern has been described by other
workers since this study was completed and can
be eliminated by absorbing the labelled antiserum
with acetone-dried bone marrow powder (Sheldon,
1953; Coons et al., 1955). Other sites of non¬
specific staining encountered in the present work
were the cytoplasm of tracheal and bronchial
epithelium (Fig.l) and a membrane lining the
lacunae of tracheal chondrocytes. No attempt
has been made to study any of this non-specific
staining in detail.
Discussion of these results will be
deferred until similar experiments with human
tissue have been described (see p. 5-1 ) .
29.
BASEMENT MEMBRANE AND RETICULIN IN HAN
The results of the study of these tissue
components in the rat indicated that the fluores-
scent antibody method was applicable to studies
of normal connective tissue antigens and that a
histochemical method of immunological specificity
was available. It was therefore decided to
repeat the observations in human tissue for
several reasons
a) the method might be applicable in
diseased as well as healthy tissues,
b) the specificity and brilliance of
staining suggested that information
might be obtained which was not possible
with other staining methods, and
c) it was desirable to get more infor¬
mation about the nature of the
antigen. If human postmortem
tissues were antigenic, material for
chemical and other analyses would be
available in much greater quantity
than if rats were used.
METHODS
Antisera were prepared in rabbits by
immunisation with a suspension of human glomeruli
isolated from kidneys obtained at autopsy (Rabbits
^8 & 52) and with alum-precipitated human serum
(Rabbit 5D. The procedures used in preparation
of antigens, immunisation of rabbits, labelling
of sera, preparation, staining and examination
of tissues were similar to those in the preceding
section/
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section of this thesis. Most of the tissues
examined were obtained at autopsy, within 24-
hour s of death; occasionally, tissue was
obtained at biopsy, e.g. thyroid, synovial tissue.
Minor modifications of the technique and protocols
of immunisation are given in the Appendix. Non¬
specific staining was eliminated by absorption
with acetone-dried sheep muscle or guinea-pig
liver powder. Specificity of staining was
demonstrated by the method described previously
(pp. 8-11). Thus, pre-treatment with unlabelled
anti-human-glomerulus serum inhibited staining,
whereas normal rabbit serum had no such effect.
Absorption of the labelled antiserum with human
kidney, glomeruli or spleen removed the antibody,
whereas absorption with rat kidney had no such
effect. Species-specificity was investigated
as described on p. 11 ; no cross-reaction
occurred except with monkey kidney. An antiserum
prepared to whole monkey kidney gave a strong
cross-reaction with human kidney (see Section III,
PP. 136 - 137 )•
The following human tissues were treated
with anti-human-glomerulus globulin:- heart,
mesenteric artery, trachea, lung, submandibular
gland, oesophagus, stomach, liver, pancreas,
kidney, bladder, uterus, uterine tube, placenta,
umbilical/
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umbilical cord, spleen, lymph node, pituitary,
adrenal, thyroid (normal and thyrotoxic),
peripheral nerve, skin, skeletal muscle, synovial
membrane and intra-articular meniscus.
RESULTS
The pattern of staining obtained with
the anti-human-glomerulus globulin in human
tissues was essentially similar to that described
in the preceding Section, but was much brighter
in all tissues examined. A brief report of
these results has been presented at a Faraday
Society Discussion (Cruickshank & Hill, 1953b).
Basement Membrane
Staining of basement membrane was
observed in the trachea, submandibular gland
(Fig.23), oesophagus, stomach (Fig.2*0, pancreas
(Fig.25)5 kidney (Fig.26), bladder, uterus, uterin
tube (Fig.27), thyroid (Figs.28-30) and skin.
Variation in thickness was again seen in different
organs, a very thick membrane being seen around
mucous glands at the lower end. of the oesophagus
and in the uterine tube (Fig.27). Splitting of
the membrane to enclose nuclei, such as was seen
in the rat thyroid and breast, was noted in the
human thyroid but was less marked than in the rat
(compare/
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Fig.23. Human submandibular gland. Basement mem-
rbrane around acini and a duct and capillary
reticulin are seen. AG (x 325)•
Fig.2Li-. Human stomach (body). A very distinct
basement membrane is seen around glands in the
mucous membrane. AG (x 325) •
Fig.25'. Human pancreas. Acini are surrounded by a
basement membrane,and an islet (centre right) is
surrounded by a fine reticulin membrane. Reticulin
is also seen in a collapsed capillary in the islet.
AG (x 325).
33.
Fig.26. Human glomerulus. The basement membrane
of the tuft is very clearly seen, that of
Bowman's capsule and convoluted tubules less
distinctly. AG (x 5-20).
Fig.27. Human fallopian tube. A very thick
subepithelial basement membrane is seen.
Capillary reticulin is visible in the stroma
of the villi, in which there is some non-specific
background staining. AG (x 250).
4
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Fig.28. Human thyroid (normal). A fine membrane
surrounds the acini and fine strands are also
seen between the acini. Differentiation of basement
| membrane and reticulin is not completely clear in
this figure. AK (x 325)•
Fig.29. Human thyroid (thyrotoxicosis). Very
extensive specific staining is seen in periacinar
I basement membrane and capillary reticulin.
| AG (x 50).
Fig.30. Detail of Fig.29. The very fine periacina
basement membrane is clearly seen. AG (x 325)•
35.
(compare Figs. 28 & 12). Reduplication of the
J membrane, such as was seen in the rat bladder
was not present in the human bladder, but was
| seen in the oesophagus, both under the surface
epithelium and around glands in the lamina propria.
In the latter situation three or four layers were
sometimes seen. Although the membrane in the
uterine tube was as thick as that in the oesophagus
no reduplication was seen.
In the lung, where difficulty in prep¬
aration of sections was again encountered,
the appearances suggested that both basement
membrane and capillary reticulin in the alveolar
walls were stained (Fig.31).
[ Reticulin
Reticulin was studied in the spleen
(Figs.32,33)? lymph nodes, liver (Fig.34), pit-
tuitary, adrenal (Fig.35), synovial tissue
(Fig.36), capillaries in all tissues, including
the placenta (Fig.37) and around plain muscle
fibres in the oesophagus, stomach, bladder (Fig.
38) and umbilical cord (Fig.39).
In the spleen a membrane was seen around
cells both in the corpuscles and in the pulp
(Figs.32 & 33); sinusoids in the latter were
clearly/
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Fig.31. Human lung. There is a suggestion of a
basement membrane as well as capillary reticulin.
(This was more clearly seen under the microscope
for the section is much thicker than the others.
The large amount of elastic tissue in the septa
also makes this figure difficult to interpret).
AG (x 200).
;
Fig.32. Human spleen. A Malpighian corpuscle show)
sing pericellular reticulin. Specifically stained
reticulin laminae are also present in the arteriole
but are not clearly distinguishable from the
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Fig.33« Hunan spleen. Reticulin surrounds sinus-
■ soids and cells in the red pulp. AG (x 480).
37.
Fig.3^. Human liver. Specific staining is
present only in the reticulin of the sinusoids.
The white globules are ceroid, distinguishable by
its bright yellow autofluorescence. (x 325).
Fig.35'. Human adrenal. Fine reticulin fibres
surround cell columns and outline sinusoids in the
cortex. There is some non-specific staining of
cell cytoplasm (as in the rat, Fig.18). Auto¬
fluorescence of collagen in the capsule was
particularly bright, but no specific green stainin
was seen there. AG (x 325).
38 =
Fig.36= Human synovial tissue. Specific staining
is seen in pericellular reticulin fibres and in the
walls of capillaries. Bright autofluorescence
in collagen beneath the surface. AG (x 250).
Fig.37. Human placenta. Very bright specific
staining of capillary reticulin in two villi.
AG (x M-80).
Fig.38. Human bladder. Cross-section of muscle
coat showing very bright reticulin around individ¬
ual muscle fibres. AG (x M-00).
39.
Fig.39. Human ■umbilical cord. A thick reticulin
fibre surrounds muscle fibres in the umbilical
artery. AG (x 650).
Fig.4-0. Human skeletal muscle. Specific staining
is seen in the fine sarcolemmal sheath and in
capillary reticulin between the muscle fibres.
AG' (X k80).
4-0 •
clearly outlined (Fig.33). Sinusoids in the
pituitary and adrenal were also outlined, as in
the rat. Sinusoids in the liver were outlined
by a thick membrane (Fig.3^)? a situation where
it had been difficult to obtain staining in the
rat. In synovial tissue a bright membrane surr-
:ounded the synovial cells and reticulin in vessel
was also stained; no other staining was seen
(Fig.36). Staining in capillaries and larger
vessels was of the same distribution as in the rat
a particularly fine result being obtained in
placental villi (Fig.37). Reticulin around plain
muscle fibres was seen as in the rat. A distinct
membrane was observed beneath the mural and
valvular endocardium.
Other Connective Tissue Components
Staining of the sarcolernma of striated
muscle (Fig.M-0) and cardiac muscle and of neuri¬
lemma was similar to that in the rat. Once
again no staining was seen in collagen fibres,
elastic fibres, cartilage matrix, or ground
substance. The contrast between the green staining
of reticulin and the blue autofluorescence of
collagen was more striking than in the rat,because
of the greater brilliance of the fluorescein-
staining in human tissues. Fig.36 shows the
appearance/
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appearance of specific staining around synovial
cells and its absence in the fibrocartilage of
the underlying meniscus.
DISCUSSION
Before discussing the main features of
these results, it is necessary to define clearly
the terms basement membrane, reticulin and
^ collagen as used here. Basement membrane is
the fine, argyrophilic structure found around
I all glandular structures and at other boundaries
between epithelium and connective tissue. Retic-
:ulin fibres are single, of uniform structure,
though varying in diameter, branching, argyrophililc
and situated at boundaries within connective tissue,
e.g., under vascular endothelium, around fat cells
: and plain muscle fibres and forming the framework
of the reticulo-endothelial system. Collagen
fibres occur in bundles, are of uniform diameter,
non-branching and react poorly or not at all
with silver methods.
The results of the experiments on
basement membrane and reticulin will be discussed
under two headings
a) basement membrane and reticulin
b) reticulin and collagen.
Basement/
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Basement Membrane and Reticulin
The results indicate that staining of
basement membranes and reticulin fibres through-
:out both the rat and man can be obtained by
treating tissues with a fluorescein-labelled.
antiserum to the kidney of the same species.
Furthermore, the same pattern of staining
occurred with an antiserum to isolated glomeruli.
Since basement membrane and reticulin components
of the glomeruli were not used separately to
immunise rabbits, it is important to determine
whether the observed reactions were due to
separate antibodies to these two tissue components
The preparations of glomeruli used were
not pure, but contained some small portions of
proximal convoluted tubule. The absence of
specific cellular staining outside the kidney
excludes cellular elements of the glomeruli as
the source of the widespread connective tissue
antigen. The possible extracellular antigens
in the glomeruli are the basement membranes of
the capillary loops and of Bowman's capsule, both
of which were present in the preparations used.
The existence of interstitial tissue in the
glomerulus - the mesangium of Zimmermann (1933)
- is still disputed and is denied by many recent
workers. Those who have observed it in
electron/
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electron microscopic studies have described
cells, but ho fibres (Mueller et al., 1955;
Folicard et al., 1955; Yamada, 1955).
The idea of a common antigenicity of
basement membrane and reticulin is supported by
several observations. First, both reacted
similarly with anti-kidney and anti-glomerulus
globulins. Second, it was possible to inhibit
staining of both elements by absorption of
labelled anti-kidney or anti-glomerulus globulins
with a homogenate of spleen which contains only
reticulin. Third, the experiments with anti-
placenta and anti-aorta sera, quoted in the
introduction, indicate that antisera to tissues
containing reticulin but no basement membrane
are nephrotoxic. The present experiments and
those already quoted with anti-lung sera cannot
be quoted in this argument for both basement
membrane and reticulin are present in lung
tissue.
There is much evidence derived from
histological, biochemical, biophysical and histo-
:chemical work which supports the immunological
evidence for the identity of basement membrane
and reticulin. First, both are argyrophilic.
Gersh & Catchpole (194-9) 5 using the periodic
acid-Schiff/
acid-Schiff technique considered that basement
membrane is condensed ground substance and
| distinct from reticulin, but most of the membranes:
they studied had an argyrophilic central portion
| which can be interpreted as reticulin. Leblond
(1950)5 using the same technique observed
that the distribution of basement membranes and
reticulin fibres in the rat was similar to
that shown by silver impregnation. McManus(1950),
Rinehart (1955)5 Bergstrand (1957) & Robb-Smith
(1957) deny that the glomerular capillary
basement membrane is argyrophilic, but the illus¬
trations of Bohle & Kreeke (1955) of rat
glomeruli, and of Allen (1951)? Jones (1951) &
Mueller et al. of human glomeruli indicate that
argyrophilia can be demonstrated. Second, both
!
j give similar staining reactions with acid-aniline
j dyes. Third, the work of the Oxford school
indicates that the electron microscopic (Little
& Kramer, 1952), X-ray diffraction (Little &
Windrum, 195^) and metachromatic (Kramer &
Windrum, 195^+) appearances of basement membrane
and reticulin from human renal cortex, liver,
adrenal, spleen, lymph node and myocardium are
the same. Fourth, Glegg et al. (1953) found
that "reticular tissue" from lymph node, lung,




carbohydrate components: several of these
were identified in renal cortical reticulin by
Windrum et al. (1955). Fifth, Brewer (1957),
using the polarising microscope, found similar
properties in reticulin and basement membrane.
Despite the many resemblances between
basement membrane and reticulin, there is evidence
that they may not be completely identical. Thus,
Lillie (1952a), using the allochrorne modifica¬
tion of the periodic acid-Schiff method (Lillie,
1951) found that intralobular reticulin in the
liver and follicular reticulin in the spleen
were allochroic, similar to collagen, whereas
reticulin in vessels, around plain muscle in
the oesophagus and in the lung all reacted
similarly to basement membrane and were not
allochroic. Scott (1957) has repeated the
present work with the fluorescent antibody method,
using anti-hurnan-glomerulus and anti-human-synoviuifi
globulins. His results with direct staining and
cross inhibition experiments are of great interest
and are reproduced in Table II. Scott suggests
that basement membrane and reticulin differ anti-
sgenically and that renal glomeruli contain both
antigens. However, the results in glomerular cap-
:illaries and tubular basement membrane and espec¬
ially the apparent difference between the reticulum
of/
Organ
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of capillaries and that of the media of arteries
do not agree with this interpretation.
There is one further point that is of
interest. Although Little & Kramer demonstrated
that isolated basement membrane and reticulin
have the characteristic periodic banded struc¬
ture of collagen in the electron microscope
(■Schmift et al., 194-2), most studies of sections
of glomeruli in the electron microscope have
not revealed such fibres (Hall, 1954- - rat,
rabbit, dog and man; van Breemen et al., 1955 -
rat; Mueller et al. - dog and man; Pease, 1955 -
rat; PolicaM et al. - rat; Rinehart - rat;
Yamada - mouse; Farquhar et al., 1957 - rat,
mouse, rabbit and man). A delicate, fibrillary
structure was noted in places in the mouse
glomerular basement membrane by Reid (1954-) and
a lamellated structure by Khodin (1955)? hut
neither detected any periodicity. Mueller et
al. described a lamellated structure in the
basement membrane of Bowman's capsule but period¬
icity is not mentioned. Neither Sjtfstrand &
Rhodin (1953)? in "the mouse, nor van Breemen et
al., in the rat, were able to demonstrate a
fibrillary structure in the basement membrane
of renal tubules. Similar results have been
described/
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described in other tissues, for although Karrer
(1955) found fibrils in the basement membrane
of the rat lung he was unable to detect any
periodicity. The discrepancy between the results
of all the other workers and those of Kramer &
Little may be explicable by the fact that the
Oxford workers used material isolated by macera-
:tion with dilute alkali or trypsin, whereas all
the others used sections. Pease commented that
fibrils may be masked by amorphous material and
Karrer that lack of contrast or inadequate
resolution may explain failure to demonstrate
periodicity. It should be noted that even
Kramer & Little found much amorphous material
in their preparations. Final morphological
identification of collagen fibrils in sections
of basement membrane and reticulin may, therefore,
be merely a technical matter.
In summary, it can be said that the
present work supports other evidence from
histological, biochemical, histochemical and
electron microscopic studies that basement
membrane and reticulin are closely similar, to
the extent of possessing common antigenicity.
Remarks about reticulin in the following para¬






The consistent inability to stain
collagen with any of the labelled globulins is
| interesting. At the time when this work was
started, there was a widespread belief that retic-
:ulin and collagen were very closely related.
Indeed, most authorities believed that reticulin
was merely immature collagen (Gross & Schmitt,
19l3-8; Angevine, 1951; Gersh, 1952: Kellgren, 1952;
Morrione, 1952; Porter, 1952). This opinion was
based, on histological and biophysical studies of
mature collagen from various sources and "reticuliri"
i fibres from the dermis. Frequently the material
.
was teased out, extracted and reprecipitated, or
otherwise isolated from its natural state before
study. It is now clear that the "reticulin"
fibres so studied were different from reticulin
as defined in the present context and that they
were immature collagen fibres.
Lillie (1953b) was perhaps the first to
draw attention to the fact that the identity of
true reticulin, in liver and kidney, and collagen
had not been demonstrated. His studies with
the allochrome procedure, mentioned above, clearly
demonstrated that mature collagen is allochroic
whereas basement membrane and most reticulin are not.
Sub s e quen tly/
5'o.
Subsequently Little & Kramer have shown In the
electron microscope that, although reticulln from
various sources contains fibrils which resemble
collagen, there is an additional amorphous compon-
sent in reticulin. This was identified by X-ray
diffraction (Little & Windrum) and chemical
analysis (Windrum et al.) as a fatty acid, which
comprises 11 per cent of the material. Windrum
et al. have also shown that the amino-acid
composition of reticulin and collagen are similar
and that the carbohydrate content of reticulin is
5 per cent, whereas that of collagen is probably
negligible. The sulphation-metachromasia technique
of Kramer & Windrum, in which sulphuric acid
esters of the carbohydrate are produced and demon-
:strated by metachromasia, confirms this for ret-
:iculin becomes metachromatic, whereas collagen
remains orthochromatic. These workers also
found that treatment with pectinase prevented the
metachromasia of reticulin but did not affect its
staining with the collagen stain picromethyl blue
and they regard this as further evidence that
reticulin consists of collagen plus polysaccharide.
Glegg et al. also found a higher carbohydrate
content in reticulin than in collagen. Brewer's
studies on birefringence also indicate that
reticulin and collagen fibres are different.
There/
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There is thus good histochemical, bio-
:chemical and biophysical evidence that reticulin
and collagen, although related, differ considerably
from one another. The present immunohistochemical
studies support this view and indicate that
labelled anti-glomerulus serum can be used as a
stain for basement membrane and reticulin which
gives results as good as those of any other
method available and has the additional advantage
of the specificity inherent in an immunological
reaction. Indeed, it has been possible to demon-
:strate clearly a basement membrane in several
situations where its presence had been doubted.
Thus there can be no doubt that a definite membrane
surrounds the thyroid acini (compare Figs.M-l & k2
with Figs.11-13 & 28-30). Lansing & Wolfe (19*+*+)
reviewed the literature and reported their own
findings with Gomori's silver method. Like earlier
workers they regarded all perifollicular reticulin
as pericapillary in nature and do not use the term
basement membrane. However, Gersh & Catchpole
described a very thin basement membrane consisting
of fine reticulin fibrils enclosed in Schiff-positiv
material and Dempsey & Paterson (1955) have
described a basement membrane in electron microscope
studies. Likewise, a membrane was demonstrated
immunohistochemically at the dermo-epidermal
junction/
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Fig.4-1. Human thyroid. The basement membrane of
; the acinus is incompletely impregnated. Reticulin
fibres in the interstitial tissue are well seen.
Gordon & Sweet reticulin stain, (x 250).
Fig.*+2. Human thyroid. Serial section to that in
Fig.HI. The acinar basement membrane is seen with
difficulty and only in a few places. Periodic
acid-Schiff-haematoxylin (x 250).
53.
junction (Fig.10). Medawar (1953) doubted the
existence of a basement membrane in this situation
and subsequent electron microscopic (Selby, 1955)
and histochemical (Cooper, 1956) work has not
revealed the presence of reticulin.
It would clearly be of interest to
determine the chemical nature of the antigen(s).
The results of Lillie (1952a) and Scott (1957)
indicate that the glyco-lipo-protein complex
from renal cortical reticulin studied by Windrum
et al. may not be the only antigen involved. The
lack of effect of hyaluronidase and the absence
of staining in cartilage matrix in the present
work suggest that neither hyaluronic acid nor
chondroitin sulphate is directly involved. However,
the immunological difference between reticulin and
collagen must be determined by the non-protein
components of the former, for both have the same
amino-acid. composition (Windrum et al.; Bowes et
al., 1955). The demonstration by Cole et al.(1951)
that a mucoid soluble substance prepared by tryptic
digestion of rat kidney could absorb out nephrotoxi
antibodies from anti-rat-kidney serum was of great
interest, for it suggested that further study of
such material might yield useful information about
the nature of the glomerular antigen(s). Some
of/
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of the immunological properties of such digests
are discussed later in this thesis (Section III,
pp. 81 - 100 ). The importance of mucopolysacc-
:harides, particularly chondroitin sulphate
(Jackson, 1952), in the metabolism of collagen
suggested that, although it is not necessarily
related to the glomerular antigen(s), an attempt
should be made to prepare an antiserum to it.
These experiments are discussed on pp. 67 - 80.
Finally, it was obviously desirable to investigate
the antigenic relationship of reticulin and
collagen in more detail. Preliminary attempts
to prepare an antibody to collagen are described
in the next Section.
SUMI1AHI
Rabbit antisera to rat kidney, rat
glomeruli and rat lung were labelled with fliiores-
scein isocyanate and applied to sections of many
rat tissues. All three sera reacted with basement
membrane and reticulin throughout the rat and
with sarcolemma and neurilemma. The immunological
specificity of the reactions was established.
Rabbit antisera to human glomeruli gave




Cross-reactions occurred only with close-
i sly related species, thus anti-rat-sera reacted
j with mouse tissues and anti-human-sera with monkey
tissues.
No reaction occurred in either species
with collagen fibres, elastic fibres, cartilage
matrix or ground substance.
The results are discussed in relation
to recent histochemical, biochemical and biophys-
sical work on basement membrane, reticulin and
collagen.
It is concluded that basement membrane
and reticulin are very closely related, if not
identicalsand that they show distinct differences
from collagen.
COLLAGEN
At the time when this work was started,
only three studies of the antigenicity of collagen
had been made. Loiseleur & Urbain (1930)
immunised rabbits with a solution of rat tail
tendons in dilute acetic acid. They obtained
complement fixing antibodies, but did not show
that these were specific to collagen rather than
to other components of the tendons. Battista
(19^9) /
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(194-9) was unable to demonstrate antibodies in
guinea-pigs or rabbits implanted with "collagen"
derived from beef bone by treatment with hydro-
:chloric acid, Waksman & Mason (19^+9) were unable
to demonstrate antibodies in rabbits or guinea-
pigs immunised with human collagen alone, coupled
to globulin or with adjuvants. They also attempted,
unsuccessfully, to produce antibodies in rabbits
to rabbit collagen alone or coupled with sulpha-
rnilic acid. The collagen preparations had
been extracted successively with sodium chloride,
sodium phosphate and ether and then suspended in
absolute alcohol and ground in a ball mill for 4-8
hours. Waksman & Mason comment that the chemical
and physical manipulations used may have affected
i
the antigenicity of the collagen.
The results of the present experiments
with anti-sera to glomeruli indicated the
desirability of making further attempts to prepare
an antibody to collagen. Human collagen was
chosen because it was more readily available in
quantity and because it was hoped to apply
labelled anti-sera to human reticulin and collagen
to a study of human pathological material. Purely
physical methods were used in the preparation of




any denaturation of the protein, and obtaining
the collagen in native or near-native form.
Antigenicity of "Native" Collagen
Adult human patellar tendon, obtained
| at autopsy, was cleaned as free of muscle and
I other tissue as possible and stored in the deep
! freeze. Sections 25^- thick were cut, in the
f
freezing cabinet and stored, without thawing, in
j a closed vessel in the deep freeze. Various
procedures were used in attempts to get a fine
emulsion for injection:
a) pushing the sections, after thawing, through
the fine sieve used to isolate glomeruli
(see Appendix, p. 186 ).
b) spinning in saline in a Waring Blender for
up to 15 minutes; the blender was kept
cool in an ice and water bath.
c) grinding in saline in a ball mill for up to
^ hours.
d) ultrasonic vibration for 1 hour at 15 watts
(performed by Dr. G.G. Selman, Department
of Animal Genetics, University of Edinburgh)
e) grinding with or without sand in a pestle
and mortar.
None of these procedures was successful
in producing an emulsion suitable for injection,
although some fine particles were obtained in
c) and d). The saline with the fine particles
(approximately 1 gm. solid in 10 ml.) so obtained
was separated from the coarser material and stored
in/
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in the deep freeze. It was used later as antigen
in complement fixation tests.
An attempt was made to prepare a powder
from small pieces of tendon which had been dehyd-
: rated for 4-8 hours at room temperature in the
freeze-drying apparatus (see Appendix, p. 202).
The dried tendon could not be pulverised in a
mortar.
As physical methods had failed to provide
a preparation which could be injected, it was
decided to implant sections of tendon at open
operation. Two rabbits (53 & 5L0 received
approximately 2.5 gm. of tendon sections intra-
jperitoneally in four doses at intervals of 15—17
days. They were bled immediately before the
second and third implantations and 15 days after
the fourth implantation. (See Appendix, p.192
for details).
The sera were tested for complement
fixing antibodies against diluted saline
suspensions of fine particles of the tendon antigen
and of homogenised glomeruli by the method of
Bedson & Bland (1929) (for details see Appendix,
pp. 200-201). The results are shown in Table III.
Absorption of the sera with approximately 1 mgm.
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tests were performed with the same sera against
human serum and chondroitin sulphate (see p. 69 )
using the interfacial ring method, with the results
shown in Table 17.
One of the sera (Rabbit 535 3rd bleeding)
was then labelled with fluorescein isocyanate,
| absorbed with sheep muscle powder and applied to
sections of human kidney and spleen, but no
specific staining was obtained.
Antigenicity of soluble collagen
Shortly after the experiments with
human tendon had been completed, Watson et al.
(195*+) reported the successful production of a
J
specific antibody to rat collagen in rabbits
immunised with a solution of tail tendon in dilute
acetic acid. These experiments were repeated
with the intention of labelling the antiserum
;
i with fluorescein and comparing its reactions with
those of the antisera to rat basement membrane
and reticulin.
Acid-soluble collagen was prepared from
rat tail tendon by the method of Watson et al.
(see Appendix, p. 189 ). Electron microscopy of
material precipitated from the solution showed













Four rabbits (150-153) each received
212 mgm. of this 0.1 per cent solution of collagen
in 1/10,000 acetic acid in four courses, and five
rabbits (160-165) each received 150 mgm. in two
courses. The solution was given intraperitoneally
in doses of 5 ml. four times a week. Rabbits
150-153 were bled thrice; rabbits 160-165 once
(see Appendix, pp. 196 & 197).
The undiluted sera were tested for
complement fixing antibodies against the 0.1 per
cent solution of collagen in acetic acid. Positive
results with rabbits 150-153 were obtained only
in the third samples of sera. Serial dilutions
of sera were not tested. Those sera which reacted
with the collagen were tested for precipitating
antibodies against rat serum. The results are
shown in Table V.




The results of these two experiments
cannot be regarded as conclusive, but they are
encouraging. The human tendon material was used,
in a form as little altered from the native state
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undegraded, other extraneous and potentially anti-
:genie substances were probably present. Serological
analysis of the antisera has excluded the presence
of antibodies to basement membrane, serum
proteins or to chondroitin sulphate. It is
therefore possible that a specific antibody to
collagen was present.
It was hoped that studies with fluorescein-
labelled serum would help to prove this, but
these experiments gave negative results. This
may well have been due to the antibody being
present in so low titre that it was lost completely
on conjugation (see Section 7, p. 166 ). The
:titre of the present sera was not determined after
conjugation, but it is possible thht this procedure
itself may have been responsible for the lack of
staining. This difficulty might be overcome by
the indirect method (see p. 166 ), but, unfortunate-
sly, no anti-rabbit globulin serum was available
when these experiments were performed.
It is doubtful whether the use of adju-
svants would increase the titre of antisera to
insoluble collagen for Watson et al. were unable
to increase the titre of antibodies to soluble
collagen by using this method. It is possible
that the low titre of the serum and particularly
the/
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the reduction in titre between first and second
bleeding of rabbit 53 was due to the presence of
an excess of antigen. Large masses of partially
necrotic tendon were found in the peritoneal cav-
:ity of both animals when they were killed.
The experiment with soluble collagen had
to be stopped before it was completed so that no
attempt was made to establish the specificity of
the antisera other than to exclude antibodies to
rat serum proteins. The antigen used was prepared
by a method closely similar to that of Watson et
al. and was shorn electron microscopically to
contain collagen. Watson et al. proved by imrauno-
:logical tests coupled with enzymatic digestion
that their antisera contained specific antibodies
'
to collagen rather than to tissue proteins or
polysaccharides. They also demonstrated that
both purified and native rat collagens completely
absorbed the antibodies from the sera. Once againj
it is possible that a specific antibody to
collagen was present in the antisera produced in
the current experiments.
It is obvious from the present experi¬
ments and. those of Watson et al. that collagen
is a weak antigen: the titres given by the
American/
66.
American workers are for antigen dilution, so that
the antibody content of their sera cannot be
assessed. Nevertheless the potential value of
an antiserum is such that further attempts should
be made to obtain it. Recent work on soluble
forms of collagen (reviewed by Jackson, 1957)
indicates that material extracted by neutral salts,
rather than that extracted by acetic acid, is the
precursor of insoluble collagen which is the form
found in mature fibrous tissue. Humphrey (1956)
has found neutral-salt-soluble collagen from
rat tendon to be antigenic. Preliminary attempts
made by the writer to obtain neutral-salt-soluble
collagen from human neonatal skin have not been
very satisfactory. Watson (1955) referred to the
difficulty of extracting human collagen. It is
planned to use neonatal dura mater and fascia
lata for extraction experiments in the hope that
these almost pure fibrous structures will be more
satisfactory than skin.
SUMMARY
Rabbits were immunised by intraperiton-
seal implantation of untreated sections of human
patellar tendon. Their sera contained complement
fixing antibodies which reacted with tendon, but





Rabbits immunised with acid-soluble
collagen from rat tail tendon produced antibodies
which reacted with acid-soluble collagen, but not
with serum.
It is possible that specific antibodies
to collagen were produced in both experiments.
CHONDROITIN SULPHATE
In September 1972, when these experi¬
ments were started, there was no direct informa¬
tion about the antigenicity of chond.roitin
sulphate. Elliott (191li-) & Goodner (1925) studied
the antigenicity of several mucins, including
material extracted from cartilage and tendon with
strong alkali. The extracts were antigenic,
but their exact chemical nature is not stated.
i Ropes et al (19^7) obtained relatively strong
precipitin and complement fixation reactions after
I
injecting bovine cartilage (? tracheal) into
- rabbits. The sera obtained reacted weakly with
< I
i bovine synovial fluid but not with mucin prepared
from that fluid. Biochemical studies, reviewed
by Meyer (1951)? had established the existence
of several different chondroitin sulphates in
the tissues and although it was assumed that
cartilage cells were the source of that variety
found/
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found in cartilage (Gardner, 1950) this had not
been proven.
It appeared, therefore, that, if chon-
:droitin sulphate were antigenic, studies with
fluorescein-labelled antisera might yield useful
information about its site of formation and
distribution in the normal tissues and perhaps
also about changes in pathological conditions.
It was decided to use whole human cartilage for
immunisation and so avoid extraction procedures
which might denature, or depolymerise the
mucopolysaccharide; it was hoped that unwanted
antibodies could be removed by appropriate
absorption tests. Preliminary experiments with
: whole cartilage had been unsatisfactory when
: Glynn & Holborow (1952 a & b) published their
observations on the conversion of polysaccharide
haptens, including human chondroitin sulphate,
to full antigens by immunising rabbits with a
vaccine of streptococci on to which the polysacc¬
harides had been adsorbed. This technique





Two preparations of chondroitin
sulphate were used, one prepared from bovine trachea
by the method of Bray et al. (194-2) and supplied
by The Evans Biological Institute, Runcorn,
Cheshire, the other prepared from human costal
cartilage by Dr. A.B. Roy, Biochemistry Department
University of Edinburgh, using the method of
Einbinder & Schubert (1950). The human material
had a protein content of approximately 55>* The
costal cartilages used were obtained at autopsy
from two patients whose blood groups are unknown.
Two further preparations of chondroitin sulphate
from individuals of blood groups A and 0 were
prepared and supplied to Professor W.T.J. Morgan,
Lister Institute. Vaccines were prepared by
exposing a culture of Group-A, Type-4- f$ - haemo-
:lytic streptococcus (N.C.T.C. Catalogue No.8326)
to solutions of the polysaccharides as described
by Glynn & Holborow (1952b). (For details, see
Appendix, p.. I87 )•
Two rabbits (66 & 67) were immunised
with divided, intravenous doses of vaccines
prepared from the bovine, and four (72-75) with
vaccines/
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vaccines prepared from the human polysaccharide.
Injection schedules are given in the Appendix
(pp.192-193)• The animals were bled 12 days
after the final injection and their sera titrated
by the capillary tube method of Swift et al. (19^-3)
against chondroitin sulphate, hyaluronic acid
(prepared from human umbilical cord and supplied
i by The Evans Biological Institute), and a Lance-
:field extract of the streptococci and by the
interfacial ring method against normal human serum
and a tryptic digest of human kidney (see Section
III, pp. 82-83). One of the antisera to human
chondroitin sulphate was conjugated with
fluorescein isocyanate and used to treat fresh-
frozen sections of kidney, trachea and articular
cartilage.
Four rabbits (102,103,1^2,1^3) were
immunised with divided intravenous doses of human
chondroitin sulphate solution only and bled 12.
days after the final injection. Injection
schedules are given in the Appendix (pp.191)- & 19'o)
The sera were titrated as above and also by the
interfacial ring method against purified blood
group substances A, B, H & Lec (supplied by
Professor W.T.J. Morgan). A pooled sample of
these sera was also tested against various antigen
by a modification of the gel-diffusion method of
Ouchterlony^
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Ouchterlony (19^9) (see Appendix, p. 200). One
of these antisera was conjugated with fluorescein
! isocyanate and used to stain fresh-frozen sections
of kidney, trachea and articular cartilage.
RESULTS
The results of precipitin reactions with
the sera of the animals injected with the chondroi
:tin sulphate-vaccines are seen in Table VI. No
reactions occurred with, the sera from animals
injected with the preparation from bovine trachea.
Anti-sera to human chondroitin sulphate-vaccine
reacted with the polysaccharide alone and the
Lancefield extract of the organism used to prepare
the vaccine. The reaction with hyaluronic acid is
probably of no significance, for it is known that
this substance frequently gives rise to a precipit
when titrated against serum (Ropes et al.).
All four of the rabbits immunised with
chondroitin sulphate alone produced sera which
reacted with the polysaccharide (Table VII). Reac¬
tions also occurred with a tryptic digest of
kidney, but not with human serum. A pooled
sample of these sera reacted with blood group
substances A,B & H, so the tests were repeated
after aliquots of the sera had been absorbed with
1 mgm. blood group substance per ml. The results
of/
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of the tests before and after absorption are
shown in Table VIII. The result obtained in the
gel-diffusion test with this serum against human°
chondroitin sulphate, tryptic digest of glomeruli
and blood group substances is seen in Fig. 4-3 -
a reaction of identity with all the antigens.
Further tests with this pooled serum
J were performed by Professor Morgan, who found:
a) no precipitation when undiluted, serum was
titrated with blood group substances at
dilutions of 1/1000 or higher. Anti-sera
prepared to blood group substances give a
distinct precipitate at 1/10,000 and
frequently at 1/100,000.
b) haemagglutination by the serum of human
erythrocytes to titres of .1/16 (Groups A
& 0) or 1/64- (Group B.). These values
occur with normal rabbit sera.
c) no evidence of blood group activity in the
original preparation of human chondroitin
sulphate or in the preparations from
individuals of known blood group.
Antisera to the vaccine-treated and
: untreated chondroitin sulphate were labelled with
!
fluorescein isocyanate and tested against human
articular cartilage, trachea and kidney. No
specific staining was obtained.
DISCUSSION
The methods employed for the extraction
of tissue polysaccharides have been reviewed
recently by Snellman (1957) who points out that
the/
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Fig.^3. Ouchterlony plate. The centre
cup contains anti-chondroitin sulphate
serum. The peripheral cups contain
chondroitin sulphate (1), blood group A
substance (2), blood group B substance
(3)5 blood group H substance (4), blood
group Lea substance (5) and a tryptic dig-
rest of glomeruli (6). Photographed after
^8 hours incubation at 37°C. Note reaction
of identity with all six antigens. The
broadening of the band between serum and
cup 3 is an artefact.
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the alkali method used by Bray et al. gives a
degraded product whereas the potassium chloride •
'
I method of Einbinder, & Schubert is milder and may
give an undegraded product. This may account for
the negative results with the bovine material used
here, though the experiments were very limited and
cannot be regarded as conclusive. There is no
doubt that the human material used was antigenic,
but the interpretation of the results is difficult.
There are several reasons for regarding them as
non-specific. Firstly, the antiserum cross-reacted
with several highly purified blood-group substances
of known chemical constitution. Antisera to these
substances do not cross-react with one another
(Aminoff et al., 1950; Annison & Morgan, 1952a &
b; Gibbons & Morgan, 195*+) • Secondly, the tests
performed by Professor Morgan indicate that blood
group substances were not present in the chon-
:droitin sulphate in detectable amounts and that
the reactions with red cells are similar to those
of normal rabbit serum. Thirdly, the gel-diffusion
test gave only a single line with the reaction of
identity (Ouchterlony, 1953) with all the antigens
tested. It seems likely, therefore, that even
the extraction method of Einbinder & Schubert




The human material used in the present
experiments has not been analysed chemically, so
that the nature of the antigen is not known.
Nevertheless the procedure of Einbinder & Schubert
was followed exactly so that chondroitin sulphate
was presumably present. Glynn & Holborow (1952b)
claimed that human chondroitin sulphate prepared
by this method was not antigenic in doses similar
to those used here, but could be made fully
antigenic by adsorption on to streptococci.
Streptococci had no adjuvant effect in the present
experiments, presumably because the protein
: present in the preparations was antigenic. Boake
| & Muir (1955) were unable to repeat the results
of Glynn & Holborow, using rabbit chondroitin
sulphate, but otherwise following exactly the
technique of Glynn & Holborow. Wilson (1955)
j & Lominski (1957) have also repeated the experi¬
ments of Glynn & Holborow, with negative results.
: Glynn & Holborow (1955) have subsequently stated
: that their antiserum probably contained antibody
to blood, group A substance, rather than to
chondroitin sulphate. Thus, the antigenicity of
chondroitin sulphate remains to be demonstrated.
The original purpose of this work was to
use fluorescein-labelled antisera to study the
site of formation and distribution of chondroitin
| sulphate/
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sulphate in the tissues. Since the work was
started, and labelled sulphate has been
used extensively in animal experiments and has
igiven much information on the distribution of
Isulphated mucopolysaccharides. Thus, Curran
|& Kennedy (1955a) have injected 35g as
sulphate ion into mice and studied its distribution
|in many tissues and Curran & Gibson (1955-56)
have described an in vitro method for use with
human tissue. There can be no doubt from this work
that the chondroitin sulphate of cartilage is pro-
:duced in chondrocytes. The origin of the poly-
::saccharide in other tissues has not been
determined, for the technique does not differentiate
:chondroitin sulphate from other sulphated mucopoly-
:saccharides, such as heparin. The granules
demonstrable in proliferating fibroblasts are of
particular interest in this respect; they have
been interpreted by various workers as glycoprotein
I (Gersh & Catchpole, 19^-9), hyaluronic acid (Curran,
1953)? collagen (Robbins et al., 1955)5 acid
mucopolysaccharide plus protein (Jackson, 1955)
and sulphated mucopolysaccharide (Curran & Kennedy,
1955b). A specific and practicable method for
demonstrating chondroitin sulphate in human tissue
is not yet available. Several new methods for
the/
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the isolation of chondroitin sulphate have been
described recently (Scott, 1956; Partridge & Davis,
1958; Muir, 1958), one of which yields the poly¬
saccharide in a complex containing non-collagenous
protein. Further immunological studies with these
preparations may provide a specific method for
studying chondroitin sulphate distribution in
human tissues.
SUMMARY
Rabbits were immunised with chondroitin
sulphate extracted from bovine tracheal cartilage
with alkali and from human costal cartilage with
potassium chloride. Injection of the latter
gave rise to antibodies which reacted not only with
the original antigen but also with a tryptic digest
of human kidney and with several purified blood
group substances.
The antigenic component of the preparat¬
ion has not been identified. Protein was present
but not blood group substa.nces. The serological
reactions are regarded as non-specific and probably
due to degradation of the chondroitin sulphate
during preparation.
The results are discussed in relation
to other work on the antigenicity of chondroitin
sulphate/
80.
sulphate and the use of 35g for the demonstration
of sulphated mucopolysaccharides. The need for
a specific method for the identification of
individual substances is emphasised.
SECTION III.
IMMUNOLOGICAL AND ItMUNOHISTOCHBMICAL
STUDIES ON TEE KIDNEY
AND BLOOD VESSELS
81.
IMMUNOLOGICAL PROPERTIES OF TRYPTIC DIGESTS OF
HUMAN KIDNEY AND GLOMERULI
The evidence which indicates that the
'
glomerulus is the source of the nephrotoxic antigen
has heen reviewed briefly earlier in this thesis
(Section II, pp. 5 - 7 ). When Cole et al.
(195D demonstrated that tryptic digestion of
rat kidney yielded a mucoid substance which could
1 absorb the kidney-damaging antibody from a
nephrotoxic serum it seemed possible that the
antigen had been obtained in soluble form. This
would be an important advance for several reasons.
First, chemical analysis of the digest might
reveal the composition of the nephrotoxic antigen,
which appeared to be identical with the basement
I membrane-reticulin antigen studied in Section I
of this thesis (Hill & Cruickshank, 1953). Second,
digests oF human kidneys or glomeruli might be
suitable preparations with which to look for
tissue antibodies in glomerulonephritis. Third,
a soluble antigen would be available for the in
vitro titration of nephrotoxic sera.
It was decided therefore a) to study the
immunological properties of digests prepared from
human kidneys and glomeruli, with a view to
confirming the work of Cole et al. and establishing
the/
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the origin of the digests immunochemically, and
h) to use the digests, along with other prepara¬
tions, in an investigation of the role of kidney
j auto-antibodies in acute glomerulonephritis.
METHODS AND RESULTS
Six extracts of normal human glomeruli
and three of whole kidney were prepared by Dr. A.B
j Roy, Department of Biochemistry, University of
Edinburgh. The kidneys were obtained at autopsy,
within 25 hours of death, from patients who gave
[ no history of renal disease; the normality of the
kidneys was checked histologically before they
were used. The organs were stored at 0°C. until
used. The procedure for isolation of glomeruli
was a modification of that described by Greenspon
& Ivrakower (1950) (see Appendix, pp. 186-187).
I11 the early preparations, the original method of
Cole et al. was used and. only small quantities wer
prepared. Later the method was modified to
include deproteinising of the tryptic digests by
Sevag's method. Later still, the glomeruli oro '
whole kidney were extracted successively with
0.15M sodium chloride, l.$M sodium chloride and
5M potassium chloride before digestion, in the
hope of removing as much polysaccharide as




| were prepared, Including one (digest 7) from
I
180 gm. of glomeruli which yielded 120 ml.; this
; preparation contained 0.8% total solid and 0.5%
protein. Full details of the final method of
preparation are given in the Appendix ( p. 187 )4
The experiments carried out with these
I extracts will be discussed under the following
headings s-
.
a; titration against antisera to whole kidney
or glomeruli.
b) absorption of specific antibody from
anti-glomerulus serum.
c) immunisation of rabbits.
d) tissue localisation experiments.
Titration against antisera to kidney or glomeruli.
The main property of the extract described
by Cole et al. was its ability to precipitate
nephrotoxic antibody from anti-kidney serum, so
: that animals injected with the treated serum did
not develop nephritis. Such an experiment was
: impossible with human material, so the extracts
were tested, in the first place, for their
reaction with rabbit anti-human-kidney or anti-
| human-glomerulus serum. The sera included those
shown previously to react with basement membrane
and reticulin (Section II, pp. 29 - 30 ) and
four/
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| four further antisera to kidney (Rabbits 89 & 90)
or glomeruli (Rabbits 92 & 169) (see Appendix,
PP. 193 & 197 ). The reactions with the immune
j sera were controlled by tests with normal rabbit
serum. Precipitin tests were performed by the
interfacial ring method, using serial four-fold
dilutions of the extracts layered on top of neat
serum. The tubes were stood for 1 hour at room
temperature before reading. The results are
shown in Table IX. Complement fixation tests,
using the technique described previously (Section
II, p„ 5 8 ) gave similar results.
!
These experiments indicate that the
digests contain a substance which precipitates with!
antisera to human kidney or glomeruli. It was
next necessary to demonstrate the specificity of
the reaction.
.
!Absorption of Specific Antibody from Anti-glomerulub
| Serum.
Wo reaction occurred in precipitin tests
I between digests and the antisera to human chondroi-
:tin sulphate or tendon described previously
(Section II). Some of the earlier digests
reacted with antisera to human serum, but this
did not occur with digests prepared by the final
method. Furthermore, the anti-kidney and anti-
glomerulus sera still reacted with the digests
!after/
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after absorption with human serum. The reaction
between digests and anti-kidney or anti-glomerulus
sera is thus not d.ue merely to the presence of
serum proteins in the digests and antibodies to
serum proteins in the anti-kidney or anti-glomerulu
sera.
Anti-glomerulus serum was absorbed with
a wet packed suspension of human glomeruli,
allowing the preparation to stand for 1 hour at
room temperature and then overnight at 4°C. This
procedure has been shown to remove specific anti-
glomerular antibodies (Section II, p,. 30 ) .
When the absorbed serum was tested for precipitation
with the digests, no reaction occurred. Equal
parts of labelled anti-glomerulus serum and. two of
the glomerular digests were mixed, stood for 1
hour at room temperature and overnight at if°C.and
then spun. Drops of the supernates were used to
treat sections of kidney. No staining was obtained
whereas no diminution in the intensity of staining
occurred, when the same serum was similarly treated
with phosphate buffer. The reaction between
digests and antisera are thus due to a specific
antigen-antibody reaction. It was next necessa.ry
to demonstrate whether the digests were full anti-
:gens or merely haptens.
87.
Immunisation of rabbits.
Two rabbits (78 & 79) were given 3.0 ml.
of one of the earlier glomerular digests (NoA)
in divided intravenous doses (see Appendix,
p. 193) an<3. bled 9 days later. The results of
precipitin tests, using sera and digests undiluted
are seen in Table X. Both rabbit sera reacted
with human serum as well as with the digests so
the tests were repeated after absorption of the
rabbit sera with human serum. A reaction was still
obtained with one of the rabbit sera and one of
the digests. It seemed possible, therefore, that
the digests might contain a full antigen of
glomerular origin. Two rabbits (80 & 81) were
then immunised intravenously with a streptococcal
vaccine similar to that described previously
(Section II, pp. 69 - 70 ) but incubating the
organisms in the glomerular digest, in the hope
of enhancing its antigenicity. Details of the
immunisation schedule are given, in the Appendix,
p.. 193 . The results of precipitin tests
(Table X) confirm that the digest used was anti¬
genic. Ouchterlony plates were also used, giving;
only a single line in the reaction between the
digest and the latter two sera.
These/
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These experiments were repeated with a
later digest (No. 7). Three pairs of litter-mates
(91 & 92, 93 & 9S 95 & 96) were used, one of each
pair being injected with the extract alone (7.5ml
of extract), the other with a streptococcal vaccin
prepared from the extract (7.5 ml. of vaccine
prepared from 1.16 ml. of extract). All injection
were intravenous. Details of the immunisation
schedules are given in the Appendix, p. 191+.
All animals were bled 12 days after the final
injection and precipitin tests performed with serial
dilutions of sera against digest diluted 1/10
and human serum. Results are shown in Table XI
and confirm that the digests contain a full antigeh
of glomerular origin. It appears that the strep-
itococci had no enhancing effect on the anti¬
genicity of the digest, but as there is a
considerable difference in the amounts of digest
used in the two groups of animals, further
experiments were performed.
Three rabbits (99 - 101) were immunised
intravenously with 1.2 ml. of the same digest in
divided doses. Two further rabbits (97 & 98) were
injected intravenously with a vaccine prepared,
by incubating the streptococci in saline instead
of in the digest; the doses used were the same
as/
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as In rabbits 91? 93 & 95- All of these rabbits
were bled 12 days after the final injection and
the sera tested as above. Results with rabbits
99 - 101 are shown in Table XI; sera 97 & 98
did not react with any of the antigens but gave a
strong reaction with a Lancefield extract of the
:
organisms. The fact that the titres in rabbits
99 - 101 are the same as those in rabbits 91, 93
& 95 and that the organisms alone produced no anti->
:bodies to the digest confirm that the streptococci
had no adjuvant effect. Furthermore, when the
digest was tested against anti-kidney or -digest
sera before and after incubation with streptococci,
no difference was noted in the reaction (Table XII).
Two rabbits (169 & 170) were immunised
with a digest from whole kidney (9) In Freund's
adjuvants (Freund & McDermott, 19*+2) in the hope
of increasing the antibody titre. Details of the
immunisation schedule are given in the Appendix
Dp, 197 ). The total amount of digest
given was 1.26 ml./rabbit. The animals were bled
36 days after the final injection. Both rabbits
then received glomerulus digest (7) 1 nil. subcut-
:aneously followed by 1 ml. intravenously the
next day and were bled l5 d_ays later. Results of
tests with these sera are seen in Table XIII.
The/
















The adjuvants apparently had a slight effect.
Table XI shows also the results of
precipitin reactions between anti-digest sera and
two other preparations, namely, chondroitin
sulphate and a digest prepared from whole rat
kidney. In view of the results obtained in the
experiments with chondroitin sulphate described in
Section II (pp. 67 - 80 ), it is likely that the
reaction now obtained is of no significance. The
lack of cross-reaction with the rat kidney digest
is in keeping with the results described previously
with antisera to rat or human glomeruli (Section
II, pp. 11 & 30).
Tissue localisation experiments,
Three sera (79, 80 & 81) were tested
for ability to inhibit the reaction obtained with
anti-human-glomerulus serum and two (92 & 96) were
labelled with fluorescein and tested on sections
of kidney. The results of all these experiments
were negative.
DISCUSSION
These experiments indicate that the
digests, whether prepared, from isolated glomeruli
or whole kidney contained antigenic materials.
Crude preparations contained serum proteins,
whereas/
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whereas purer preparations contained species
specific glomerular antigens only. Cole et al.
; mentioned preliminary experiments which indicated
that the material was not antigenic, though they
.
had demonstrated that it was haptenic. Yagi et
al. (1956) confirmed the haptenic property of
I digests from rat kidney by demonstrating their
.
ability to decrease the tissue localising activity
of ^31 I-labelled rabbit anti-rat-kidney sera.
Electrophoretic analysis indicated the presence
of five components. Two of these, which were
removed by digestion with ribonuclease and deoxy-
sribonuclease had little effect, whereas the other
J three,which consisted primarily of protein,had a
I much more marked effect in decreasing localisa-
:tion. Immunisation experiments were not reported.
These results were confirmed by Goodman & Baxter
(1956) who also found the digests to be weakly
antigenic in rabbits and the resulting sera to have
weak nephrotoxicity. Glynn & Eolborow (1952b)
found that rabbit antisera to a streptococcus-rat
| kidney digest-vaccine were nephrotoxic. Liu et al.
(1957) found that rabbit antisera to rat kidney
digest were antigenic but. not nephrotoxic, whereas
streptococcus-digest vaccine produced higher titre
sera which were nephrotoxic. The differences
j between these and the present results may be
explained/
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explained, at least partly, by differences in the
amount of antigen injected. Thus Liu et al. gave
digest equivalent to 1. 9 gm. of kidney, whereas
in the present experiments the highest titres
were obtained with amounts equivalent to 10.75 gm.
of isolated glomeruli.
■
It is difficult to account for the failur
to increase the antibody titre with streptococcal
'
vaccine in the present experiments. However, it
should be noted that Glynn & Iiolborow did not
state whether their digest itself was antigenic
and they believe that the effect of streptococcal
, vaccines is due to adsorption of haptenic poly¬
saccharides on to the bacterial particles (Glynn
& Holborow, 1952a). It seems unlikely that the
digests contain any significant amount of poly¬
saccharide, as their activity is not significantly
altered by treatment with hyaluronidase, /3 -gluc¬
uronidase, £< -amylase, ,9 -amylase, pectinase or
lysozyme (Pressman et al. , 1951+5 Goodman & Baxter).
Furthermore, Lin et al., using the passive
haemagglutination method to titrate anti-digest
sera found that positive results were obtained
when tanned, cells were used but not when non-tanned
cells were used. Tests using purified antigens
from tubercle bacilli to inhibit the agglutination
: of red cells by antisera have provided information
|about/
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about the nature of the antigens adsorbed, by tanned,
and non-tanned cells (Middlebrook & Dubosjl^;
G-rabar et al. , 1952). It is now generally accepted
that protein antigens require tanned cells,
whereas polysaccharide antigens will adsorb on to
non-tanned cells.
The human source of the digests used in
the present work precluded nephrotoxicity tests.
However, it was hoped to confirm the specificity
of the antibodies and demonstrate the histological
distribution of the antigen(s) by tissue-localisa-
stion experiments. It is difficult to explain the
failure of the antidigest sera to inhibit staining
with anti-human-glomerulus serum otherwise than
Ih.
that antibody titre was too low. This is also likely
to be the reason why the labelled anti-digest sera
gave no reaction. The titre of the present sera
was not determined after conjugation, but a fall
in titre such as that observed by Fabius (see
Section V, p. 166) would certainly eliminate any
reaction on sections. This difficulty could be
overcome by using the indirect method, but
unfortunately no labelled anti-rabbit globulin was
available when these experiments were performed.
The histological source of the glomerular
digests has not been defined with greater precision
than/
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than that they are derived from glomeruli. However,
it seemed justifiable at the outset of these
experiments to assume that the digests might be
derived from the nephrotoxic antigens. Cole et alj
had found that extraction with saline, alkaline and
acid solutions, alcohol and diethylene glycol
failed to bring the nephrotoxic antigen of rat
kidney into solution. Sisen & Pressman (1950)
showed that the antigen which absorbs ^81 I-labelled
kidney-localising antibody from rabbit anti-rat-
kidney serum was not soluble in saline, acetone
or ether. Krakower & Greenspon (195D demonstrated
that the antigen is concentrated in basement
membrane, isolated by ultrasonic vibration and
optically free of cells; isolated glomerular
cells were found to be 50 times less antigenic
than basement membrane on the basis of nitrogen
content. The results presented in Section II of
this thesis appeared to confirm that the basement
membrane was the nephrotoxic antigen. Thus the
tryptic digests were assumed to be derived from
this insoluble basement membrane. Subsequent
work which supported this assumption was the
observation that the concentration of nephrotoxic
antigen in immature glomeruli, where the basement
membrane is thin, is less than in mature glomeruli
(Krakower & Greenspan, 195^)•
However/
However, there is considerable evidence
which indicates that this assumption is erroneous,
i'irst, tne reaction obtained in the present
experiments between anti-digest sera and saline
extracts of whole kidney (Table XI) suggest
that the glomerular digest was derived in part
from a saline-soluble source, for the saline extract
had been spun free of suspended material. Lippmanh
et al. (1950) found that at least 12 per cent of
the globulin in anti-rat-kidney serum was
precipitated by the saline-soluble portion of a
kidney suspension. Second, Baxter & Goodman (1956)
observed that saline extracts of rat kidney had
some effect in absorbing nephrotoxic antibodies
from rabbit antisera. Third, Rothenberg et al.
(1956) found that the passive haemagglutination
titre of anti-rat-kidney serum, using a saline
extract of rat kidney as antigen, is closely
correla,ted with the nephrotoxicity of the serum.
Fourth, and even more significant, Liu et al. note
a good correlation between the nephrotoxicity of
rabbit anti-rat-kidney sera and its cytotoxic effect
for rat kidney cells in tissue culture. Finally
Dresner & Schubert (1955) have shown that





It must be concluded, therefore, that
tryptic digests of glomeruli represent mainly
cellular breakdown products; digests of whole
| kidney contain an even greater proportion of such
material. Furthermore, the relative importance
of glomerular basement membrane and cells as
the antigens responsible for nephrotoxic nephritis
must be regarded as still unproven. Goodman &
Baxter have shown that tryptic digests of rat lung,,
skeletal muscle, heart and liver also contain
! antigens capable of absorbing nephrotoxic antibodies
from anti-rat-kidney serum. It seems likely,
therefore, that endothelial cells, -which are common
to all these organs, rather than epithelial cells
peculiar to the glomeruli should be investigated
as the source of a nephrotoxic antigen. Until
this point has been settled, there is little to
I be gained from chemical analysis of digests.
SUMMARY
Immunological studies have been conducted
on six tryptic digests of human glomeruli and
three tryptic digests of whole human kidney.
The digests have been shown to contain
hapten!c/
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haptenic material specific to the glomerulus.
Rabbits were immunised with both types
of digest alone, adsorbed on to streptococci and
in Freund's adjuvant. The digests themselves were
antigenic and no adjuvant effect was noted. The
antisera reacted with the digests and also with a
saline extract of whole human kidney. Attempts to
localise the antigen(s). with fluorescein-labelled
antisera were unsuccessful.
The results are discussed in relation
to other work on tryptic digests of kidney and on
nephrotoxic nephritis.
It is concluded that the antigenicity of
the digests is due to protein rather than poly¬
saccharide and that they consist mostly of
cellular breakdown products rather than material
derived from basement membrane..
THE ROLE OF "AUTO-ANTIBODIES" IN HUMAN GLOMERULO¬
NEPHRITIS.
.
Although the literature contains many
art 1 eles purporting to describe the occurrence
'
of auto-antibodies to kidney tissue in human
glomerulonephritis, the role of' such substances
is still uncertain. Thus, few workers have
established/
102.
established that the reactive substance in the
serum is gamma globulin and few have attempted to
identify accurately the antigen or hapten in
kidney tissue or extracts. Furthermore, some of
the techniques used are known to be unreliable.
The object of the present study was to obtain
information about the presence of a pathogenetic
tissue antibody in acute glomerulonephritis.
Evidence has been sought of a direct reaction
between serum and human kidney or its derivatives
and the serological specificity of such reactions
have been investigated. Tissue-localising
antibodies have been sought by the fluorescent
antibody technique. Attempts have been made to
elute antibodies from isolated glomeruli and the
eluates have been subjected to the same procedures
as the sera. The results have been presented at




Sera and glomeruli were obtained as
indicated in Table XIV. Acute appendicitis and
chronic cholecystitis were chosen as non-renal
diseases, more or less comparable in their general






























































unlikely to be associated with an immune mechanism.
Rabbit anti-human-glomerulus serum (Rabbit 169)
was used as a positive control. Details about the
cases of acute glomerulonephritis are shown in
Table if/. The diagnosis was confirmed histologically
in all cases where glomeruli were obtained, in the
remaining cases of disseminated lupus erythematosus
by biopsy in one case of anaphylactoid purpura and
in all cases of appendicitis and cholecystitis.
The source of all sera will be found in the
Appendix, pp. 205 - 207.
Sera were separated, clarified when
necessary by the method of McFarlane (194-2) and
stored in the deep-freeze until used. Some of
them were fractionated with ammonium sulphate to
give euglobulin, pseudoglobulin and albumin frac¬
tions. The globulin precipitates were dissolved
in phosphate buffer at pH 7.0, dialysed free
of SOq." and brought to the original volume by the
addition of buffer or dialysis against 15 per
cent polyvinylpyrrolidone in phosphate buffer.
The albumins were dialysed free of SO^1' and reduce
to the original volume by the same method. Several
of these fractions were analysed by filter paper
electrophoresis.
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reactions were absorbed with a wet preparation of
normal human glomeruli in the proportion of
1 mgm/ml. This absorption was repeated a second
time if the reaction was unchanged by one absorption,
! Eluates.
Glomeruli were isolated by the method
used previously; all preparations being kept at
^-°C. during the isolation and washing (see Appendix
;p;186 ). Elution was performed by methods
which have been proved successful in other studies
of tissue antibodies, namely, heating at 60°C.
(Korngold & Pressman, 1953)? N sodium hydroxide
i at pH 11 (Pressman & Sherman, 195D and 0.2M
citric acid at pil 3 (Talmage et al. , 195^+). The
method of Heidelberger & Kendall (1936), using
15 per cent saline followed by barium salts was
also used. Samples of diseased glomeruli
varying from 0.1 to 0.5 gni. were used, the same
quantity of each preparation being subjected to
each of the procedures. A further sample of each
preparation was extracted with normal saline at
37°C. for 1 hour as a control. Samples of normal
glomeruli were subjected to each of tne procedures
Details of the elution procedures are given in
the Appendix (pp. 199-200 and the source of the
glomeruli on pp.205-207).
The eluates were spun to remove insoluble
material/
107.
material and the supernates separated. An equal
volume of saturated ammonium sulphate was added
and the tubes stood overnight at A°C. They were
then spun, the precipitates dissolved in phosphate
buffer and dialysed until free of SO."^, The
volume was adjusted to 2 ml. in each tube and
any insoluble material spun off. The tubes were
then stored in the deep-freeze until used. The
globulin concentrations of the. eluates were
determined by the method of Kingsbury et al. (1926)
and from the results obtained the amount of globu-
:lin per gin. (wet weight) of glomeruli was calculated.
Antigens.
The "antigens" .used were tryptic
digests of normal human glomeruli (7?13) or
| kidney (9,11 & 12) used in the preceding experi¬
ments (pp. 81 - 100), a saline extract of
| whole normal human kidney (Rothenberg et al.,
1956) and a suspension of trypsinised normal
I human glomeruli (Milazzo, 1957). Details of
preparation of the antigens are given in the
Appendix (pp. 187 & 198)
.
Serological Procedures.
Sera ana eluates were tested for
.
| precipitins against the tryptic digests and saline
extract by the interfacial ring method and the
capillary/
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capillary oube method and for complement fixing
antibodies against all the antigens by the
| method used in Section II ( p„ 58 ). The
sera were also tested for tissue-localising anti-
:bodies by the direct and indirect fluorescent
antibody methods. The general principles of
these experiments has already been described
(Section I ). Fresh frozen sections of
normal human kidney were treated with the various
sera. In the direct method, samples of the
patient's sera were labelled with fluorescein
isocyanate, the globulin fraction salted out and
absorbed twice with acetone-dried guinea-pig
liver powder. In the indirect method the procedure
. of Weller & Coons (195*+) was followed, namely,
sections were treated with unlabelled. patient's
serum, washed for 10 minutes in phosphate buffer
and then treated with the globulin•fraction of
The almost complete absence of cross-reactions between this
antiserum and purified, fractions of human plasma is seen
in Fig.4*+. Fig.*+5 shows that a single band of
precipitation, with the reaction of identity, occurred when
unlabelled and labelled samples were tested against
purified gamma globulin.
and inhibition of staining; the remaining sera
were tested by all the methods described. Only
the indirect fluorescent antibody method was used
in/
108a.
Fig.44. Ouchterlony plate. The centre cup
contains anti-human globulin serum. The peri¬
pheral cups contain serum (1), albumin (2),
oL & 15 globulins (Cohn Fraction IV) (3),
% globulin (4 & 5 - two different samples) and
antihaemophilic globulin (6). Note the single
band between the antiserum and cups 4- & $'•
^ globulin is responsible for the' bands between
tne antiserum and cups 1 & 6.
Fig.4-5. Ouchterlony plate. The upper cup contains
human jf globulin, the lower left unlabelled anti-
human-£ -globulin and the lower right fluorescein
labelled anti-human- -globulin.
109.
in testing the eluates.
RESULTS
The overall results are shown in Table
XVI. Only one positive result was obtained in
| precipitin tests, when one of four samples of serum
I from a case of Type II nephritis reacted with the
tryptic digests. Absorption with glomeruli had
no effect upon the reactions. No reaction was
[ obtained between this serum and the other antigens,
complement fixation tests with the digests were
negative and no tissue localising antibodies were
demonstrable. This case is of considerable inter-
jest for the nephritis commenced shortly after
immunisation with poliomyelitis vaccine; the
relationship between these two features will be
discussed later (pp. 1+2 ). None of the
i sera or eluates gave positive results in agglutinin
tests. No evidence of specific tissue-localising
antibodies was obtained with any of the sera or
eluates.
Positive complement fixation tests were
obtained with 16 sera; 10 others were anticomple-
smentary. The titres obtained with the various
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reactions were obtained with tryptic digests of
whole kidney and one such preparation (9) was
used for further tests after absorption or
fractionation of the sera. Similar reactions were
obtained with tryptic digests of isolated glomeruli
The effect of absorbing the reacting sera with
normal human glomeruli is also seen in Table
XVII. Reduction in titre by more than one tube
was seen on two occasions. In the remaining
instances, initial titres of 1/1 or 1/2 were
abolished or the absorption produced no diminution.
Indeed, in two instances increase in titre by one
or two tubes occurred, even after a second absorp¬
tion. Sufficient material for fractionation of
five sera was available. The fractions, adjusted
to the volume of the sample from which they were
derived, were tested against the antigen(s) with
which the original serum had reacted, and the
results of tests with these fractions are seen in
Table XVIII. Insufficient antigen was available
to perform all of these tests with serial dilutions
of the serum fractions. Positive results were
not confined to the euglobulin fractions. Filter-
paper electrophoresis indicated that all the
albumin fractions and the pseudoglobulin fraction
of serum 29 were free of ^ -globulin and that the
pseudoglobulin fractions of sera 81 and 88
contained approximately one-half and one-fifth of
the/





Acuteappendicitis814.16 8814 xWherereciprocalofserumdilutionn tgiven,lythundiluted fractionwasused.
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"the y -globulin present in the corresponding
euglobulin fractions. The fractions of serum 63
were not analysed.electrophoretically.
The results of tests with the eluates
are shown in Table XIX. No attempt was made to
titrate serial dilutions of these preparations.
Positive results occurred only in complement
fixation tests with the tryptic digests. It should:
be noted that the eluates from normal and amyloid
1
glomeruli gave similar reactions to those from
nephritic glomeruli and that there is no correla¬
tion between the globulin .concentrations and the
results of the complement fixation tests.
DISCUSSION
Witebsky et al. (1957) have recently
suggested certain criteria which should be fulfilled
in order to prove the role of an auto-antibody in
the pathogenesis of a disease. It Is pertinent
to discuss the present and previous results in
glomerulonephritis in relation to these criteria.
'Direct demonstration of free, circulating antibodies
that are active at body temperature or of cell-bound
antibodies by indirect means.1
A pathogenetic auto-antibody must, by
definition, react with the patient's own tissues.
Neither the present experiments nor any of those
described/
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described previously have attempted to show that
the serological changes are those of a true auto¬
antibody. The reagents involved have been serum
and the tissues of another human subject. Any
antibodies demonstrable in such experiments are
really a form of iso-antibody - a homo-antibody
in transplantation terminology. However, the
results of studies with other tissue antigens,
such as brain, lens, sperms and thyroglobulin
suggest that such an antibody would also act as
a true auto-antibody. The term "auto-antibody"
is used in this thesis with this reservation.
No evidence of any agglutinating or
tissue-localising activity has been found in the
present study, either in the serum or in eluates.
A precipitin reaction was obtained with one of
four samples of serum from one case of Type II
nephritis, but this was proved non-specific by an
absorption test and by inability to get a reaction
with that serum in other tests. Several nephritic
sera and most eluates gave positive complement
fixation tests which were regarded as non-specific
for the following reasons. Firstly, absorption
with glomeruli had no significant effect upon the
reaction except in two instances. Secondly, similar
reactions occurred with sera from cases of acute
appendicitis/
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appendicitis and eluates from normal glomeruli;
these results also were unaffected by absorption.
Thirdly, reactions occurred at the same or higher
titres with serum fractions from which ^ -globulin
was absent ,or in which the concentration was much
reduced,as were found with fractions containing
normal serum concentrations of ^ -globulin.
Fourthly, there was no correlation between the
protein concentration in the eluates and the
intensity of the reactions; indeed, reactions
occurred with some preparations which probably
contained no protein. It should be emphasised
that the highest total protein concentration in
eluates from nephritic glomeruli was one five-
hundredth of the normal serum level. Fifthly,
none of the other tests with sera or eluates which
gave these complement fixation reactions was
positive. There is thus no concrete evidence
that antibodies were responsible for the reactions
observed.
These results are supported by those
of Spielmann et al. (195L0 who obtained complement
fixation reactions in controls as well as in
nephritics using the original Wassermann technique,
but no reactions using 50 pen cent haemolysis
as the end-point. They concluded that certain
proof of auto-antibodies by the complement fixation
technique/
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technique is not possible. Kay et al. (194-1)
had previously been unable to demonstrate comple¬
ment fixing auto-antibodies in post-scarlatinal
nephritis. A critical examination of other previous
work indicates that the nature of the seruin cornpon-j
sent responsible for complement fixation (Vorlaender,
1952s Wendelberger & Frohlich, 1955) or passive
haemagglutination (Vorlaender, 1955; Vorlaender
& Nilssgens, 1957) has not been identified,
Gadjusek (1958) has demonstrated a complement fixa-
stion reaction, which is a property of the
globulin fraction, but which lacks either tissue-
or species-specificity. Furthermore, this so-
called 'auto-antibody' did not react with antigens j
prepared from the patient's own tissues (Mackay
et al., 1957)° Absorption tests to establish
the specificity of the reactions do not appear to
have been performed by any of these workers.
The same criticisms apply to results obtained with
the collodion particle technique, which is
notoriously unreliable (Morris, 19^+2; Cavelti,
19k7); indeed, some of those who have used it for
this problem have themselves commented on this
point (Lange et al. , 19^9; Bialestock, 195D'
'Recognition/
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'Recognition of the specific antigen against which
this antibody is directed.'
Only one of the antigens used in this
work has been identified histologically, namely,
the suspension of trypsinised glomeruli. This is
cell-free and consists of the basement membrane
of the glomerular tufts and Bowman's capsule,with
small quantities of tubular basement membrane.
Similar preparations, obtained by maceration in
dilute alkali, have been studied in detail and
accurate information is available about the
physical, biochemical and histochemical properties
(see Section II, pp. kk - )• Milazzo has shown
that the antigenicity of glomerular basement
membrane is not impaired by tryptic digestion.
Only one nephritic serum in the present study
reacted with this antigen. The reaction occurred
in a complement fixation test, was not affected
by absorption with glomeruli and was not confirmed
by the other techniques used. Some features of
the tryptic digests have been discussed in the
preceding Section (pp. 97 - 100 ). The saline
extract of whole kidney is similar to those used
by most previous workers in serological tests
in nephritis. Its histological and chemical
nature is not known, but it must contain serum
proteins and soluble materials derived from
many/
many cells and interstitial tissues: the basement
membrane is not represented as it is insoluble in
saline. Glomerular cells have not been present
in undegraded for i in any of the kidney extracts
used in this or previous work in human nephritis.
I If they can be prepared from human material, the
specific mixed agglutination technique of Coombs
et al, (19li-5) might be applied. However, no immuno-
rhistochemical evidence of an antibody to glomerula
cells could be demonstrated in the present work.
|Studies with tryptic or saline extracts may be
complicated by the fact that they may give
reactions such as those described by Kidd &
jffriedewald (19H2a,b) in rabbits and attributed by
them to normal tissue antibodies. The antigen
responsible for this reaction was present in
highest titre in the kidney. There is some
evidence that such an antibody occurs in man
(Thomas et al., 19^3). Fischel (1957) suggests
that a false positive Wassermann reaction has
also to be considered in assessing complement
fixation tests.
The present negative and inconclusive
results might be attributable to the techniques
used. However, all of these and all of the tissue
extracts have been of some value in studies of
antisera to kidney or glomeruli produced experi¬
mentally in a heterologous species.
Furthermore/
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Furthermore, precipitin, complement fixation and
tissue localisation studies with the fluorescent
antibody method have been successful in demon-
:strating circulating antibodies in human diseases
such as Hashimoto's disease (Roitt et al., 1956;
Trotter et al., 1957; White, 1957) and disseminated
lupus erythematosus (Holborow et al., 1957; Selig-
:mann, 1958)* It is, of course, possible that
the tests used in the present work were not
sufficiently sensitive and that small quantities
of antibody might have been detected by passive
haemagglutination. However, Stavitsky (1954-) has
pointed out that the great sensitivity of
haemagglutination reactions may be a drawback with
impure antigens. It is also possible that the
sera were not obtained at a time when antibodies
were present. Sixteen of the sera were collected
two weeks or less.after the onset of the disease
and five of these within one week of onset. If
circulating tissue antibodies are responsible for
the renal damage they should have been detected
in at least some of the samples.
Theoretically, there are good reasons
why antibodies to glomerular components are
unlikely to be found in the serum, even if they
are formed. First, the amount of tissue available
for combination with any such antibody is so great
that/
that enormous quantities would have to be produced
to attain any excess free in the circulation.
Pressman & Eisen (1950b) were unable to saturate
the anti-kidney antibody-binding sites in the
mouse with 15 mgm. of globulin from a rabbit anti-
mouse-kidney serum. The close antigenic relation¬
ship between the basement membrane of the glomerulus
and that elsewhere (see Section II) Indicates that
antibodies directed against the glomerular basemen 1
membrane would be bound to many other organs and
tissues. This is probably also true for anti¬
bodies against glomerular endothelial cells.
There is no evidence of excessive activity in the
reticuloendothelial system or of plasma cell
infiltration of the kidney in acute nephritis.
Second, it is known that circulating heterologous
antibodies to kidney are rapidly bound to the
tissues (Sarre and Wirtz, 1939; Pressman et al.,
1950; Lippman et al., 1952). Auto-antibodies to
kidney in human glomerulonephritis would therefore,
be much more likely to be bound to tissue than free
in the serum. It is usually assumed that the
auto-antigen is located in the glomeruli and is
produced by the action of a bacterial product.
As the infection which precedes acute glomerulo¬
nephritis is frequently a streptococcal tonsillitis,
it is surprising that no attempt has been made to
demonstrate/
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demonstrate such a tissue alteration in the tonsil,
where the concentration of bacteria and their
products is highest. The tonsil could, furthermore
be the source both of an auto-antigen and its
specific auto-antibody. Such an auto-antibody
might then cross-react with antigenically related
normal tissue components in the glomeruli and so
produce nephritis. If auto-antigens can be
produced in man by this mechanism a significantly
high incidence of glomerulonephritis and rheumatic
fever is to be expected in those cases of agamma-
:globulinaemia where the antibody-producing
apparatus recovers.
Whatever the source of a tissue-localisin
antibody it should eventually be demonstrable in
the tissue which is the site of the primary
pathological lesion, in this instance the glomeruli
Mellors & Ortega (1956), using the fluorescent
antibody technique have demonstrated ^ -globulin
in the glomeruli in human glomerulonephritis.
Their results have been criticised by Vazquez &
Dixon (1957) on the grounds that comparative
studies of other serum proteins were not made and
that there are possible non-immunological explana¬
tions for the observations. However, the
sections prepared by Mellors & Ortega were washed
repeatedly/
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repeatedly In phosphate buffer before application
of the labelled antiserum, so that any soluble
^ -globulin was almost certainly removed, Never-
| :theless, it is difficult to see how this approach
could be used to investigate the role of a tissue
|antibody. It seemed more likely that elution
methods, known to be satisfactory for such anti-
:bodies, would provide the answer. The non-specificity
of the present results with eluates has already
been discussed. The protein concentrations in the
eluates have been calculated in terms of the amount
eluted per gm. of tissue (Table XIX). There is
no significant difference between the controls
and the cases of nephritis, so it is unlikely
that any tissue-bound antibodies have been eluted.
As with the sera, the tissue was obtained within
two weeks of onset in four of the five cases
studied. However, only one of the autopsies was
performed within twelve hours of death, so that
post-mortem changes may have affected the results.
'Production of antibodies against the same antigen
in experimental animals; appearance of pathologi-
;cal changes in the corresponding tissues of an
actively sensitised animal that are basically
similar to those in the human disease.'
No attempt has been made in these studies
to produce either auto-antibodies or lesions in
experimental animals. The model upon which most
work of this nature has been based is that of
Cavelti/
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Caveltl & Cavelti (19^+5) • Many workers have
repeated this work and been unable to confirm the
results. Bohle et al. (195^) reviewed in detail
the literature on this and other forms of experi¬
mental nephritis and conducted a comprehensive
series of experiments. No serological studies
were reported but neither clinical nor pathological
evidence of diffuse nephritis was obtained. The
authors concluded that no one has reproduced diffuse
glomerulonephritis with the Cavelti technique or
modifications thereof. It is unfortunate, there¬
fore, that they and other writers have used the
term "Cavelti-nephritis". Subsequent work by
j Sarre & Rother (195^) had similar results. The
only attempts to produce true auto-antibodies seem j
to be those quoted by Grabar (1957)j who was unable
; to demonstrate circulating auto-antibodies in
| rabbits immunised with one of their own kidneys.
Unless pathogenetic auto-antibodies and. the
I antigens responsible can be conclusively identified
in human glomerulonephritis there is no place for
further animal experiments of this type.
CONCLUSIONS
At the present time, none of the four
criteria suggested by Witebsky et al. have been
fulfilled in respect of human glomerulonephritis.
There are undoubtedly features about the disease
which/
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which suggest that it may he initiated by an immune
mechanism but there is no unequivocal evidence
that auto-immunisation to kidney is responsible.
The role of auto-immunisation in the later stages
of the disease is not yet established. Fischel,
in reviewing this question, has suggested that the
J nephrotic syndrome and chronic nephritis may be
j interpreted as non-allergic sequelae of an initial
; renal injury. The present work indicates that
! immunological studies in such patients must be
pursued with caution and rigorously controlled.
SUHHAHY
Sera from cases of acute glomerulonephritis
j and other renal diseases have been examined for
precipitating, agglutinating or complement fixing
antibodies against tryptic digests of normal
| human glomeruli, cell-free glomerular basement
[ membrane and a saline extract of kidney. No
conclusive evidence has been found for the presence
of circulating tissue antibodies. Such reactions
as were observed were shown to be non-specific.
Eluates prepared from nephritic glomeruli
showed no evidence of tissue-bound antibodies
but gave similar non-specific reactions.
None/
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None of the sera or eluates contained,
tissue-localising antibodies detectable by the
fluorescent antibody method.
The results are discussed in relation
to recent work on experimental nephritis and
on serological reactions in humeri nephritis.
There is no unequivocal evidence that auto-immun-
:isation to kidney is responsible for the disease.
THE ROLE OF "AUTO-ANTIBODIES" IN ANAPHYLACTOID
PURPURA
The aetiology of anaphylactoid purpura
is unknown, though it is generally believed to be
a manifestation of hypersensitivity. Gairdner
(19^-8) emphasised the importance of streptococcal
infection preceding the onset or provoking relapses
or exacerbations. Lewis (1958) observed that an
upper respiratory tract infection preceded the
onset in 73 out of 116 cases; throat swabs were
taken in 93 cases and haemolytic streptococci were
isolated from 35 of these. Stefanini & Mednicoff
(195^) claimed that the serum of patients with
anaphylactoid purpura gave a precipitin reaction
with extracts of blood vessels.
It seemed desirable, therefore, to
determine whether auto-immunisation to vascular
tissue, in the manner postulated for acute
glomerulonephritis/
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glomerulonephritis, occurred in anaphylactoid
purpura. The investigation followed much the same




Sera were obtained from 16 patients
suffering from the disease, 9 of whom had evidence
of renal involvement. Two samples of serum were
; obtained from each of two patients in the nephritic
group. Sera were separated and stored in the deep¬
freeze until used. Biopsies, taken to include a
lesion and adjacent uninvolved skin, were obtained
from two of the patients without renal involvement.
The sex, age and time between the onset of the
disease and collection of serum are shown in Table
XX; the source of all sera is given in the
Appendix (pp. 205-207).
The "antigens" included all those used
: in the study of glomerulonephritis, three
prepared from normal mesenteric arteries by
extraction with normal saline, 5M potassium
chloride and trypsin respectively and cell free
; reticulin prepared from mesenteric arteries by
: tryptic digestion (as for glomerular basement
membrane in the previous study). For details of
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(pp. 198 - 199 ).
The serological procedures were those
used in the study on glomerulonephritis. The
blood vessel extracts were used only for inter-
:facial precipitin tests; the arterial reticulin
only for agglutination tests. Tests for tissue-
localising antibodies were performed on sections
of normal skin and kidney and on the two biopsies.
RESULTS
The results are shown in Table XXI.
Sixteen sera were negative in all tests, though
three of these xvere anticomplementary. The two
positive results occurred in complement fixation
tests with a tryptic digest of kidney. The tests
were repeated after the sera had been absorbed
with glomeruli (see p. 104- ). The initial titres
of 1/1 and 1/2, became lA and negative. None
of the other tests with these two sera was
positive.
DISCUSSION
The points made in the preceding
discussion concerning the non-specificity of
the complement fixation tests are again applicable,









tissue has been found. It must be admitted,
however, that the blood vessel preparations were
not obtained from vessels of the type primarily
involved in anaphylactoid purpura, namely
capillaries, arterioles and venules (Gairdner).
Theoretically, endothelial cells and reticulin
throughout the vascular tree should be similar
and there is considerable evidence that they are
closely related antigenically. Thus, Clark &
Jacobs (1950) found that the injection of dogs
with rabbit antisera to dog aortic endothelium
resulted in widespread haemorrhagic purpura.
Similar results following injection of guinea-
pigs with rabbit antisera to guinea-pig aortic
endothelium are mentioned by Bernard et al.(1955)
and Strehler (1951) produced nephrotoxic nephritis
in guinea-pigs by injecting rabbit anti-guinea-
pig-aorta serum. ^-^I-labelled rabbit antisera
to rat liver blood vessels (Pressman et al., 1951)
and rat aorta (Pressman et al., 1952) both localise
in liver, kidney and lungs. The work described in
Section I of this thesis provides further evidence
of the close antigenic relationship between reticu-
:lin in arteries and capillaries. Indeed, the
only evidence to the contrary is that of Scott
(1957), who found that arterial and capillary
reticulin were antigenically different. However,
his results are not clear-cut (see Table II,p. ^6
and/
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and have not yet been confirmed.
The absence of undegraded endothelial
I cells from the "antigens" used must again be noted.;
It would appear that they were the major antigen
in the experiments of Clark & Jacobs and of
|Bernard et al. Furthermore, purpura is not a
j feature of nephrotoxic nephritis. If tissue anti-
:bodies are concerned in anaphylactoid purpura it
seems more likely that they will be directed against
the endothelium than the basement membrane of the
capillaries.
The argument developed in the preceding
discussion concerning the relative importance of
tissue-bound and circulating antibodies is equally j
applicable to the disease now under discussion.
The possibility of obtaining tissue from which
antibodies could be eluted Is remote, but the
opportunity should not be neglected If it arises.
However, it seems unlikely that auto-immunisation
to vascular tissue is responsible for the disease.
SUMMARY
Sera from cases of anaphylactoid purpura
have been examined for precipitating, agglutinating
or complement fixing antibodies against tryptic
digests of normal human glomeruli and artery,
cell/
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cell-free glomerular basement membrane and
arterial reticulin and saline extracts of kidney
and artery. No conclusive evidence has been
found for the presence of circulating tissue
antibodies. Such reactions as were observed were
non-specific.
None of the sera contained tissue-
localising antibodies detectable by the fluorescent!
antibody method.
It is concluded, that auto-immunisation
to vascular tissue is unlikely to be responsible
for the disease.
135.
itefhrotoaich'y studies in relation to poliomyelitis!
VACCINATION.
.
The British poliomyelitis vaccine, like
j those produced elsewhere, is grown in tissue
■ cultures of rhesus monkey kidney. In September,
: 1955- I was asked by the Medical Research Council
j Subcommittee on Poliomyelitis Vaccine l) to
investigate the possibility that the vaccines
might contain antigenic material capable of
stimulating the production in man of antibodies
which might combine with human kidney and. cause
glomerulonephritis, and 2) to investigate the
immunological relationship between monkey kidney
and. human kidney. The results of these
experiments were submitted in Memoranda to the
Subcommittee in May and December, 1955.
Antigenicity of the Vaccine,
_
The material used in these experiments
has been supplied by Messrs. Glaxo Laboratories
Ltd. and I am indebted to Dr. W. Mood of those
Laboratories for the following information.
'Before addition of the seed virus, monkey
kidney tissue is incubated with the synthetic
protein-free culture medium Connaught No. 199
(Morgan et al,, 1950) by a method similar to
that of Farrell et al. (1953). No animal
serum or extraneous protein other than that
!derived/
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derived from the monkey kidney tissue is added.
The fluid removed from such cultures contains
approximately 20-30 mgm./lOO ml. total nitrogen,
12 mgm./lOO ml. amino nitrogen and less than
1 mgm./ml. protein nitrogen. Since these values
are of the same order as those in the final vaec- I
:ine, it was decided to use the culture fluid in
the present experiments. Before use the fluid
was clarified by passing through sintered
glass filters of graded porosity according to the
usual technique followed in vaccine production.
The pore size of the final filter is 0.7 - 3*0
microns. Thus, the spent culture fluid used
differs from the final vaccine only in the absence
of the virus.
Two experiments were performed:
1) production of generalised anaphylaxis in
guinea-pigs. Six animals (14—19) received
sensitising doses of 2 ml. intraperitoneal!^
and shocking doses of 10 ml. intravenously
10 days later. No reaction occurred.
2) production of antibodies in rabbits. Two
animals (156 & 157) received a total of
25 ml. each in 12 divided intravenous
doses at two-day intervals. They were
bled 18 days after the last dose. The
sera were tested by the precipitin ring
reaction using serial dilutions of both
sera and culture fluid. No reaction
occurred. Each serum was then tested in
3 guinea-pigs (20-25) for its ability to
produce passive cutaneous anaphylaxis by
the method of Ovary (1952). No reaction
occurred. Both rabbits subsequently
produced antibodies to human gamma
globulin.
Details of the injection schedules are
given in the Appendix (pp. 196 & 198)
137.
Antigenic relationship between monkey kidney and
human kidney.
Two rabbits (Ikk & Ik5) were immunised
! with a suspension of whole monkey kidney, by a
; procedure similar to that used previously
(Section II5 protocols in Appendix, ~p . 196 j
Antibodies to monkey serum and red cells were
! removed, by absorption and the sera conjugated with
I fluorescein. Sections of monkey kidney treated
j with one of the labelled sera and examined in the
| fluorescence microscope showed staining in the
same sites as had previously been demonstrated
with antisera to rat kidney (Hill & Cruickshank,
1953)5 namely the basement membrane of glomeruli
j and tubules, reticulin in vessels and tubular
| epithelium. The specificity of this staining was
established by inhibition and absorption tests
as described, previously (Section II, pp. 8-11 )
The other labelled serum failed to react.
The application of the active labelled
serum to sections of human kidney produced
precisely the same pattern of staining, also due
to specific antigen-antibody union.
Antihuman glomerulus sera used in the
experiments described in Section I and anti-human-
kidney sera prepared subsequently (Section III,
p . 8k ) produced identical staining in
monkey/
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monkey kidney to that seen in human kidney.
Antibodies to kidney in the sera, of vaccinated
human sub .i e c ts.
In view of the completely negative
results following immunisation of guinea-pigs and
rabbits no systematic examination of the sera of
vaccinated human subjects has been undertaken.
This decision was endorsed by the Medical Research
Council Subcommittee on Poliomyelitis Vaccines.
However, one patient encountered in the study
of auto-antibodies 'in nephritis is of interest
for the attack of nephritis commenced shortly
after the second injection of poliomyelitis vaccine.
Abstract of Case Notes:
Christopher M. aet 2-§-.
3.7*56. Admitted Belvid.ere Infectious
Diseases Hospital.
No past illnesses. No personal or family
history of allergy or sensitivity;
no adverse reaction to diphtheria immunis-
:ation at 9 months.
Present Illness:
25.5.56. 1st poliomyelitis vaccination -
Glaxo Batch 5A.
26.5.56. Developed generalised itchy rash,
more profuse over arms, and leg of inocu-
:lated side. Red spots with small blister
on top. Rash lasted for a week.
Diagnosis: papular urticaria.
22.6.56. 2nd poliomyelitis vaccination -
Glaxo Batch 6E.
26.6.56. Eyes puffy, becoming more severe
over next week with oedema developing in





Remains of rash on legs. Oedema of
abdomen, penis, legs' and feet. Throat a
little red.
Laboratory Investigations;
5.7.56. Albuminuria (14- gm./litre) 5
granular casts; blood ++. Antistreptolysin 0
125 units./ml.
6.7.56. Serum proteins 5.8 gm./lOO ml.;
albumin 2.0 gm./lOO ml.: globulin 3*8 gm./
100 ml. '
Blood urea nitrogen 32 mgm./lOO ml.
9.7.56. Throat swab - haemolytic streptococci.
14-.7.56. Transferred to Royal Hospital for
Sick Children, Yorkhill.
Diagnosis: Type II nephritis.
16.7.56. Prednisolone commenced.
21.7.56. Serum proteins (after diuresis).
Total 4-.9b gm./lOO ml. <*6-globulin 1.31,
/6 -globulin 1.02, Y'-globulin 0.8l,
albumin 1.84-.
30.8.56. Discharged.
21.3.57 - 9.5.57) Readmitted with relapse.
3.10.57 - 9-11.57)Responded to prednisolone
on both occasions.
Samples of serum obtained on 5.7-56,
8.8.56 and 29.8.56 gave no reactions in precipitin,|
agglutination and complement fixation tests with
the antigens described previously and no evidence
of tissue-localising antibodies. A sample
obtained on 31.7.56 reacted in the precipitin
ring test with a tryptic digest of whole kidney to
a dilution of 1/4-; following absorption of the
serum with glomeruli, only neat serum gave a reac¬
tion. A complement fixation test was performed
with the same reagents. The undiluted serum was




| a 1/9- dilution5 the result was negative. No
reaction was obtained in a precipitin or complement
fixation test with the saline extract of kidney or
in an agglutination or complement fixation test
with cell-free glomerular basement membrane. No
tissue localising antibodies were detected.
DISCUSSION
Although it is commonly believed that the
|antigen responsible for nephrotoxic nephritis is
located in the glomerular basement membrane,
several observations suggest that the glomerular
cells may play some part in the process (see pp. 99
j 100 ). The method of preparation of the monkey
kidney cells for tissue culture probably removes
the greater part, if not all, of the basement
membrane. The subsequent treatment of the culture
;after inoculation with the virus is such that any
1
Ismall portions of basement membrane originally
jpresent are excluded from the vaccine. The cells
used in the tissue culture are derived mainly from
renal tubules. Cortical tubular epithelium is
■
related antigenically to glomerular epithelial
cells (Hill & Cruickshank; Goodman et al.5 1955)
and may therefore be nephrotoxic. However, whole
cells are not present in the vaccine, though
soluble products and insoluble particles resulting
;from/
• from metabolism of the cells or the cytopathogenic :
| effect of the virus will be present (Robbins et al.,
11950; Melnick, 1955) • Mayer et al. (1957)
have shown that infected monkey kidney tissue
| culture fluid contains monkey kidney antigen;
with cultures of trypsinised cells this antigen
j was removed by ultracentrifugation. The close
: immunological relationship between monkey kidney
I and human kidney indicated by the cross-reaction
j obtained with the rabbit antisera suggest that
immunisation of either species with kidney tissue
I of the other would be difficult, probably requiring
large doses of antigen and a strong adjuvant.
This information is interesting, but of secondary
importance to the antigenicity of the vaccine.
The present experiments indicate that filtered
j spent culture fluid contains no antigenic material j
resulting from cellular metabolism. No attempt
has been made to test the final vaccine for such
antigens. Although this may seem theoretically
desirable, it was not considered necessary by the
Medical Research Council Subcommittee on Polio¬
myelitis Vaccines. It should be noted, in this
respect, that the final vaccine and the spent
culture fluid contain the same quantity of protein
-
nitrogen and furthermore that no adjuvant activity
has been demonstrated in any known virus.
The decision against examining the sera
of/
of vaccinated human subjects is endorsed by the
work of Neva & Salk (1955) who found no urinary
abnormality or changes in serum chemistry in
! patients inoculated repeatedly with poliomyelitis
; vaccine: there is no other known example of renal
| disease which might be causally related to vaccina-
; :tion than the one cited here (Macrae, 1958)* On
: these grounds alone it may be questioned whether th
vaccination was responsible for the nephritis.
Furthermore, there is no confirmatory evidence that
the single serological reaction obtained was due tc
antibodies to kidney. The occurrence of urticaria
immediately after the first injection must not be
overlooked, for allergic reactions of a minor
nature have been reported after vaccination
(World Health Organisation, 1956). However, the
! urticaria did not recur after the second injection.
: In considering the aetiology of the nephritis it
must not be forgotten that haemolytic streptococci
were isolated from a throat swab shortly after
admission to hospital. A streptococcal infection
prior to the onset of the illness was not
established, but it cannot be excluded. The
precise aetiology of the nephritis cannot be
determined; the relationship to the vaccination





Fluid from monkey kidney tissue cultures i
was investigated for the presence of antigenic
material. Attempts to produce anaphylaxis in
guinea-pigs and circulating antibodies in rabbits
were unsuccessful.
Fluorescein-labelled rabbit antisera to
human kidney and monkey kidney gave identical
staining reactions in the two species. It is
unlikely that monkey kidney could stimulate anti-
:body production in man.
The occurrence of nephritis shortly after
vaccination is reported in a 2-g year old bojr. The ;
presence of anti-kidney antibodies was not
established. The relationship of the nephritis
to the vaccination is discussed.
SECTI01 IV
IMMPKOLOGICAL STUDIES OF HPMAN AM'BRIOR
PIE 'JITARY HORi'iOHES
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ImGhOLOGlCAL STUDIES OF HUAAH AflTERlOR
PITUITARY HORnCMES
The precise cellular localisation of the anterior
pituitary hormones is not possible with any of the usual
histological or histochemical techniques. Nevertheless, it is
| generally supposed that growth hormone and prolactin are
| secreted by the acidophils. The association of gigantism and
| acromegaly with acidophil adenoma of the pituitary is fairly
sure proof that growth hormone is secreted by the acidopiails in
man. Ealmi (1950) used a modified aldehyde-fuehsin method and
demonstrated two types of basophil in the rat. Pearse (1952),
used a periodic acid-Schiff technique on human tissue and
showed that no carbohydrate-containing substance was demonstrable
in the acidophils and concluded that follicle-stimulating
hormone, luteinising hormone and thyrotrophic hormone (TSH),
which are generally believed to be glycoproteins, must be
secreted by the basophils. Purves and Griesbaeh (1951, 1954)
claimed that three types of basophil could be differentiated in
the rat by the periodic acid-Schiff technique and that these are
the sites of production of the three glycoprotein hormones.
Similar results have been obtained by electron microscopy in
the rat (Farquhar and Hinehart, 1954a, b). Barrnett, Ladman,
McAllaster and Siperstein (1956) used the differential solubil¬
ity of proteins, various staining procedures and bio-assay
methods in an extensive study of the glycoprotein hormones.
Their results suggest that the two gonadotrophins may be
secreted by the same cell. Purves and Griesbach (1955) were
also able to correlate the glycoprotein content of the cells
with the hormone content of the gland as measured by bio-assay.
The changes described by Russfield (1955) in the basojrhils in
diseases of the human thyroid suggest that TSH is secreted by
these cells in man. There is also evidence that adrenoeortico-
trophic hormone (ACTH) is secreted by the basophils in man.
This view is supported by the changes demonstrated in these
cells in Gushing's syndrome by Crooke (1935), in Addison's
i ihera.py
disease by Crooke and Russell (1935), after ACTH/by Golden et al.
(1950-), after cortisone therapy by laqueur (1950) and as a
x-esult of stress by Currie and Symington (1955a, b). All
these/
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these findings are only presumptive, for they did not involve
the specific staining of any of the hormones.
Marshall (lS5l), in the first paper to describe the
application of the fluorescent antibody technique to the localis-
ttat
ation of a tissue component, showedAa labelled antiserum to hog
ACTH reacted with basophils in the hog pituitary. He concluded
that these cells secrete the hormone. This work has been
widely accepted but has not yet been confirmed. In view of
this, and of the successful results obtained by Hill and
Cruickshank (1953) with kidney antigens, it was decided to attempt
to develop specific staining methods for human ACTH, TSH, growth
hormone and gonadotrophins, using the fluorescent antibody
technique. This section of the thesis describes experiments
designed to prepare specific antisera to these hormones,
serological studies of those sera and the results obtained with
early localisation experiments. The work has been reported by
Cruickshank and Currie (1958).
METHODS
Antigens
The hormone preparations used to produce the antisera and
in the serological tests with those sera have been extracted
from human pituitaries (pituitary extracts) or from human urine
(urinary extracts), because other workers have shown that some
anterior pituitary hormones are species-specific (Chow, 1942;
Van Dyke et al., 1950; Marshall, 1951). The preparations used
were:
a) pituitary extracts:
ACTH (Hewett et al., 1954)
TSH (Currie, Cruickshank, Dekanski and Skinner, 1956)
growth hormone, extracted by Mr. L.G. Skinner of
Organon Laboratories and tested for activity by-
Prof. F.G. Young
b) urinary extracts:
post-menopausal gonadotrophin (HMG-20A, Organon)
TSH (Currie, Cruickshank, Dekanski, Hewett and
McGirr, 1956).
For ease in reference, the TSH prepared from the pituitary will
be denoted 'pituitary TSH' and that prepared from urine 'urinary
TSH1. The biological activity of the various preparations is
shown in Table XXII. Although most of them have been shown to
contain more than one biologically active substance, they will
be/
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be referred to by the name of the major hormonal component.
The use of the term 'antigen' for such a preparation does not
imply that there is only one antigenic component.
Several other preparations were used in the serological
tests: hog ACTH (Organonj containing 30.9 I.U. per mgrn.: ox ACTH
(Armourj containing 2.5 I.U. per mgm.; ox growth hormone
(Armour; having 75 - 100 per cent activity of the Armour standard,
preparation; human chorionic gonadotrophin (Pregnyl, Organonj
containing 2060 I.U. per mgm.; a kaolin-acetone extract from
normal human male urine containing 0.1 units of HMG-20A per mgm.
(Loraine and Brown, ISO4; Loraine, 1956); purified pregnant
mare serum gonadotrophin (Gestyl, Organon) containing 4000 I.U.
per mgm; and normal human serum.
Immunisation Procedure
Adult, cross-bred rabbits, kept in individual cages on a
mixed diet, were used to produce the antisera. Subtotal
adrenalectomy, thyroidectomy or castration were performed in
those animals immunised with ACTH, the thyrotrophic hormones
or gonadotrophin respectively. These operations were performed
in order to prevent rapid utilisation of the injected hormone
by its target organ. Details of the operative procedures are
given in the Appendix (pp. 190 - 19l). Immunisation was
commenced two weeks after the various operations.
The hormones were injected as alum-precipitated suspensions
in divided doses, either intramuscularly, or intraperitoneally
and subcutaneously (Marshall, 1954a); growth hormone was also
injected along with Freund's adjuvants. The animals were bled
at intervals aad the injections continued until the undiluted
sera reacted with the homologous antigen diluted to at least
l/lOQO parts in saline. In some instances,the final course
of injections was of a solution of the hormone in saline, given
intramuscularly and/or intravenously. Two rabbits were used
for each of these schedules, except where stated to the
contrary. Details of the immunisation schedules are given in
the Appendix (pp. 194 - 197). When satisfactory titres had
been obtained, the animals were bled and the sera to each
hormone pooled.
Serological Procedures




Biological activity of extracts
Biological activity
Extract ACTH* TSHP SH HMG
(iU/rngm) (H-LU/mgfflJ1" ( gm/mgm) (U/iogm)
ACTH 2.0 0.05 » o t» ♦
TSHP 0.015 1.0 • • • o
SH 0.025 0.1-0.2 111 • •
HMG nil • o 1.0
TSHU 0.2 0.25 ® * 0.8 X
Abbreviations used, in this and other tables are:
ACTS - adrebocorticotrophic hormone
TSHP - thyrotrophic hormone extracted from pituitary
SH - growth hormone
EM! - post-menopausal gonadotrophin
CG - chorionic gonadotrophin
TSHU ~ thyrotrophic hormone extracted from urine
MUE - extract of male urine
HES - normal rabbit serum
* thymus-involution method of Bruce et al. (.1552)
f 1 Heyl-Laqueur unit is approximately equal to
0.1 International Unit of TSH
X ovarian freight method
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against the hormones dissolved in saline. Stock solutions of
one part of antigen to 1000 parts of saline (w/v) were made up.
The pituitary extracts were much less soluble than the urinary
extracts; considerable proportions of all of the former failed
to dissolve, whereas no such difficulty was encountered with
the latter. For use in the tests, the stock solutions were
diluted, with saline in four-fold steps to l/256, giving a final
dilution of the hormone of 1/256,000 (w/v). Precipitin tests
were performed by the interfacial ring technique, antigen
being layered upon serum. Subsequent tests were performed
with serial four-fold dilutions of the antisera in saline
against a constant dilution of the various antigens. All of
these were used a^a dilution of l/lOOO, except normal human
serum, which was used undiluted.
Absorption-precipitin tests were performed by adding
various antigens to the undiluted sera in the proportion of
1 ing. per ml., allowing the mixture to stand for several hours
at room temperature, spinning and then titrating four-fold
dilutions of the absorbed sera against a l/lOGO dilution of the
various antigens. Usually a single absorption gave a clear-cut
result; occasionally the procedure bad to be repeated once.
Agar-gel diffusion precipitin tests were performed by a
modified Ouchterlony technique, using 2 per cent Difco agar
containing 0.85 per cent saline and 1/10,000 thiomersalate.
The plates were poux-ed in a single layer and the cups cut by
hand with cork-borers. Undiluted antiserum was placed in the
central cup and. 1/1000 dilutions of antigens in the peripheral
cups. Duplicate plates were poured; one plate of each system
was incubated at 37°C, the other at room temperature. The
cups were refilled with saline when required. When the plates
were satisfactorily developed they were photographed, using
transmitted light from a Pointolite source aid a plate camera.
The antiserum to ACTH (anti-ACTH) was tested for hormone-
specific antibodies by its ability to precipitate the hormone
from a solution of the extract used to produce it. 15 mg.
portions of the extract were added to 20 ml. of the antiserum
and to 20 ml. of normal rabbit serum. The mixtures were
allowed to stand for several hours at room temperature and then
overnight at 4°G. They were then spun, the precipitates
discarded/
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discarded and the supernatant fluids freeze-dried. Each of the
resulting powders was then tested by Dr. J.B. Dekanski of
Organon Laboratories for ACTE activity by the thymus-involution
method and by the in vitro method of Saffran and Schally (1955).
The original extract was retested at the same time by the thymus-
involution method.
Localisation Experiments
Globulin fractions of the antisera were labelled with
fluorescein isocyanate (see Appendix, pp. 201-202). Sections
of fresh-fraz en tissues were prepared by the method already
described and by the Altmann-Gersh freeze-drying method, followed
by fixation in cold methanol (see Appendix, p. 202) All
sections were treated with labelled antisera by a modification of
the method of Coons and Kaplan (see Appendix, p. 205) and
examined in the fluorescence microscope. Tests for the
specificity of staining were performed according to the
abbreviated method discussed on p. 11; in addition portions of
the labelled antisera were absorbed with the homologous antigen
before use. The adjacent section to that treated with the
fluorescent antiserum or, in some instances, the same section
was then fixed in 10 per cent formol-calcium ana stained by a
modification of the trichrome-periodic acid-Schiff technique of
Pearse (1949). Adequate staining of both fresh-frozen and
freeze-dried material has been obtained.
RESULTS
Precipitin Tests
The initial precipitin tests were performed with undiluted
sera and serial dilutions of antigens, because labelled undiluted
serum, or its globulin fraction, is used in the fluorescent
antibody technique to detect unknown amounts of antigen in the
tissues. It was desirable, therefore, to know the quantity of
antigen which could be detected by the various antisera.
The final titres obtained with the various antisera against
their homologous antigens were:
anti-ACTH: 1/4000 (l rabbit), l/l6,000 ( 4 rabbits)
and 1/64,000 (l rabbit)
anti-pituitary TSH: l/40Q0 (l rabbit)
anti-growth hormone: l/4000 (2 rabbits)
anti-gonadotrophin: l/l6,000 (l rabbit) and
1/64,000/
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1/64,000 ( 1 rabbit)
anti-urinary TSH: 1/4000 (l rabbit) and.
1/16,000 (l rabbit).
The reaction between ACTH arid anti-ACTH resulted in the loss
of 58 - 67 per cent of the activity of the extract (in vitro
method) and 75 per cent of the activity of the extract (thymus-
involution method).
Serial dilutions of the antisera were titrated for cross-
reactions with heterologous antigens, with the results shown
in Table XXIII. It will be noted that the antisera to each of
the pituitary extracts reacted with all of them, but not with
any of the urinary extracts, and vice versa. In particular,
the antisera to the two thyrotrophic hormones reacted with their
homologous antigens but not with the extract of similar
biological activity prepared from the other source.
Anti-AUTH gave no reaction with hog or ox ACTE. Hone of
the antisera reacted with ox growth hormone. Anti-gonaaotrophin
and anti-urinary TSH reacted with Pregnyl and with the kaolin-
acetone extract from normal male urine. Anti-gonadotrophin
gave no reaction with pregnant mare serum gonadotrophin. None
of the antisera reacted with normal human serum.
Absorption-precipitin Tests
Portions of the antisera to the pituitary extracts were
absorbed with, and then titrated against, each of these extracts.
The results are shown in Table XXIV. The only reaction
remaining after two absorptions was that between anti-growth
hormone absorbed with ACTS, and pituitary TSH. Ho specific
antibodies were detected.
Portions of the antisera to the urinary extracts were
absorbed with , and then titrated against, each of these
extracts. Similar absorptions were performed with Pregnyl and
the extract of male urine. The results are shown in Table XXV.
Ho reaction remained. In view of the results in Table XXIII,
no attempt was made to perform absarption-precipitin tests in
in which antisera to pituitary extracts were absorbed with
urinary extracts, or vice versa.
Absorption of each of the antisera with 100 mgm. of
acetone-dried human liver powder per ml. did not alter the




Cross-reactions with various antisera
Antiserum
to ACTH TSHP SE
Antigen
EliG CG TSHU MJE
ACTH 256 4 4 - - - -
TSHP 1 4 1 - - - -
SH 4 16 16 - - - -
HMG - - - 4 4 4 4
TSHU - - 16 16 16 4
FAS - - - - _ - -
Figures given are the reciprocals of the highest dilution
of antiserum which reacted with the antigens, all of
which were used at a constant dilution of l/lOOG.
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Table XXIV
Absorption-precipitin reactions with antisera
to aCTH, to growth, hormone and to
pituitary tliyrotropliin
Antiserum Absorbed Antigen
to with ACTH TSHP SH
ACTH - 256 4 4
ACTH - - -
TSHP - - -
SH - - -
SH - 4 16 16
ACTH * - 4 -
TSHP* - - -
SH * - - -
TSHP - 1 4 1
ACTH - - -
TSHP - - -
SH - - -





Absorption-precipitin reactions with antisera
to urinary gonadotrophia and to
urinary thyrotrophin
Antiserum Absorbed Antigen
to with KMG CG TSHU MUE
HMG - 4 4 4 4
TSHU
( HMx
16 16 16 4
Both ( CG - - -
sera / TSHU






Antisera to each of the pituitary extracts were put up
against all of' these extracts. The result with anti-ACTH is
seen in Figure 46 . Three lines developed, between the antiserum
and the homologous antigen, two lines between the antiserum and
growth hormone and one line between the antiserum and pituitary
TSH. The last-named line fused with one of the other lines
between ea.ch of the other antigens and the antiserum. This
•reaction of identity' (Ouchterlony, 1955) indicates the
presence of an antigen in common to the three preparations.
When anti-growth hormone was similarly tested, one line
developed between the antiserum and the homologous antigen and
two lines between the antiserum and the other two antigens.
Fusion of lines was again seen. Only one line developed
between anti-pituitary TSH and each of the antigens; fusion was
again present. When the absorbed antisera were put up, the
only precipitate which developed was between anti-growth
hormone absorbed with ACTS and pituitary TSH (of. Table XXIV).
Antisera to each of the urinary extracts were put up
against all of these extracts, including Pregnyl and the extract
of normal male urine. Once again, lines which fused developed
between the central and peripheral cups (Figure 47). Second
lines developed between anti-gonadotrophin and both pregnyl and
the extract of male urine; these lines also fused. Three lines
developed between anti-urinary TSH and post-menopausal
gonadotrophin. In all other instances only one line developed.
There is thus at least one antigen shared by the various urinary
extracts. When the absorbed antisera were put up no precipit¬
ate developed (cf. Table XXV*).
Localisation Experiments
The anti-ACTH and anti-gonadotrophin were labelled and
applied to sections before the extent of the cross-reactions
was known. Anti-ACTH reacted with granules Sb the cytoplasm
of some cells, identified by the trichxbme-periodic aeid-Schiff
method as basophils, in sections from several pituitaries.
However, it was not possible to inhibit this reaction by
applying unlabelled antiserum before the labelled sample, nor
was it prevented by absorbing the labelled sample with the





Figure 46. Gel-diffusion reaction oetween
anti-ACTH and ACTH ( eupl), pituitary TSH (cup 2)
and growth, hormone (cup 5).
Cup 1
Cup 2 Cup 4
Cup 3
Figure 47. Gel-diffusion reaction between
anti-HMG and HMG (cup l), Pregnyl (cup 2), urinary
TSH (cup 3) and extract of male urine (cup 4).
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be regarded as non-specific. The pattern of staining with the
labelled anti-gonadotrophin was similar, though not necessarily
involving the same cells as those reacting with anti-ACTH.
Again, it was not possible to demonstrate that the staining was
WluUt Aa-at Wtvv i tV-wsi - to "C
specific. Ihen the same sera were used some months later no
A
reaction was obtained with anti-ACTH, whereas anti-gonadotrophin
still reacted. The pattern of staining obtained with anti-
urinary TSH was again similar aid non-specific; anti-pituitary
TSH was not labelled. labelled anti-growth hormone reacted
with the nuclear membrane and adjacent cytoplasm of many cells
of different distribution from all of the above; these cells
were not identified. This reaction could not be inhibited but
it was abolished by absorption of the conjugate with ACTE,
pituitary TSH or growth hormone.
Hone of the conjugates gave staining in human kidney,
liver or- adrenal. All of them gave bright granular staining
of the cytoplasm of acidophils in the ox pituitary (figure ).
The same cells were stained by a labelled antiserum to ox growth
hormone (For details of the preparation of this antiserum see
Appendix, pp. 196 ). The reaction in the ox pituitary with
all of these conjugat es could neither be inhibited nor absorbed.
The unlabelled anti-ox growth hormone did not give a cross-
reaction with any of the human hormones in precipitin or gel-
diffusion tests, nor did the labelled sample give staining in
human pituitaries.
D1SCUSSI0H
These results raise two questions: (l) the specificity
of the antisera obtained by immunisation with the preparations
of hormones and (2) the reliability of the fluorescent antibody
method for localising normal tissue components.
Hormone-specific Antibodies
The initial object of this work was the demonstration by
the fluorescent antibody method of the site of formation of
ACTH, TSH, growth hormone and gonadotropiiin in the human
pituitary''. This was dependent upon the production of hormone-
specific antisera. There is very little evidence that this
has been achieved. Thus the precipitin test between ACTH and
anti-ACTH gave a higher titre than similar tests with other
antisera and their homologous antigens (Table**"]) and the gel-
diffusion/
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Figure 48. Fresh-frozen section of ox pituitary
treated with fluorescein-labelled anti-human ACTH.
Fluorescent material is in the cytoplasm of
acidophils. Inhibition and absorption tests had
no effect oh this staining. (x 3Q(X)
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diffusion test suggested a specific line between the same
reagents. However, precipitin and gel-diffusion tests after
absorption of the antiserum with the other pituitary extracts
failed to confirm this result. The bio-assay performed after
the precipitin test indicated that the hormonal activity of the
ACTH preparation was reduced by exposure to the antiserum.
This could be due to the presence of a hormone-specific antibody,
but it might also occur if the hormone were attached to an
antigenic carrier and were precipitated with that protein.
The localisation experiments failed to show the presence of any
specific antibody. No antibody specific to either preparation
of TSH was demonstrated in the absorption-precipitin or gel-
diffusion tests. The absence of any cross-reaction between
these two extracts of the same hormone and their respective
antisera is further evidence that neither antiserum contained a
hormone-specific antibody. No evidence of a hormone-specific
antibody to post-menopausal gonadotrophin or to growth hormone
was obtained.
Although no clear-cut evidence of hormone-specific
antibodies was obtained, all of the preparations is ed were
antigenic. The results of the serological tests indicate that
there was an antigen common to the three pituitary extracts and j
another antigen, or antigens, common to all of the urinary
extracts. It would be interesting to know whether these
antigens are related to the biologically active components of
the extracts, say as carrier proteins. If this is so then
further purification of the extracts to remove these proteins
might result in preparations which have increased hormone
content but which may be no longer antigenic.
Previous studies on the ability of the anterior pituitary
hormones to stimulate the production of hormone-specific
antibodies have also led to conflicting results. Thus Chase
(1S4S) claimed that a preparation of ACTH which was homogeneous
by electrophoresis and ultracecitrifugation and in which there
was no evidence of growth, gonadotrophic, thyrotrophic or
lactogenic hormonal activity with the bio-assay methods used,
was capable of provoking precipitating antibodies in mice.
These antibodies neutralised the biol ogical activity of the
hormone preparation. Gordon f1949j was unable to produce
precipitating antibodies in rats immunised with hog ACTH, though
some/ '
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some of the animals became refractory to the hormone. The
antiserum used by Marshall (lS5l) was produced by immunising
adrenalectomised rabbits with hog ACTH and it precipitated
10-20 per cent of the biological activity of a preparation of
the hormone 120 times the standard potency. Morrison et al.
(1952) found that a preparation of hog ACTH which was electro-
phoretically homogeneous (irishman, 1947) was not antigenic in
intact rabbits. Allergic reactions have occurred in human
patients after treatment with ACTH but, in most instances, it
has not been established whether this was due to the hormone
itself or to an impurity. However, in the patient studied by
Feinberg et al. (I95l)» there was evidence that the reaction
was due to the hormone. On the other hand, Clayton et al.
(1952) demonstrated that a complerueny-fixing antibody had no
effect on the biological activity of the ACTH preparation used
and that there was no correlation between the antibody level
and the clinical response. Recent clinical studies have
suggested that 'purified' hog ACTH may not be antigenic.
Thus, perkoff et al. (1955) performed Prausnitz-kustner passive
transfer tests with the serum of a patient who had developed a
severe anaphylactic reaction to hog ACTH. Positive reactions
were obtained with the hog ACTH used in treatment, with another
preparation, of hog ACTH and one of sheep ACTH, but no reaction
oecurred with 'highly purified' oxycellulose hog aCTH.
West (1956) found that patients with acquired resistance to the
effect of various ACTH preparations, including some 'purified'
and 'improved' corticotrophins, responded clinically and by-
increased steroid excretion to corticotrophin A-^ (Dixon ana
Stack-Bunne, 1955). Some of the patients had, in addition,
developed local 'allergic' reactions to the earlier perparation£
but showed no such reactions with corticotrophin A^.
Similar stixdies of growth hormone (Blberg and Li, 19$ ;
PergusOn and Hoyden, 1951; Morrison et al., 1952), pituitary
gonadotrophin (Chow, 1942; Van Dyke et al., 1950; Steelman and
Bunting, 1955) and thyrotrophic hormoxie (Eichbaum and Kinder-
mann, 1936; Rowlands and loung, 1933) have also produced
conflicting results.
There are several reasons why these earlier results are
difficult to interpret. The animal source, the method of
extraction/
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extraction, the purity of the hormone preparations and the
bio-assay methods used have varied. In some instances there
has been no indication of the biological activity or purity of
the preparation. The animal species used for the production
I of the antisera and the methods for determining the antibody
| consent of these sera have varied. Many previous workers have
| used one, or at most two, hormone preparations from the same
species. The hormone-specificity of the antisera has been
judged from cross-reactions between the antisera and serum
protein or extracts from other organs of the species from which
the hormones themselves were extracted and, sometimes, from
cross-reactions between the antisera and preparations of the
same hormone from different species. Tests for cross-reactions
between the antisera and other hormone extracts derived, from the
same species as the hormone in question have rarely been made.
The results presented here indicate that, in studies of
anterior pituitary hormones, it is essential to test the antiser*
against different hormones from the same source of the same
species before concluding that hormone-specific antibodies are
present.
Although some believe tliaf the serum component responsible
for precipitation of a hormone is also responsible for
neutralising its biological activity (Twombly, 1936; Wolfe et al
1945; Chase, 1945)> others believe that these two properties
of an antiserum are unrelated (Bachman, 1935; Rowlands, 1937-8;
Zondek and Sulman, 1942) and use the terms 'precipitating
antibody1 an<i:'neutralising antihormone' to describe them.
Clear-cut evidence that these factors can be unrelated has been
produced by Van den Bride (l94l), who worked with chorionic
gonadotrophin. Such information is not available for any of
the anterior pituitary hormones, so that results based only on
the ability of an antiserum to neutralise the biological
activity of the hormone may not necessarily indicate the
presence of hormone-specific precipitating antibodies.
Tissue Localisation
It would appear to be of little value to attempt tissue
localisation studies with antisera such as those produced in the
present study. However, the results obtained with the labelled
samples of these sera are such as to make the interpretation of
any/
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any future work difficult. Despite the lack of proof of a
honaorie-specific antibody, staining was obtained with anti-ACTH
in the very site in which it was to be expected if the serum
had contained such an antibody. The failure to reproduce the
staining with anti-ACTH after some months is puzzling but
could be explained if this serum had contained a hoimone-
specific antibody, for Sulman (1939) mid Chase (1945) have
shown that hormone-specific antibodies to gonadotrophins
detiorate on storage. Staining with the other antisexa also
occurred in the cytoplasm of cells in the anterior pituitary.
Tests to establish the nature of this staining merely confirmed
the results of the serological tests. Coons (1956) has
suggested that quantitative absorption of labelled aa tisera to
a pituitary hormone with extracts containing differing amounts
of the hormone might remove unwanted reactions and establish
the specificity of staining. It is doubtful if any of the
hormone preparations currently available are sufficiently pure
or contain a sufficiently high concentration of the biologically
active hormone to be effective in such a procedure.
The studies reported here were commenced in the belief,
founded on the previous publications quoted., that the fluor¬
escent antibody technique could be used to demonstrate the
precise cellular localisation of anterior pituitary hormones
in man. The results indicate some of the pitfalls encountered
aid serve to indicate the necessity for careful immunological
control of such studies. Clearly, much further work is
required before such normal tissue components as the anterior
pituitary hormones can be localised in their c£lls of origin.
SUMnRI
1. Antisei'a have been produced to adrenocorticotrophic hormone,
thyrotrophic hormone and growth hormone extracted from human
pituitaries and to gonadotrophin and thyrotroph!!? hormone
extracted from human urine.
2. Precipitin, absorption-precipitin and gel-diffusion tests
have been performed with these antisera.
3. No conclusive evidence was obtained of the presence of a
hormone-specific aatibody in any of the antisera.
4. Cross-reactions occurred indicating the presence of an antiger
common to those extracts prepared from the pituitary and
another/
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another antigen, or antigens, conmion to those extracts
prepared from urine.
Despite the absence of hormone-specific antibodies,
fluorescein-labelled samples of the arrfcisera gave staining
in the cytoplasm of cells in the anterior pituitarjjfcut




This work has exposed and emphasised some of the difficult¬
ies involved in the application of the fluorescent antibody
technique to the localisation of tissue components. They are
best discussed in relation to the various steps in the technique,
under the following headings:
a) preparation and purity of antigens,
b) analysis of immune sera,
c) effects of conjugation and
d) specificity of staining.
Certain additional problems associated with studies on auto¬
antibodies will then be discussed. This section of the thesis
ends with suggestions for further work arising from the
experiments already conducted.
PREPARATIOH AND PURITY OF aHTIGEKS
It is obviously ideally desirable to immunise animals with
a purified antigen of known chemical composition, preferably a
single substance. This is not often possible with tissue
components. It is easier if the antigen is insoluble and more
resistant to mild treatment than other components of the same
tissue than it is with a soluble antigen. Thus, previous work
on nephrotoxic nephritis, reviewed in Section II, pp. 5-7
led to the present work on basement membrane and reticulin,
using glomeruli rather than whole kidney as the antigen.
Isolation of glomerular basement membrane can be achieved by
physical — ultrasonic vibration (Xrakower and Greenspon, 1951)
— or chemical methods — dilute sodium hydroxide (Little and
Kramer, 1952) or tryptic digestion (hilazzo, 1957). Considerable
purification of complex solutions, such as plasma proteins can
be achieved by precipitation under suitable conditions (Cohn et
al., 1950), chromatography on ion-exchange resin columns (Sober
et al., 1956) or various forms of electrophoresis.
It must be noted, however, that methods for the extraction
surd purification of tissue components may be adequate for
purely chemical or biological work but unsatisfactory for
immunological studies. This as particularly so if the extraction
is not accompanied by histological examination to check the
source of the material, as in the case of tryptic digests of
kidney and glomeruli and the pituitary hormone preparations.
I
Furthermore, the extraction procedure may itself alter or
destroy the antigenicity of the material. The chondroitin
sulphate/
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sulphate preparation used here seems to have been altered in
such a way that the antigen present stimulated seia with
extensive cross-reactions but no specific antibody.
Denaturation is a constant problem in all procedures for the
isolation of plasma proteins. Thus, the plasma and urinary
mucoproteins isolated by Anderson and Maclagan (1955) have no
immunological activity (Grant, 195&).
ANALYSIS OF IMMUME SERA
The work with the anterior pituitary hormones emphasises
the need for careful and detailed preliminary serological tests
before labelling antisera. Marshall (1951), whose work with
hog ACTH stimulated the present work, did not report tests for
cross-reactions with other pituitary hormones. In the light
of the experiments now reported his conclusions must be acc^ted
with considerable reserve. In a later study, Marshall (1954b)
claimed to have localised three pancreatic enzymes within the
acinar cells. His antigens were crystalline preparations but
no preliminary serological tests were reported. The distrib¬
ution of the staining with the labelled antisera to two of these
enzymes was identical; staining with the third antiserum
occurred in these and other sites. Without proper preliminary
tests these observations are meaningless.
Antisera should be tested against all known antigens in
the preparations used for immunisation and against all possible
cross-reacting antigens or haptens. The value of the
Ouchterlony gel-diffusion method in such tests can be judged
from the work of Vaughan and Eabat (1954) who detected a
previously unidentified antibody in antisera to egg albumin by-
its use: the antigen responsible constituted less than 1 per cent
of the total protein in egg white. Even with an insoluble
antigen, such as basement membrane, preliminaiy serological
analysis is desirable. Two unwanted antibodies, namely to red
cells and to serum proteins were detected in the antisera to
kidney used here. More detailed analysis of such antisera is
probably necessary in view of the close association of endothelia
cells with glomerular basement membrane and with reticulin in
many tissues and of the probable importance of cellular antigens
in nephrotoxic nephritis. Complement-fixation tests or the
agglutination tests described by Milazzo should give the
necessary/
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necessary information about antibodies to the insoluble antigens.
This will be essential in studying the antigenic relationship of
different types of reticulin (see later}. In addition to the
procedures used in the present work with soluble antigens, the
immuno-electrophoretic method of Grabar and Williams (1955) is of
great value, particularly in the analysis of antisera to plasma
(Gell, 1957) or urinary (Grant, 1957) proteins. The analytical
properties of both gel-diffusion and immuno-electrophoresis can
be increased by the use of stains for the identification of
immune precipitates containing lipoproteins and glycoproteins
(Uriel and Grabar, 1956).*
When the various antibodies present in an immune serum
have been identified, it is frequently possible to absorb out
those which are not required. Thus, in the present work the
antibodies to red cells and serum proteins were removed from the
antikidney sera. Sera should not be used for labelling if the
antibodies present cannot be identified, as in the experiments
with the tryptic digests, or the unwanted or cross-reacting
antibodies cannot be removed, as in the experiments with chondr-
oitin sulphate and the pituitary hormones. lire extent to which
I
such absorptions may have to be carried is shown in the work of
Humphrey (1955), who demonstrated the immunological identity of
I
platelets and megakaryocytes. The specificity of the reaction
was apparent only after the antiserum to guinea-pig platelets
had been absorbed repeatedly with red cells, liver, kidney, spleen
and polymorphs. Henry and Van Dyke were able to reduce the
number of detectable antibodies in their anti-ICSH sera from six
to one by appropriate absorptions. They then demonstrated that
the absorbed serum inhibited the biological activity of the
hormone in question. This is an additional test which is
available in immunological studies on hormones and enzymes and
it is essential if the immunising preparation contains impurities
The work of Gitlin et al. (1953) on the distribution of homolog¬
ous plasma proteins in human tissues also indicated that useful
information can be obtained with antisera containing' unwanted
antibodies, provided that careful preliminary tests are performed
This was the first of many articles, from this and other groups
of workers on the localisation of plasma proteins with the
*Henry and Van Dyke (1958) have obtained useful information
about the antibodies produced by the injection of biologically
pure sheep interstitial cell stimulating hormone (ICSH) from
a combination of continuous paper electrophoresis and gel-
diffusion tests. No less than six antibodies were detected
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ATTACHMENT AND PROPERTIES OF THE FLUORESCEIN LABEL
Coons (1954), in a review of different types of label for
immuno-histochemical work, defined the ideal properties of such a
label. It should have no effect of its own on the antibody, the
reaction between antigen and antibody, or on the tissues; it
should remain firmly attached to the antibody molecule during and
after the reaction; it should be readily identifiable in the
tissue after the reaction has occurred and be distinguishable
from heterologous material. Fluorescein isocyanate fulfils
most oi these criteria but it has two drawbacks — the labelling
procedure causes a fall in the titre of the antibody, and some
fluorescein is adsorbed on to the protein rather than chemically
bound to it.
Both of these drawbacks were encountered by Coons himself,
who found that a specific reaction was demonstrable with some
antisera before conjugation yet no staining occurred with the
labelled sample, although the specific antigen was known to be
present in the tissue (Coons et al., 1942). Fabius (1955) has
shown that the titre of rabbit anti-human globulin serum may fall
from 1/2048 to 1/8 (serum dilution) on conjugation and that the
procedures accompanying the conjugation may cause a four- to
eight-fold fall in titre. Van Doorenmaalen (1957) found that the
titre of anti-frog lens serum fell from l/20,000 to l/l260 (antigfen
dilutionj on conjugation. This observation is particularly
significant, for it suggests an alteration in the avidity of the
antibody, which is much more serious than a fall in the serum
titre. The latter can be overcome by concentrating the conjugate
and both effects by using the indirect method (Weller and Coons,
1S>4). This is, in effect, a Coomb's test with a labelled
anti-globulin serum and it increases the sensitivity of the method
by about ten-fold (Coons, 1956). The tissue is treated with
unlabelled immune serum, or globulin, washed and then treated
with a labelled antiserum to the globulin of the species in which
the immune serum was prepared. This second serum, which can be
obtained in high titre and is thus less affected during labelling,
reacts with the precipitated immune globulin and can be visualised
in the usual way. The efficacy of this method was shown in some
experiments, not recorded her9, with rabbit anti-mouse kidney sera.
No reaction occurred when, the labelled immune serum was used, but,
when unlabelled anti-mouse kidney serum was followed by laoelled
goat/
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goat anti-rabbit-globulin serum, bright staining occurred.
Adsorbed fluorescein is removed by absorbing the labelled
immune serom with an unrelated tissue powder before use on the
tissue sections (Goons and Kaplan, 1950). prolonged storage of
the labelled antiserum is associated with dissociation of some
more fluorescein, so that further absorption becomes necessary.
There is considerable loss of fluid at eac,h absorption, with the
acetone-dried tissue powders used by Coons, so that, when labelled
antisera are prepared in small quantity, this may become a serious
nuisance. Kaplan (1958a) has recently described wet tissue
preparations which are suitable for absorption and should to some
extent overcome this difficulty. The fluorochrome lissamine
rhodamine RB200, introduced by Chadwick et al. (1958)> appears
to be less liable to this disadvantage than fluorescein and has
given satisfactory results with the anti-human-glomerulus serum.
SPECIFICITY OP STA3HIHS
Inhibition and absoiption tests, such as those described
on pp. 8-11 , should be sufficient to establish the specificity
of staining in most instances, provided adequate preliminary
tests have been performed with the unlabelled antisera. The
results in the present experiments with pituitary hormones
emphasise the necessity for establishing the specificity of
staining and show, also, that non-specific staining' may occur in
sites where specific staining is to be expected. There^s, at
present, no explanation for this troublesome artefact, which has
not been described by other workers but will have to be kept in
inind in future work. Occasionally, as in the work of Scott (1957)»
discussed in Section II, pp. 45-47 , it may be difficult to design
suitable absoiption tests but cross-inhioition tests with
antisera to closely related antigens can be used.
Still further precautions aie necessary in some studies,
particularly those of plasma proteins. Thus Dixon et al., (1958)
believe that much of the gamma globulin demonstrable in the
Lesions of experimental serum sickness accumulates non-specifically
as part of an inflammatory exudate. They suggest that this may
also be true of gamma globulin in human lesions, such as
amyloidosis and glomerulonephritis, and have shown that the use
of more than one labelled antiserum is necessary to obtain
unequivocal results (Vazquez and Dixon, 1957). Considerable care
us/
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is required in the use of the indirect method when the immune
serum has been injected in vivo (Mellors, Siegel and Pressman,
1955) rather than applied to tissue sections, as described above.
Normal (non-immune) serum proteins take up a characteristic
distribution in the tissues after intravenous administration in
an animal of a different species (Coons et al., 1953)-.
Presumably similar fractions of an immune serum similarly
injected will become distributed in the same way, in addition to
the specific distribution of the gamma globulin at sites where
it reacts with antigen. If the in vivo method is used it is
desirable to inject purified immune globulin, to use purified
gamma globulin for the production of the anti-globulin serum and
to establish that neither the immune globulin nor the anti¬
globulin serum contains unwanted antibodies. In the experiments
of Mellors, Siegel and Pressman and of Ortega and Mellors (1956)
the immune globulins injected were impure and it is not clearly
established that the anti-globulin sera used in these and other
studies (Mellors, Arias-Stella, Siegel and pressman, 1955) were
specific. This difficulty is less serious when the indirect
method is used entirely for in vitro work, as in the studies
reported here in human nephritis and anaphylactoid purpura, but
it is still preferable to use a pure anti-globulin serum, as was
done here (see Pigs. 44 and 45, p. 108)l.
STUDIES ON AUTO-ANTIBODIES
The present work has emphasised the need for careful
analysis of all reactions between human sera and tissue extracts
before they can be interpreted as immunologically significant.
The criticisms of previous work on nephritis (Section III, pp. 114-9)
apply also %o the extensive literature on other diseases, most
of which has been reviewed in a recent book (Miescher and
Vorlaender, 1957). It is essential that strict criteria, such
as those suggested by Witebsky et al. (1957), should be fulfilled
before the presence of auto-antibodies is claimed or auto-
immunisation implicated in the pathogenesis of a disease.
By these criteria, the only human diseases in which auto-antibodies
have been demonstrated are paroxysmal haemoglobinuria and some
other forms of acquired haemolytic anaemia, systemic lupus
srythematosus and Hashimoto's disease. The last-named is the




It is more convenient and. economical to use the indirect
fluorescent antibody method in studies on auto-antibodies, for
only one serum — anti-human-globulin — need be labelled,
whereas each individual human serum must be labelled if the
direct method is used. The use of the indirect method becomes
essential in circumstances where antibodies may be present in
low titre in the human sera (see above). This may explain the
inability of Hill and Cruiekshank (1950) to obtain staining of
nuclei, using labelled sera from cases of systemic lupus
erythematosus, wheras subsequent workers have been successfulA
with the indirect method (Holborow et al., 1957; Holman and
Kunkel, 1957; Eriou et al., 1958). Indeed, the direct method
may be unsuccessful even when antibodies can be demonstrated in
high titre by other methods, as in Hashimoto's disease. Thus,
both White (1958) and the author have been unable to get staining
with labelled samples of patients' sera which gave bright
staining in the indirect method with a labelled rabbit anti-
human-globulin serum. Non-specific staining may be a consider¬
able nuisance in such studies, particularly when an anti-globulin
serum is used on tissues of the species from which the globulin
was derived. However, Kaplan (1958a) has recently introduced
a manoeuvre which abolishes such non-specific staining when
labelled anti-rabbit-globulin is applied to rabbit tissues and
which should be applicable to labelled anti-human-globulin.
SUGGESTIONS FOR FURTHER WORK
There is considerable scope for further work with the
fluorescent antibody technique on some of the problems studied
already and on many other aspects of tissue antigens.
The suggestion from Scott's work (1957) that basement
membrane and reticulin may be antigenically distinct, is
supported by the results of Lillie (1952a)■ with the allochrome
procedure, and of Goodman et al. (1955)> in studies on the
antigenicity of various components of the canine kidney. As
indicated already, however, Scott's results are not clear-cut
and have not been confirmed. In further studies on the
antigenic relationship of basement membrane and reticulin,
attention should be paid also to the argyrophilic, trypsin-
sensitive and collagenase-resistant fibres described in the ovary
W
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by Robb-Smith (1952) and. in the ciliary region of the vitreous
body by Bembridge et al. (1953). Some of this work has been
started already and labelled antisera to human arterial reticulin
and to human synovium are available; these and anti-human-
glomerulus serum have been labelled with both fluorescein
isocyanate and lissamine rhodamine RB200 (Chadwick et al.)•
It is also proposed to use the anti-human-glomerulus serum to
study the basementAof the thyroid in some detail, particularly
in relation to Hashimoto's disease for, although it is accepted
that auto-antibodies to thyroglobulin are responsible for the
progressive thyroid damage, the pathogenesis of the initial stage
is unknown. There seem to be two possibilities — inability
to confine thyroglobulin within the acini or lack of a means of
destroying such thyroglobulin as does escape during the
physiological activity of the gland. The former could be the
result of maldevelopment of, or damage to, the basement membrane
of the acini. The 1mmuno-histochemical method appears to be
the most satisfactory way of tackling this problem, particularly
as it is superior to other methods for demonstrating the thyroid
basement membrane (see Section II, p. 51.-52).
The results of the experiments with collagen are sufficient¬
ly encouraging to suggest that further attempts should be made
to obtain an antibody, which can be used either by the direct or
by the indirect method. The choice of an antigen for these
experiments is more complicated now than it was when the earlier
experiments were conducted. Several forms of soluble collagen
have been described and there are differences of' opinion about
their relationship with mature collagen (see Tunbridge et al.,
1957). Bowes et al. (1957) have shown that the protein
composition of these soluble collagens differs slightly and
Pessler (1957) has obtained three different fractions from one
of the soluble collagens. It will thus be necessary to use
several, if not all, of these soluble collagens in future work.
In the meantime, rabbits are being immunised with preparations
from human granulation tissue, on the assumption that the fine
argyrophilic fibres found there are immature collagen, rather
than true reticulin. However, there is evidence that regenerat¬
ing connective tissue contains both types of' fibre (Robb-Smith,
1957; Windrum, 1958) and the capillaries in such tissue certainly
contain true reticulin, so that very careful analysis of the sera
will/
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will be necessary. Preliminary results of other experiments,
in which rabbits have been immunised, with mouse kidney or mouse
granulation tissue suggest that both antisera contain antibodies
to reticulin: no antibody to collagen has been demonstrated so
far. It is hoped to study pathological changes in human
reticulin and collagen if good antisera to the various fibres
can be prepared, but there is still much preliminary work to be
done before such studies can be contemplated.
The need for a means of distinguishing different sulphated
mucopolysaccharides has already been discussed (Section II, pp.
77-79). It is proposed to use some of the newer preparations
for immunisation and arrangements have been made to obtain some
pig chondroitin sulphate from Dr. Helen Muir. The attempts to
prepare an antibody to heparin should also be repeated. A
specific means for identifying hyaluronic acid in the tissues
is not at present available and would be of great value in
studies of connective tissue mucopolysaccharides. The rather
meagre information available suggests that hyaluronic acid may
not be antigenic. Thus Humphrey (1943), using potassium
hyaluronate from human umbilical cords, obtained no antibody to
the mucopolysaccharide moiety of hyaluronate-serum complexes.
Cruickshank (1950) immunised rabbits with human rheumatoid
synovial fluid. After the antisera had been absorbed with
normal human serum they failed to give any reaction with the
synovial fluid. These results may not be significant as the
hyaluronic acid of rheumatoid synovial fluid is known to be
degraded (Ropes et al., 1947). This may also be true of
extracted hyaluronic acid. Further attempts, using undegraded
synovial or umbilical cord mucin with adjuvants are indicated.
It is not proposed to pursue the pituitary hormone problem
further until much purer preparations are available. Biological
purity, as in the preparation of ICSH, used by Henry and Van
Dyke (see above) is not sufficient for immunological work, for
antigenicity may be due to impurities. An absorbed serum,
.
such as they obtained, with a single detectable antibody capable
of inhibiting the hormonal activity of a biologically pure
preparation, could be used for tissue localisation studies
provided it gave no cross-reaction with other purified hormones
extracted from the pituitary of the same species. There seems
little likelihood of obtaining sufficiently pure preparations
from/
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from the human pituitary for a long time.
There is obviously a need for further work on basement
membrane and cellular antigens in nephrotoxic nephritis.
However, this wholly experimental procedure can have no counter¬
part in human disease and it is not proposed to undertake any
such experiments. It has been suggested (Section III, p. 122)
that,if auto-immunisation plays any part in human nephritis,
the tonsil is the most likely source of both antigen and antibody.
However, the present results and the absence of a reproducible
experimental model, despite repeated attempts, do not make this
an attractive hypothesis. On the other hand, recent work on
anaphylaxis suggests more likely possibilities. Thus Hich
(1956) has shown that all the lesions of human glomerulonephritis
can be produced in rabbits by hypersensitivity to foreign
proteins and the importance of soluble antigen-antibody complexes
in anaphylactic shock and serum sickness have been demonstrated
by Germuth and McKinnon (1957) and Dixon et al. It may be that
streptococcal antigens and their antibodies occur in similar
complexes in human glomerulonephritis. Alternatively, Kaplan
(1956b) has shown that streptococcalM protein localises in the
glomerulus after injection into the mouse: the streptococcal
types used included those shown by epidemiological studies to be
nephritogenic (Eammelkamp, 1995-56). If this occurs in man,
then the reaction between this protein and its antibody might
result in nephritis. Attempts to demonstrate streptococcal
antigens in human kidneys have so far been unsuccessful (Dixon,
1956) but should not be abandoned.
In conclusion, it can be said that much useful information
should be obtained from the further application of the fluoresc-
ent antibody technique to the localisation; , provided that the
difficulties and weaknesses of the method are appreciated and
that careful control is maintained at all stages.
SUMMARY
Problems involved in the use of the fluorescent antibody
technique for the localisation of tissue components are
discussed.
The need for pure tissue extracts for the immunisation of




The dangers of inadequate preliminary analysis of immune
sera are indicated. The need for accurate identification of
all antibodies in an immune serum and methods for achieving this
are discussed. Appropriate absorptions can be used to get rid
of unwanted antibodies and examples axe given of results
obtained with such purified antisera.
Measures to counteract the fall in antibody titre caused
by conjugation with fluorescein and the presence of adsorbed,
rather than chemically conjugated, fluorescein are discussed,
including the indirect fluorescent antibody method.
Precautions necessary to establish the specificity of
staining with the direct and indirect methods are described.
Problems peculiar to studies on auto-antibodies are
discussed.




Rabbits were immunised with rat kidney, glomeruli or lung,
the resulting immune sera absorbed with rat erythrocytes and
serum and then conjugated with fluorescein isocyanate. The
labelled antisera reacted with basement membrane and reticulin
throughout -he animal and with sarcolemma and neurilemma. No
reaction occurred with collagen fibres, elastic fibres, cartilage
matrix or ground substance. Species cress-reactions occurred
only in che mouse. Similar results in human tissues were obtained
with fluorescein-labelled antisera to human glomeruli. Species
cross-reactions occurred in the rhesus monkey. The results are
discussed in relation to those of other workers with different
techniques on the relationship between basement membrane,
reticulin and collagen. There is histological, histochemical,
biochemical, biophysical and now immuno-histodremical evidence
that basement membrane and reticulin are closely related, if not
identical, whereas collagen is a separate entity.
Preliminary experiments have confirmed the antigenicity of
collagen from rat and human tendon. Localisation experiments
with fluorescein-labelled antisera were unsuccessful.
Attempts to produce a specific antibody to human chondr-
oitin sulphate were unsuccessful. The extracted material was
antigenic, but the antiseia gave extensive cross-reactions,
particularly with blood-group substances.
Tryptic digests of human kidney and glomeruli were antigenic
in rabbits. The antisera reacted with saline extracts of kidney
as well as with the tryptic digests. Localisation experiments
with fluorescein-labelled antisera were unsuccessful. The
results, together with those of other workers on nephrotoxic
jjiephritis, suggest that much of the material in tryptic digests
is derived from cells, rather than basement membrane, and that the
relative importance of these two kidney components in the
production of nephrotoxic antisera requires further investigation
Sera,and eluates from kidneys obtained at autopsy, from
cases of acute glomerulonephritis and controls have been examined
for antibodies against several extracts of normal human kidney by
precipitin, agglutination and complement fixation tests. The
direct and indirect fluorescent antibody techniques were used in
attempts to demonstrate tissue-localising antibodies in the sera
and eluates. Reactions occurred in complement fixation tests
vfith nephritic and control sera and eluates against tryptic digests
if/
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of kidney or glomeruli and were shown to he non-specific. No
evidence of specific antibodies to kidney components was
demonstrated. The results are discussed in relation to those
of other workers on experimental nephritis and on auto-antibodies
in human diseases. It is concluded that there is no evidence
that auto-immunisation to kidney is responsible for acute
glomerulonephritis in man.
A similar investigation in anaphylactoid purpura showed
no evidence of a specific antibody to kidney or blood vessel
components.
Immunisation of guinea-pigs and rabbits with poliomyelitis
vaccine revealed no evidence of monkey kidney antigens. A case
of nephritis, which commenced shortly after vaccination, is
reported; no evidence of auto-immunisation to kidney was found.
Rabbits were immunised with several human anterior
pituitaiy hormones. The resulting immune sera gave extensive
cross-reactions in precipitin and gel-diffusion tests.
Similar tests after absorption of the sera revealed no evidence
of hormone-specific Antibodies. Nevertheless, fluorescein-
labelled samples of the antisera reacted with the cytoplasm
of cells in the anterior pituitary. Previous work on hormone-
specific antibodies is critically discussed.
Proolems involved in the use of the fluorescent antibody
technique for the localisation of tissue components are
discussed in relation to the present work and that of other
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APPENDIX
TECHNICAL PROCEDURES, ANIMAL PROTOCOLS
AND SOURCE OP HUMAN MATERIATfi
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In order to avoid unnecessary repetition, the lay-out of
this Appendix will follow the series of procedures involved in
a complete localisation experiment.
PREPARATION OF AM'IGEHS FOR INJECTION
Kidney
Rats (l - ll) were anaesthetised with ether and the
abdominal aorta exposed by a ventral incision. The vessel was
tied off just above the bifurcation and a glass cannula inserted
and tied in position between the bifurcation and the renal
arteries. The inferior vena cava was incised and the animal
perfused with 0.5 - 1 1. of saline. Blood was collected from
the inferior vena cava during the first few moments of perfusion
and the serum separated for later use. Usually the kidneys
blanched quickly; those which did not were discarded.
The kidneys were emulsified by pressing through mono-
metal gauze, washed with saline, spun and the supernatant fluid
removed. The washing and spinning were repeated until the
supernatant fluid was free of haemoglobin. The final super¬
natant fluid was discarded and the residue made up in a 10 - 20
per cent suspension in saline. This, and other particulate
antigens, was ground in a Tenbroek tissue grinder (Griffith
tube) before injectionand il/l0G;,00G thiomersalate added as a
preservative.
Monkey kidneys were obtained from the Physiology Department,
University of Edinburgh. Human kidneys were obtained at
autopsy as shown on p. 204. The monkey and human kidneys were
homogenised with saline in a Waring Blender and then processed
as above to give a 10 - 20 per cent suspension.
Glomeruli
Rat glomeruli were prepared from perfused kidneys ( rats
17 - 20, 25 - 28). These were pressed with a glass rod through
mono-metal gauze (145 mesh/inch). The resulting paste was
collected and the glomeruli washed free of cellular debris with
saline and spun at 2000 r.p.m. for three minutes; this process
was repeated about six times. A 10 - 20 per cent suspension
was used for immunisation.
Human glomeruli were prepared from kidneys obtained at
autopsy as shown on p. 204 . The original method was to remove
the cortex from the medulla, homogenise in a Waring Blender,
press through mono-metal gauze (80 mesh/ inch) and proceed as
for the rat glomeruli. This method is tedious, particularly
when large quantities of glomeruli are required, as for the
preparation of tryptic digests, so various modifications were
tried. The final method used was to freeze the kidney solid
in the deep-freeze, separate cortex from medulla while partially
frozen and mash in a vegetable mill. The resulting paste was
suspended in a large volume of saline and allowed to stand for
about one minute, during which the larger particles sedimented.
The supernatant fluid was then decanted through mono-metal gauze
(80 mesh/inch) and washed repeatedly with chilled saline: the
glomeruli were allowed to settle either by standing at 4 C or by
slow centrifugation (2000 r.p.m.). When the supernatant fluid
was free of haemoglobin, the glomeruli were either packed by
spinningjfor storage in the deep-freeze,or processed for
injection/
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injection as above. Figs. 49 and 50 show a topical preparation.
Tryptic Digests of Kidney or Glomeruli
Digests 4, 6 and 7 were prepared from glomeruli and digest
8 from whole kidney by the method of Cole et al. (1951) and
deproteinised by Sevag's method. Digests 9» 11 and 12 were
prepared from whole kidney and digest 13 from glomeruli by the
following modification. Kidneys were obtained at autopsy as
shown on p. 204 and glomeruli isolated as described above.
100 gm. of kidney or glomeruli were minced and extracted
successively with 0.15 M NaCl, 1.5 M DaCl and 5 M KC1, using six
200 ml. portions of each solvent. The final residue was washed
with 0.15 M HaCl, suspended in 0.15 M NaCl to give 100 ml., the
pH taken to 6 with 0.1 M sodium borate and 1 gm. crystalline
trypsin added. The mixture was incubated for 3 hr. at 37°C,
adjusting the pH to 8 as required. The debris was spun off and
washed with 25 ml. 0.15 M NaCI, washings being added to the
original supernatant. The washing was repeated. The combined
supernatant and washings was chilled and 3 vols, ethanol added,
the mixture stood for 1 hr. and centrifuged at -10°C. The
precipitate was dissolved in 10 ml. water. The solution was
made 5 M KC1, stood overnight at 0°C, the precipitate spun off
and discarded, and the supernatant dialysed overnight against
running water.
Digests 4-11 were prepared by Dr. A.B. Roy, Department
of Biochemistry, University of Edinburgh; digests 12 and 13 by
the author.
Digest-Vaccine: Control Vaccine
Group-A, type-4£-haemolytic streptococcus (N.C.T.C.,
Catalogue No. 8326J was incubated overnight in Todd-Hewitt broth.
The culture was spun down and the organisms washed twice in
saline. They were then suspended in 1 ml. of the digest and
incubated for 1 hr. at 37°C. The tubes were spun and the
organisms washed twice in saline, resuspended in saline to give
an opacity of about 1 x 10 cocci/ml. and killed by heating at
56°C for 30 min. Fresh vaccine was prepared weekly.
The control vaccine was prepared in the same manner, using
1 ml. of saline in place of the tryptic digest.
Digests-Adjuvant Mixture
Digest 9 was mixed with adjuvants of the Freund type as
follows:
The digest and Crill 16 ( an emulsificant supplied by CrodaLtd.,
Smith, Goole, Yorks) were warmed to 45 - 50°C and emulsified in
a Tenbroek tissue grinder. The liquid paraffin, containing the
killed tubercle bacilli (supplied by Ministry of Agriculture,
Afeybridge), was warmed to the same temp, and added to the mixture,
which was further emulsified.
Rat Lung










12 ml., containing 0.42 ml.
digest/ml.
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Figure 49. Human glomeruli. Preparation used
for immunising raobits, isolation of tryptic
digests and preparation of trypsinised glomeruli.
Unfixed and unstained , wet preparation. (x80).
Figure 50. Human glomeruli. Preparation similar
to Fig. 49. A few fragments of proximal convoluted
tubule are present. Fixed and stained with
methylene blue. (x6o).
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Blender, washed free of haemoglobin, as for the rat kidney, made
up as a 10 - 20 per cent suspension and ground in a Tenbroek
tissue grinder. Some difficulty was experienced in obtaimng
a homogeneous emulsion and large particles of tissue had to be
discarded.
■
Rat and Human Serum Proteins
The proteins from whole serum were precipitated with 1 per
cent alum/100 mgm. protein by the method of Heidelberger and
;Kendall (1935), the precipitate washed in saline and made up in
a concentration of 5 or 10 mgm. protein/ml.
Human gamma globulin, from 10 ml. serum, was precipitated
with sodium sulphate and mixed with Freund's adjuvants as follows
gamma globulin 2.5 ml.
Crill 16 2.0 ml.
liquid paraffin 2.5 ml.
tubercle bacilli 5.0- mgm.
6.5 ml.
Chondroitin Sulphate and Chondroitin Sulphate-Vaccine
The bovine material, isolated by the alkali method of
Bray et al. (1944) and human material, isolated by the neutral
potassium chloride method of Eindinder and Schubert from costal
cartilages, were injected as 1 per cent solutions. Further
samples of human chondroitin sulphate were prepared from two
patients of known blood-group and; supplied to Prof. W.T.J.
Morgan. The sources of the costal cartilages are shown on p. 204
Vaccines were prepared as described above, using the same
strain of streptococcus and 1 per cent chondroitin sulphate in
place of the tryptic digest.
•
Acid-soluble Collagen
Three preparations were made using a total of 24 rats.
The tendons were extracted from the tail by cutting across each
segment (separating distally) and pulling out with fine forceps.
They were then finely cut with shaip scissors in a small amount
of normal saline and transferred to a beaker containing approx.
100.ml of normal saline where they were stood at 4 C overnight.
After washing in more saline, the pieces of tendon were
transferred to l/l0,000 acetic acid , in which they swelled and
became translucent. After 2-5 days the amount of acetic acid
was gradually increased to 2 1. In this they were stood for a
further indefinite period. Gentle mixing with a stirring
motor at a temp, as near 0 C as possible was then performed
and the material left to stand overnight. The gelatinous fluid
was then transferred to 250 ml. centrifuge containers and stood
at 4°C overnight. The following morning these containers were
spun at 4°G for 1 hr. On removal from the centrifuge the
material was found in two phases — a compact, gelatinous mass
(about 10 ml) at the bottom arid the remainder a supernatant
fluid. The fluid was aspirated off, the gelatinous material
pooled and freeze-dried. A 0.1 per cent solution in l/l0,000
acetic acid was used for injection and, later, for complement
fixation tests.
These preparations were made by Dr. D.L. Gardner,




ACTH, TSH (both preparations), postmenopausal gonadotrophin
and growth hormone (human and ox) were all used as alum-
precipitates. Each extract was dissolved in saline and 5 per
cent disodium hydrogen phosphate and 5 per cent potassium alum
were added in the ratio of 4:3. The mixture was shaken, spun
and the precipitate washed twice with saline and made up in
concentrations varying from 0.6 to 2.0 mgm./ml.
Human growth hormone was also used with Freund's adjuvants,
the mixture containing:
growth hormone 15.0 mgm,
saline 2.5 ml.
Grill 16 1.0 ml.
liquid paraffin 3.0 ml.
tubercle bacilli 6.0 mgm,
6.5 ml.





This proved difficult, particularly on the right side,
where the gland lies in the angle between the renal vein and the
inferior vena cava, with the capsule of the medial aspect
inseparable from the vena cava. Indeed, in some animals
adrenal cortical tissue was found histologically in the wall of
the vein. line rabbits were lost as a result of the operation
before a satisfactory technique was evolved.
The final technique was as follows. Left adrenalectomy
was performed, under nembutal supplemented by ether, through a
left paramedian incision. The gland was mobilised by cutting
through the parietal peritoneum and freeing it from the surround¬
ing fat. The vessels were tied with double ligatures and cut.
The gland was then excised in one piece. Little trouble was
experienced on this side, though in one rabbit which survived to
the end of the experiment (rabbit 122), the left kidney was
eventually found atrophic, fibrosed and extensively calcified,
though it appeared normal at the operation. Fourteen days later
the right adrenal was removed, under similar anaesthesia, through
a subcostal incision. Allport1s self-retaining retractor
proved very useful in allowing access to the deep tissues.
The adrenal was approached from the ventral aspect, if possible:
if not, the kidney was mobilised and retracted forward. Veins
in the retroperitoneal fat were often troublesome and had to be
ligated. The adrenal was mobilised from the ventro-lateral or
lateral aspect, the capsule incised, the gland removed piece-meal
and the stump carefully cauterised. It was possible, in this
fray to remove at least three-quarters of the gland. sulpnonamide'
penicillin powder was dusted into the deep part of the wounds
and into the muscles. The animals were given procaine penicillin
or streptomycin intramuscularly immediately after each operation
and morning and afternoon for the next two days. 2 mgm. DOCA
In oil (Organon) was given immediately after the second operation
and on the next day; thereafter a salt block was left in the cage
immunisation was begun 14 days after the second operation.
Thyroidectomy
Bilateral thyroidectomy was performed, under nembutal
supplemented/
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supplemented by ether. Occasional difficulty was experienced
in differentiating the gland from adjacent muscles. Bleeding
was often troublesome and was most easily controlled by
cauterisation. One rabbit died the day after operation from
asphyxia due to haemorrhage at the operation site. Another
died 58 days after operation: no cause of death was found at
autopsy. Sulphonamide-penicillin powder was dusted into the
operation site and procaine penicillin given immediately and on
the next day.
Castration
Male rabbits were used for immunisation with gonadotrophin,
so that castration was easily performed through small scrotal
incisions. No anaesthetic was used.
IMMUNISATION PROTOCOLS
Rabbits 42 - 44
Antigen: rat kidney suspension, intraperitoneally (ip.)
1st course: 1 ml. injected on 4 & 5/10/51, 11 & 12/lO/51>
18 & IS/10/51, 25 & 26/10/51.
Dose of kidney 1 gm.
Bled on l/ll/51.
2nd course: 1 ml. injected on 2 & 3/ll/51, 8 & 9/ll/51,
15 & 16/11/51, 22 & 23/11/51.
Dose of kidney 1 gm.
Bled on 30/ll/51 and exsanguinated on 3/12/51.
Rabbit 46
Antigen: rat lung suspension ip.
1st course: 1 ml. injected on 30 & 3l/l/52, 6 & 7/2/52,
13 & 14 /2/52, 19 & 20/2/52, 4 & 5/3/52.
Bled on 10/3/52 and 18/3/52. Dose of lung 2 gm.
2nd course: 1 ml. injected on 2 ci5/4/53> 7 & 8/4/52, 10/4/52,
17 & 18/4/52, 24/4/52. Dose of lung 1.6 gm.
Bled on 1/5/52.
Rabbit 47
Antigen: rat glomerulus suspension ip.
1st course: 1 ml. injected on 18 & 19/2/52, 26 & 27/2/52,
4 &5/3/52, 11 & 12/3/52. Dose of glomeruli 120 mgm.
Bled on 18/3/52.
2nd course: 1 ml. injected on 19 & 20/3/52, 25/3/52, 2/4/52,
8/4/52, 17/4/52.
Dose of glomeruli 75 mgm.
Exsanguinated on 1/5/52.
Rabbit 48
Antigen: human glomerulus suspension ip.
1st course: 2 ml. injected on 18 & 19/2/52, 26 & 27/2/52,
4 & 5/3/52, 11 & 12/3/52.
Dose of glomeruli 240 mgm.
2nd course: 1 ml.injected on 5/4/52, 7 & 8/4/52, 10/4/52, 17/4/52.





Antigen: rat serum protein (
alternate days.
1st course: dose 1











./ml.) intravenously (iv.) on
(19/2/52)
(21/3/52)
Bled on 1 & 2/4/52.
2nd course: 0.5 ml., containing 2.5 mgm
Exsanguinated on 22/4/52.
32.5 ml., containing 160 mgm. antigen
antigen.
Rabbit 52
Antigen: human glomerulus suspension ip.
1 course: 2 ml. injected on 30/5/52, 31/5/52
1 ml. injected on 6 & 7/6/52, 13 & 14/6/52, 21 &■23/6/52
Dose of glomeruli 1.25 gm.
Exsanguinated on 5/7/52.
Rabbit 51
Antigen: human serum protein (10 mgm./ml.) iv. on alternate days.
1 course: dose 1
doses 2 & 3
doses 4-7
dose 8
doses 9 & 10
doses 11-14











32.75 ml., containing 327.5 mgm. antigen
Rabbits 53 and 54
Antigen: human tendon sections implanted ip. under ether or
nembutal.
Dates and amounts implanted: 30/5/52 (0.5 gm.), 13/6/52 (0.5 gm.)
15/7/52 (0.5 gnu), 22/8/52 (lgm.)
Bled on 13/6/52, 15/7/52, 10/9/52.
Rabbits 66 and 67
Antigen: bovine chondroitin
days.

















4.0 ml., prepared from 4.0 ml.
chondrditin sulphate.
2nd course: dose 1 0.1 ml. (13/1/53)
dose 2 0.2 ml.
doses 3-5 0.5 ml.
doses 6 & 7 0.75 ml.
doses 8 & 9 1.0 ml.
doses 10 & 11 1.5 ml. (6/2/53)




Rabbits 72 and. 73
Antigen: human chondroitin sulphate - vaccine iv. on alternate
days.
1st course: doses 1-9 as for rabbits 66 & 67 (1st course)
doses 10-12 JUO ml. (4/12/52)
7.0 ml., prepared from 5.0 ml.
chondroitin sulphate.
Bled on 16/12/52.
2nd course: as for rabbits 66 & 67 (2nd course) (13/l/53 -
6/2/53).
Bled on 18/2/53.
Rabbits 74 and 75
These animals received the 2nd course given to rabbits 72 & 73.
Bled on 18/3/53
Rabbits 78 and 79
Antigen: human glomerulus digest (No. 4) iv. on alternate days.
1 course: dose 1 0.1 ml. (3/3/53)
dose 2 0.25 ml.
doses 3 & 4 0.5 ml.
dose 5 0.8 ml.
dose 6 0.9 ml. (14/3/53)
3.05 ml.
Bled on 26/3/53.
Rabbits 80 and 81
Antigen: Human glomerulus digest (no.4) - vaccine iv. on
alternate days.
1 course: dose 1 0.1 ml. (3/3/53)
dose 2 0.2 ml.
doses 3 & 4 0.5 ml.
doses 5 & 6 0.75 ml.
doses 7 & 8 1.0 ml.
dose 9 1.2 ml.
dose 10 1.75 ml (24/3/53)




Antigen: human glomerulus suspension ip.
1st course: 1 ml. injected on 15 & 16/4/53
1.5 ml. injected on 23 & 24/4/53, 30/4/53, l/5/53,
14 & 15/5/53
1 ml. injected on 21/5/53. Dose of glomeruli 3.0 gm.
Bled on 3 & 12/6/53-
2nd course: 1 ml. injected on 30/6/53
1.5 ml. injected on l/7?53, 8 & 9/7/53, 15/7/53
Dose of glomeruli 1.4 gm.
Exsanguinated on 10/8/53.
Rabbits 89 and 90
Antigen: human kidney suspension ip.
course: 1 ml. injected on 29/5/53, 4 & 6/6/53
1.5 ml. injected on 11 & 12/6/53
2 ml. injected on 20 & 22/6/53.
Dose of kidney 2 gm.
Bled on 7 & 9/7/53.
Rabbits/
194
Babbits 91, 93 and 95
Antigen: human glomerulus digest (No. 7)-vaccine iv. on alternate
days.
1 course: dose 1 0.1 ml. (22/7/53)
dose 2 0.2 ml.
doses 3-5 0.4 ml.
doses 6 & 7 0.75 ml.
dhses 8-10 1.0 ml.
dose 11 1^. ml. (9/8/53)
7.5 ml., prepared from 3.5 ml. digest.
Thus, each rabbit received vaccine made from 1.16 ml.
digest.
Bled on 21/8/53.
Rabbits 92, 94 and 96 (litter-mates of 91, 93 and 95)
Antigen: human glomerulus digest (No. 7) iv. on alternate days.
1 course; doses as for rabbits 91. 93 and 95
Dose of digest/rabbit 7.5 ml.
Bled on 21 & 23/b/53-
Rabbits 97 and 98
Antigen: vaccine only iv. on alternate days.
1 course: doses as for rabbits 91, 93 and 95
Rabbit 97 found dead on 17/8/53. Autopsy showed extensive
coccidiosis, abscesses in kidneys and pleural effusions.
Contaminants isolated from kidney, but no streptococci.
Rabbit 98 bled on 21/8/53.
•
Rabbits 99 - 101
Antigen: human glomerulus digest (No.7) iv. on alternate days.
1 course: dose 1 0.2 ml. (7/8753)
doses 2 & 3 0.5 ml. (11/8/53)
1.2 ml.
Bled on 21/&/53.
Rabbits 102 and 103
Antigen: human chondroitin sulphate (10 mgm./ml.) iv. on alternate
days.
1 course: dose 1 0.1 ml. (24/10/53)
dose 2 0.2 ml.
doses 3 - 5 0.5 ml.
doses 6 & 7 0.75 ml
doses 8 - 10 1.0 ml.




containing 75 mgm. chondroitin
sulphate.
Rabbit 122
Antigen: human ACTH, alma-precipitated
Operations: lefadrenalectomy on 11/5/54; right adrenalectomy on
25/5/54.
1st course: dose 1 0.6 mgm in 1 ml. saline (3/6/54).
doses 2-4 1.2 mgrn.in 2 ml. saline (5,21, 22/6/34).
dose 5 1.8 mgm.in 3 ml. saline (23/6/54)
6.0 mgm.




2nd course: dose 1 1.8 mgm. in 3 ml. saline (28/6/54)
dose 2 3.6 mgm. in 6 ml. saline (29/6/54)
5.4 mgm.
Routes of administration as above.
Exsanguinated on 6/7/54.
Rabbit 124
Antigen: human ACTH, alum-precjjitated.
Operations: left adrenalectomy on 24/5/54; right adrenalectomy
on 2/6/54.
1st course: as for rabbit 122 (1st course) (10/6/54 - 30/6/54)
Bled on 5/7/54.
2nd course: as for rabbit 122 (2nd course) (5 & 7/7/54)
Total dose of ACTH 11.4 mgm.
Bled on 14 & l6/>7/54.
Rabbits 127 and 12b
Antigen: human post-menopausal gonaaotrophin (HMJ-2QA)
Operations: castration on 25/5/54.
1st course: doses and routes of administration as for rabbit 122
(3/6/54 - 27/6/54).
Bled on 28/6/54.
2nd course: doses and routes of administration as for rabbit 122
(29 & 30/6/54).
Bled on 6/7/54.
3rd course: 1.8 mgm. in 3 ml.saline sc. on 26/9/54.
Bled on 15/9/54.
4th course: 1.8 mgm in 3 ml. saline sc. on 7/10/54.
Total dose of HMG-20A 15 mgm.
Exsanguinated on 26/10/54.
Rabbits 135 - 138
Antigen: human ACTH
Operations: left adrenalectomy on 19/10/54 (135 & 136) or
2l/l0/54 (137 & 138); right adrenalectomy on
2/11/54 (135 & 136) or 4/ll/54 (137 & 138).
1st course: 2.5 mgm. alum-pptd. ACTH in 5 ml. saline intramusc¬
ularly (im.) on 18 & 19/ll/54.
Bled on 22/12/54.
2nd course: 2.5 mgm. alum-pptd. ACTH in 5 ml. saline im. in two
sLifces on 23/12/54.
Bled on 13/l/55.
3rd course: 2.5 mgm. ACTH in saline im. on 1/2/55
1.0 mgm. ACTH in saline iv. on 2/2/55.
Total dose of ACTH 11 mgm.
Bled on 5 & 10/2/55.
The doses and routes of administration used for these and
later animals injected with hormone preparations, except for
rabbits G3 and G4, were recommended by Mr. H. Proom, Wellcome
Research Laboratories (1955).
Rabbit 141
Antigen: human thyrotropin, c hormone (urinary extract).
Operation: bilateral thyroidectomy on b/2/55
1st - 4th courses: 7.5 mgm. alum-pptd. TSH in 3.25 ml. saline
im. in two sites on 15/3/55, 14/4/55, 5/10/55,
7/11/55
Bled on 13/4/55, 9/5/55, 4/11/55, 30/11/55
5th course: 8 mgm. alum-pptd TSH in 4 ml. saline im. in two sites
on 7/12/55
2.5 mgm. TSH in 0.5 ml. saline
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iv. 011 2 & 4/2/96.
Total dose of TSH 43 mgm.
Bled on 7/2/56
Rabbits 142 and 143
Antigen: human chondroitin sulphate (lOmgm./ml.) iv. on alternate
days.
1 course: as for rabbits 102 and 103 (ll/2/55 - 4/3/55).
Dose of chondroitin sulphate 75 mgm.
Bled on 16/3/55.
Rabbits 144 and 145
Antigen: monkey kidney suspension ip.
1 course: 1 ml. injected on 1 & 2/3/55, 7 & 10/3/55, 15 & 16/3/55,
22 & 23/3/55.
Dose of kidney 1 gm.
Bled on 7/4/55.
Rabbits 146 and 147
Antigen: ox growth hormone.
1st course: 5 mgm. alum-pptd. hormone in 5 ml. saline im. in two
sites on 15/3/55
Bled on 13/4/55
2nd course: 4 mgm. alum-pptd. hormone in 4 ml. saline im. on
14/4/55
Bled on 7/5/55
3rd course (rabbit 147 only): 2.5 mgm. alum-pptd. hormone in
2.5 ml. saline im. on 16/5/55
1 mgm. hormone in saline iv. on
20/5/55
Total dose of hormone 12.5 mgm.
Rabbit 147 bled on 21/5/55.
Rabbits 150 - 153
Antigen: acid-soluble rat collagen (0.1 per cent in l/lO,GOO
acetic acid ip.
1st coyrse: 4 ml. injected on 20-23/7/55, 26-29/7/55, 2-5/fci/55,
9-12/8/55, 15-1S/&/55, 22-26/8/55,30/8-2/9/55,
7 & 8/9/55
Dose of collagen 128 mgm.
Bled on 5/10/55
2nd course: 4 ml. injected on 8/10/55, 11-14/10/55, 19 & 20/10/55
Dose of collagen 28 mgm.
Bled on 3/11/55
3rd course: 4 ml. injected on 15-18/11/55, 22-25/11/55
Dose of collagen 28 mgm.
4th course: 4 ml. injected on 29/2/56, 1-3/3/56, 7-10/3/56
Dose of collagen 28 mgm.
Bled on 26/3/56.
Rabbits 156 and 157
Antigen: poliovaccine culture fluid iv. on alternate days
(2/8/55)1 course: dose 1-2 0.5 ml.
doses 3-4 1.0ml.
doses 5-6 1.5 ml.
doses 7-8 2.0 ml.
doses 9-10 3.0 ml.
dose 11 4.0 ml.






Antigen: human thyrotrophic hormone (urinary extract)
Operation: bilateral thyroidectomy on 20/9/55
Injections and bleedings as for rabbit 141 from 5/10/55
Total dose of TSH 28 mgm.
Rabbits 160 - 164
Antigen: acid-soluble rat collagen (as for rabbits 150 - 155)
1st course: 4 ml. injected on 15 - 18/11/55, 22 - 25/ll/55,
29/11 - 2/12/55
2nd course: 4 ml. injected on 1 - 4/2/56, 6 - 9/2/56, 15 - 14/2/56,
20 - 22/2/56, 1 - 5/5/56, 7 - 11/5/56
Total dose of collagen 140mgm.
Bled on 26/3/56.
Rabbits 169 and 170
Antigen: human kidney digest (No. 9) - adjuvants
1st course: 1 ml. digest-adjuvant mixture sc. in four sites on
2/2/56, LO/2/56, lb/2/56
Total dose of digest 1.26 ml.
Bled on 26/5/56
2nd course: 1 ml. digest in saline sc. on 50/5/56
1 ml. digest in saline iv. on 31/3/56
Bled on 14/4/56.
Antigen: human glomerulus suspension ip.
1st course: 1 ml. injected on 12 - 15/2/57, 14 - 16/3/57,
20 - 23/3/57, 26 - 28/3/57, 2 - 5/4/57
Dose of glomeruli 3.4 gm.
Bled on 22/4/57 and 4/6/57
2nd course: 1 ml. injected on 18 - 20/7/57
Dose of glomeruli 60 mgm.
Bled on 5 & 9/8/57.
Rabbits 03 ana G4
Antigen: human growth hormone.
1st course: 1 ml. hormone-adjuvant mixture sc on 17/7/56,
24/7/56,2/8/56
Bled on 10/9/56
2nd course: 5 mgm. alum-pptd. hormone in 2.5 ml. saline im. in
two sites on n/9/56, 18/9/56
Total dose of hormone 16.9 mgm.
Bled on 2 & 4/10/56
Rabbit 07
Antigen: human thyrotropin.c hormone (pituitary extract)
Operation: subtotal thyroidectomy on 16/10/56
1st course: 7.5 mgm. alum-pptd. TSH in 3.25 ml. saline im. in
two sites on 30/10/56
6.5 mgm. alum^pptd. TSH in 3 ml. saline im. in two
sites on 17/12/56
Bled on 10/l/57
2nd course: 4 mgm. alum-pptd. TSH in 2 ml. saline im. on 14/l/57
Bled on 4/2/57
3rd course: 2.5 mgm. TSH in 1 ml. saline iv. on 11/2/57
Bled on 14/2/57.
Rabbit G23
Antigen: human gamma globulin
1st course: 1 ml. protein-adjuvant mixture sc. in two sites on
3/6/57





Bled on 22, 23 & 25/7/57
2nd course: 1 ml. gamma globulin in saline sc. on 26/7/57
0.1 ml. gamma globulin in saline ip. on 27/6/57
Bled on 30/7/57, 1, 2 & 7/b/57
The immune serum reacted with l/lO human serum to a titre
of l/64 and with l/lOOQ gamma globulin to a titre of l/4.
Figs. 44 and 45 (p. 108a) show the reactions of this serum in
Ouchterlony plates.
Guinea-pigs 14 - 19
Antigen: poliovaccine culture fluid (active anaphylaxis expt.)
Doses: 2.0 ml. fluid ip. on 18/7/55
10 ml. fluid iv. on 28/7/55
Result; no reaction.
Guinea-pigs 20 - 25
Antigen: poliovaccine culture fluid (passive cutaneous anaphylaxis
expt.)
Doses: 0.1 ml. serum from rabbits 156 and 157 intradermally in
separate sites on 14/ll/55
0.1 ml. culture fluid and 0.25 ml. trypan blue (l per cent)
iv. six hours 1& ex.
Result: Ho reaction.
AHALISIS OF IMMURE SERA AND ELUATES
Antigens
Certain preparations, iraddition to those used for
immunisation were used in these tests.
The supernatant fluid of the kidney suspensions (see p. 186)
was used in precipitin tests in the basement membrane experiments.
It was prepared by spinning the suspensions for 15 min. at 5000
r.p.m. and removing a portion of the clear fluid.
The saline extract of kidney used in Section III was
prepared by homogenising human kidney in the Waring Blender,
preparing a 2 per cent suspension and spinning for 1 hr. at
14,000 r.p.m. in a refrigerated centrifuge (Rothenberg et al.,
1956).
Rat, human or monkey red cells were prepared by collecting
blood in 3»8 per cent sodium citrate, washing the red cells
repeatedly in saline and making up a 5 per cent suspension in
saline.
The Lancefield extract was prepared from the streptococci
by following exactly the method of Mackie and McCartney (1945).
Trypsinised glomeruli were prepared by a modification of
the method of Milazzo (1957). Glomeruli were isolated as
described on p. 186. A thick suspension was incubated for 2 hrs.
at 37°C with 0.25 per cent Difco trypsin at pH 8 (borate buffer).
The preparation was then spun and washed twice in saline. The
sediment was resuspended in saline and homogenised at top speed
in a Melco homogeniser for 2 hrs. The vessel containing the
glomeruli was immersed in an ice bath during this procedure.
The preparation was then spun for 20 min. at 3000 r.p.m. and the
supernatant fluid separated and diluted with saline to match the
opacity of tube 1 in the Brown series.
Trypsinised arterial reticulin was prepared from superior
mesenteric/
199
mesenteric vessels, obtained at autopsy as shown on p. 204
The vessels were dissected free from the surrounding tissue
and the intima and media obtained by drawing the vessels under a
scalpel blade while exerting- firm downward pressure on the blade.
The intima and media were cut into small pieces and processed
as for the glomeruli.
Blood vessel extracts were also prepared from superior
mesenteric arteries, obtained as shown on p. 204. The vessels
were freed from the surrounding tissue and cut into small
pieces. The saline extract was prepared by incubating for 1 hr.
at 37 C and spinning for 1 hr. at 14,000 r.p.m. in a refrigerated
centrifuge. The supernatant fluid constituted the saline
extract. The residue was treated with 5 M K01 for 15 min. at
37 °C, spun and the supernatant fluid dialysed against running-
tap water overnight. The dialysed solution was spun for 1 hr.
at 14,000 r.p.m. and used undiluted. The remaining solid
material was incubated for 2-j hr. at 37°C with 500 mgm. Armour
trypsin at pH 8 (borate buffer). It was then heated for 30 min.
at 60°C, spun for 1 hr. at 14,000 r.p.m. and used undiluted.
For absorption of immune sera, wet organ preparations
were packed solid and used in the proportion of 1 part to 3 parts
of serum. Red cells were used in a concentration of 20 per
cent in the serum. Noimal serum was used in the proportion
of 1 part to 9 parts of immune serum. Solid, dry preparations
were used in the proportion of 1 mgm./ml. of immune serum.
Elution Methods
Glomeruli were isolated as described on p. 186 and stored
in the deep freeze until used. Each preparation was then
suspended in a suitable volume of saline and divided into six
equal portions, five ox which were used in the experiments and
the sixth kept in reserve. The quantities of glomeruli in the
portions varied from 0.1 to 0.5 gm. depending on the total
quantity available. The portions were stored in the deep
freeze until used.
Elution by heat (Korngold ana Pressman, 1953). The
glomeruli were spun down and resuspended in 5 ml. borate buffer
at pH 8. They were then stood at 60°0 for 15 min., the tubes
spun for 10 min. at 3000 r.p.m. and the supernatant fluids
separated.
Elution by saline and barium salts (Heidelberger and
Kendall, 1935).The glomeruli were spun down and resuspended
in 5 ml. 15 per cent saline. After incubation at 37°C for
1 hr., they were spun at 3000 r.p.m. for 10 min. and the
supernatant fluids separated. The process was repeated and
the supernatant fluids combined and dialysed for 48 hrs. against
saline.
The residues were then washed once in noimal saline, spun
down and resuspended in 5 ml. saline. Saturated Ba(oH)2 was
added to bring the pH to 11 (0.25 - 1 ml. was sufficient; and
the tubes stood for 1 hr. in an ice-bath. 1 ml. 10 per cent
BaCl2 was then added and the tubes replaced in the ice-bath
for 15 min. They were then neutralised with 20 per cent acetic
acid, spun for 10 min. at 3000 r.p.m., the supernatant fluids
separated and dialysed against saline until the dialysate
was fn&e' of Ba**.
The/
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The saline and barium salt eluates were then combined.
Elution by sodium hydroxide (Pressman and Sherman, 1951)•
The glomeruli were spun down and resuspended in 5 ml. saline.
N-NaOH was added to bring the pH to 11, the tubes shaken and
immediately spun for 10 min. at 3000 r.p.m. The supernatant
fluids were then separated, brought to pH 7 with phosphate
buffer, stood for 1 hr. at room temgrature, spun and the
precipitates discarded.
Elution by citric acid (Talmage et al., 1954). The
glomeruli were spun down and resuspended in 5 ml. saline.
0.2 M citric acid was added to bring the pH to 3.2 and the tubes
stood for 15 min. at room temperature. They were then spun
for 10 min. at 3000 r.p.m. and the supernatant fluids neutralised
with 0.5N-Na0H.
Control The glomeruli were spun down and resuspended in
5 ml. saline. They were incubated for 1 hr. at 37 C, spun for
10 min. at 3000 r.p.m. and the supernatant fluids separated.
Globulins from all the eluates were precipitated by adding
i vol. saturated (BH.^SO^ and standing- overnight at 4 C.
The tubes were then spun, the precipitates dissolved in 1 - 2 ml.
saline and dialysed for 48 hrs. against saline. The volumes
were adjusted to 2 ml. by addition of saline or dialysis against
15 per cent polyOinylpyrollidone in phosphate buffer.
Serological Methods
Precipitin tests were performed by the interfacial ring
and capillary tube methods. In the former, serum was pipetted
into the tube and an equal quantity of antigen layered on top.
The tests were read after incubation for 1 hr. at room temperature.
In the latter, serum was drawn up into the tube, followed by an
equal quantity of antigen, care being taken to avoid air bubbles.
The tube was stood upright in plasticine, incuoated for 2 hrs.
at 37C and then stood overnight at 4 C.
Agglutination tests with trypsinised glomeruli and
arterial reticulin were performed by the capillary tube method.
Agar-gel-diffusion tests were performed by a modification
of the Ouchterlony technique. After several unsatisfactory
trials with moulds, it was found that satisfactory results could
be obtained when the cups were cut by hand with cork borers.
A similar method has been used by Gell (1955). The medium
was 2 per cent Difco agar, containing 0.&5 per cent saline and
l/l0,000 thiomersalate: it was poured in a single lay er.
Duplicate plates were poured for each new antigen-antibody
system, one being incubated at 37 C, the other at room temperature.
A moistened filter paper was placed inside the cover of the
Petri dish during incubation and the cups refilled with saline
when required. The plates were photographed with transmitted
light from a Pointolite source.
Complement fixation tests were performed with 5 per cent
sheep cells , 2 MED of complement, a fixed concentration of
antigen and serial dilutions of serum. Rabbit sera were
incubated at 60 C, human at 56 C to inactivate complement.
Serum, antigen, complement and cell controls were used in all
tests. Preserved complement was used in the tests with animal
sera, fresh complement with human sera. The complement titre
was determined before each series of tests. The actual test
was/
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was performed in the following manner: 0.1 ml. quantities of
serum, antigen and complement, plus 0.2 ml. saline were incubated
for 30 min. at 37°C; 0.2ml. haemolytic system and 0.3 ml. saline
were added and the tubes incubated for a further 30 min. at 37°C.
COHJEFOmOH OF SERA
The labelled antisera used in the basement membrane experi¬
ments were prepared by Firs. Audrey Crossland, using fluorescein
amine donated by Dr. A.H. Coons. The anti-collagen, -chondroitin
sulphate, -tryptic digests, human and some anti-hormone sera
were labelled by Dr. Lynda Roy, using fluorescein prepared by
herself or Boots Pure Drug Co. The remaining anti-hormone sera,
anti-human globulin and later anti-human kidney and -glomerulus
sera were labelled by the author, using amine prepared by Boots.
An attempt was made by the author to synthesise the amine, but
was abandoned when arrangements were made to have the material
prepared on a large scale by Boots.
Preparation of Fluorescein Isocyanate
The procedure used by Coons and by Firs. Crossland and Dr.
Roy is to bubble phosgene gas through a solution of the amine in
acetone and to remove the gas at the end of the reaction by
evaporating the acetone. The author has used phosgene-in-toluene
(B.D.H.) instead of the gas and this makes the evaporation more
difficult. The procedure has been as follows.
The requisite quantity of fluorescein, weighed as the amine,
was dissolved in 3 - 4 ml. acetone, dried by storage over CaCl^.
This was added drop-wise to 6 - 8 ml. phosgene-in-toluene at
45°C. The mixture was stood for 30 min., with frequent shaking-,
by which time all the precipitate had redissolved and the soltuion
was a pale yellow-green. It was evaporated to dryness, using a
waterpump to draw dried air through the solution. The phosgene
was removed from the evaporsbe in a trap containing- 20 per cent
NaOH. The evaporation was accelerated by intermittently
creating a vacuum in the apparatus. The dried isocyanate was
immediately dissolved in the requisite quantity of acetone/dioxane
and added dropwise to the reaction mixture.
Conjugation
The reaction mixture contained serum (or globulin, prepared
by salting out with half-saturated ammonium sulphate), saline,
carbonate-bicarbonate buffer, acetone and dioxane in the proport¬
ions recommended by Coons and Kaplan (1950). It was cooled in
an ice-bath. After adding- the isocyanate, the flasks containing
the mixture were shaken for- 18 hours at 4^0 with a Microid flask
shaker. The mixture was then dialysed against saline at pH 7
(phosphate buffer) for 48 hrs. and the globulin precipitated
with half-saturated ammonium sulpiiate. The precipitate was
spun down, dissolved in phosphate-buffered saline and dialysed
against this solution until the dialysate was free from fluoresc¬
ein when examined in ultra-violet light.
Acetone-dried Tissue Powders
Human muscle, sheep muscle, sheep liver and guinea-pig
liver were used at various times in the preparation of these
powders. 50 - 100 gm. of tissue in an equal volume of saline was
homogenised/
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homogenised, in the Waring Blender and transferred to a large
Weaker. 4 vol. acetone were added, with constant stirring,
and the solid matter allowed to settle. The supernatant fluid
was removed by suction and the solid matter washed repeatedly
with saline, until free of haemoglobin. 1 vol. saline and
4 vols acetone were then added, the containers spun and the
supernatant fluid removed; the process was repeated once.
The tissue was then suspended in acetone and transferred to
a Buchner funnel, where it was dried for 2-4 hrs. The semi-
i>
drj> tissue was further dried overnight at 37 C. The dried
poAder was stored in a dessicator and used in the proportion of
100 mgm./ml. of labelled antisera.
PREPARATION OF TISSUES
Two methods were used — fresh-freezing1 and freeze-drying.
In the former, blocks of tissue not more than 2 mm. thick were
placed against the side of a test-tube, which was then plunged
into a drikold-alcohol mixture at -78"c for 10 sec.. The tube
was transferred to the deep-freeze for storage. Sections were
cut in a freezing cabinet of the type described by Coons and
Kaplan (constructed by the pressed Steel Co., Oxford), using
a Cambridge flat-cutting microtome, with the special "window"
attachment to the knife-blade described by Coons et al. (1951).
Sections were cut at 6*. and thawed on to slides by warming with
the tip of a finger. Gelatinised slides were used in the early
work but were not used later, except in the indirect method.
The sections were dried in a current of cold air. If not used
immediately, they were stored at 4°C for up to 48 hrs.: longer
storage leads to marked increase in auio-fluorescence. In
order to obtain satisfactory sections of fresh-frozen lung, a
block 2 mm. thick was fixed in absolute ethanol for 2 hrs.,
washed in phosphate buffer at pE 7 for lhr. and placed in 10
per cent gelatin overnight at 37 C. Next day the block was
hardened, trimmed and frozen in the usual way. Sections were
cut at 12a/ and washed in buffer for 5 min. before staining.
Freeze-drying was performed by an Altmann-Gersh method.
In early experiments the tissue was quenched in dichloro-
difluoromethane (Arcton 6, I.C.I.) cooled to -150°C to -160°C
in liquid air in a Dewar flask (Bell, 1S52). The dehydration
apparatus used was the freeze-drying unit No. 2 described by
Glick and Malmstrom (1952), adapted to fit directly on to an
Edwards Speedivac 2S/20 vacuum pump. The tube was surrounded
by a drikold-diethylene glycol mixture in a Dewar flask and the
water trap filled with liquid oxygen by day and drikold overnight.
Satisfactory dehydration was obtained after 48 hr^. The tissue
was transferred to paraffin wax in a vacuum embeding oven for
10 min. and then embedded. Blocks were stored in a dessicator.
Some trouble was experienced in flattening the sections on to
slides, but this was overcome by floating them on methanol
after cutting. Before treatment with labelled antisera, the
sections were dewaxed in xylol, fixed in methanol for 30 min.
at 37°C and washed in phosphate buffer at pH 7. In later
experiments quenching was performed in isopentane cooled to
-150"C to -160 "C in liquid nitrogen and dehydration and
embedding in an Edwards Tissue Drying Apparatus.
TREATMENT OF SECTIONS WITH LABELLED ANTISE.RA
The/
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The method of Coons and Kaplan was followed in early
experiments, namely, treatment for 2-3 hrs. at room temperature
followed by washing in two changes of phosphate buffer for
10 min. and mounting in reagent glycerol containing 10 per cent
of the same buffer. Later on, variations in the staining- time
were introduced, such as 30 min. at 37°C, overnight at 4°C
and, finally, 30 min. at room temperature, all of which gave
equally satisfactory results.
Inhibition tests were performed by using unlabelled sera
for t - 3 hrs., washing in buffer and treating- with labelled
sera for -2 - It hrs.
In the indirect method, unlabelled immune serum and
labelled anti-globulin serum were each used for 30 min. at room
temperature.
EXAMINATION 0? SECTIONS
Two sets of apparatus were used. First, a 250-watt,
high-pressure mercuiy vapour lamp (Mazda ME/0 26) with a Watson
monocular microscope. A Corning 3840 ultra-violet filter and
a 1 inch cuvette of 10 per cent copper sulphate were used to
filter the light and a quartz or glass collecting condenser
and a stainless steel reflecting mirror. Equally satisfactory
results were obtained with either type of condenser. A Wratten
2B filter and a glass cell containing- 2 per cent sodium nitrite
(Metcalf and Patton, 1944) were used in the eyepiece. Second,
a Leitz BX20 fluorescence microscope, using a carbon arc or a
150-watt compact source mercury vapour lamp (philips ME/0 103803)
Photographs were taken with the first apparatus on Ilford
Special Rapid Panchromatic plates, using exposure times of
20 - 60 min. and Ilford PanF 35 mm. film, using exposure times
of 25 sec. - 4 min. No photographs have yet been taken with
the second apparatus.
204






EM 1581 B F 8 multiple injuries kidney
EHA 1660 B m 66 emphysema: cardiac failure glomeruli
PM322/52 RIE M 65 multiple injuries
PM238/52 RIE F 32 bronchiectasis: cardiac failure kidney, liver,
F 50 rheumatic heart disease spleen, thyroid,
M 66 cup arthroplasty: pulm. embolism etc.
F 21 congenital heart disease
































RIE M 58 volvulus
RIE M 79 multiple injuries
M 34 Hodgkin's disease
F 34 multiple myeloma
M 47 ependymoma
F 46 subarachnoid haemorrhage
M 62 glioblastoma multiforme
f 36 carcinoma of colon
F 23 rheumatic heart disease
F 79 coronary thrombosis
I 65 cirrhosis of liver
F 49 hypertensive cardiac failure
M 66 bronchial carcinoma
M 12 congenital heart disease
M 69 coronary thrombosis
M 75 duodenal ulcer: haematemesis
M 49 bronchial carcinoma
M 69 bronchial carcinoma
F 45 rheumatic heart disease
F 60 hypertensive cardiac failure
F 69 malignant astrocytoma
M 63 bronchial carcinoma
MM 5299 eg F 54 bronchial carcinoma
PM 48/53 rie F 23 rheumatic heart disease
MM 5472 eg F 60 carcinoma of oesophagus
MM 5477 wg F 25 rheumatic heart disease
MM 5480 eg M 71 bronchial carcinoma






M 73 head injury (blood-group a)
M 13 congenital heart disease
F 43 congestive cardiac failure
M 58 rheumatic heart disease
M 49 duodenal ulcer: haematemesis








immunisation of rabbit 48
immunisation of rabbit 52
staining- with labelled
antisera
tendon from PM325 for immun¬
isation of rabbits 53 & 54
chondroitin sulphate for
immunisation of rabbits
72-7,5, 102, 103, 142, 143
tryptic digest No. 4
immunisation of rabbit a2
(1st course)
portions of whole kidney
for immunisation of
rabbits 89 & 90
portions of glomerular
suspension for immunisation
of rabbit 82 (2nd course)
remainder of glomeruli
for tryptic digest No. 7'
tryptic digest Ho. 8
tryptic digest No. 9
costal cartilages chondroitin sulphate
mesenteric arteries blood vessel extracts
costal cartilages chondroitin sulphate
mesenteric arteries blood vessel extracts
glomeruli and
kidney
glomeruli used for immun¬
isation of raboits 169 & 170
kidney for staining- with
nephritic sera
glomeruli trypsinised glomeruli
mesenteric arteries arterial reticulin









PM171/58 GRI M 49 myocardial infarction
P 39 rheumatic heart disease
M 40 cerebral infarction
M 61 carcinoma of bladder
M 48 multiple myeloma
M 64 congestive cardiac failure









normal control in elution
experiments
SOURCE OP SERA AND ELUATES








1 RIE/29 A.P. M 33
2 RIE/29 A.F. M 13
3 RIE/26 B.H. M 51
7 RIE/26 H.O. M 60
8 RIE/29 T.M. M 16
9 RIE/30 J.B. F 64
10 sce/i G.C. M 4
11 SCE/2 C.L. F 5
12 SCE/2 m.P. F 5
13 RIE/29 V.B. m 31
14 RIE/29 j.s. m 48
15 RIE/27 H.L. F 17
16 RIE/26 J.D. F 23
17 sce/i G.K. m ?
18 RIE/23 j.h. M 24
19 RIE/32 D.S. m 43
20 SCE7 R.I. m 5
21 eg/ M.B. F 29
23 sce/i F.W. F 10
24 RIE/26 R.h.' m 33
27 sce/i n.h. F 6
29 B/Q8 A.B. m 44
Zo sce/5 B.L. m 4
31 wg/cw A.C. m 5
32 RIE/26 A.T. m 57
35 l/5 R.F. m 13
36 RIE/30 C.B. F 23
38 SCE/5 J.H. F 6
39 SCE/5 S.C. M 4
40 sce/i A.B. F 6
41 SCE/5 B.S. M 4
42 SCE/5 I.McP. F 7
43 sce/i J.P. M 6
44 SCE/5 P.B. F 7
46 sce/i H.A. h 5
'

















































































































































49 sce/l g.s. M 2
50 sce/5 D.D. f 3
52 sce/5 c .g. f 7
53 sce/2 g.p. M 2
54 sce/i b.c. F 6
55 sce/i v.c. f 10
56 l/cw C.H. f 7
57 sce/3 t.s. M 3
59 i/cw a.d. M 9
60 sce/5 e.M. M 9
62 r/5 J.M. f 25
63 wg/c4 c.w. f 15
64 sce/2 f.s. f «?
65 sce/5 M.T. f 5
67 BID/9E J.D. M 6
68 h/2 a.¥. M 64
69 ngh/i a.c. M 45
70 rie/22 T.B. M 46
71 WG/a6 j.b. M 32
72 ng/i M.B. f 37
73 ng/i M.McG. f 30
74 ng/i G.M. f 14
75 grl/6 c.s. f 15
76 gel/9 w.k. M 33
77s scv C.McP. M 2
80 grl/37 W.McC. M 37
81 grl/38 e.k. f 23
82 grl/35 F.McM. M 23
86 GRl/37 l.MCA. M 38
87 GRl/37 R.T. M 58
88 grl/33 ff.o"!. f. 18
89 grl/33 P.McG. f 18
90 GRl/33 e.k. f 37
91 GRl/33 c.u. f 23
92 s/ r.p. M 39
93 grl/31 j.h. M 14
9,94 GRl/37 W.C. M 17
95 grl/27 e.r. f 65
















































































































































































97 GRl/36 M.S. F 23 20/1/58 24/1/58 acute appendicitis recovered
98 GRl/36 I.W. F 53 20/1/58 24/1/56 chronic cholecystitis II
99 GRl/36 H.M. F 39 20/1/58 24/1/58 acute appendicitis 11
100 GRl/39 M.G. F 46 18/1/58 25/1/58 chronic cholecystitis II
101 GRl/31 T.H. M 15 18/2/58 20/2/58 acute appendicitis fl
102 GRl/32 T.M. M 19 lb/2/58 20/2/56 II II 11
103 GRl/32 J.H. M 11 18/2/58 20/2/58 II II It
105 GRl/32 J.R. M 16 1/4/58 5/4/56 ft H fl
108 GRl/32 P.G. M 32 5/4/58 10/4/58 II It ti
109 GRl/32 J.C. M 24 5/4/58 10/4/58 It It tl
died: PM 9378"f110 SCG/ J.G. F 1 23/6/57 — acute glomerulonephritis
111 GRl/9 T.E. M 33 7/4/58 18/4/58* it ii died: PM 166/56*
114 GRl/36
S./4
L.O'N. F 39 14/4/58 19/4/58 acute appendicitis recovered
115 A.M. M 15 28/12/53 - acute glomerulonephritis died: PM 65/53 t
116 RIE/26 A.D. M 59 30/12/53 — amyloidosis (primary-) died: PM 36/54
117 DWP J.W. M 40 16/4/53 - amyloidosis (ankylosing died: PM EHA 1995*
GRl/53
spondylitis)
119 A.J. F 42 23/4/58 26/4/58 chronic cholecystitis recovered
Key to abbreviations, etc.
B Bangour Hospital
BID Belvidere Hospital, London Road, Glasgow
DWF Dunfermline and West Fife Hospital
SG Eastern General Hospital, Edinburgh
GRI Glasgow Royal Infirmary
H Hairmyres Hospital, East Kilbride
L Leith Hospital
KG Northern General Hospital, Edinburgh
R Roodlands Hospital, Haddington
RIE Edinburgh Royal Infirmary
S Strathclyde Infectious Diseases Hospital, Motherwell
SCE Rpyal Hospital for Sick Children, Edinburgh
SCG Royal Hospital for Sick Children, Glasgow
WG Western General Hob pital, Edinburgh
CW Childrens' Wing
< serum obtained on subsequent admission
t glomeruli kept for elution
% serum obtained at autopsy
| detailed abstract in thesis, Section III, p.138 - 139
